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Figure 1.1: DNA chemical structure by Madprime.[6]
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1.1 Introduction
The origin of life is one of the most fundamental and oldest questions which the 
scientific community has asked itself.[1] Answering this question could shed light on 
how life functions and how the world as it is now came into being. Additionally, if 
we know how life originated we might be able to reproduce it, opening the door 
towards artificial life. To allow one to investigate the origin of life, a general definition 
of “life” has to be developed. Even though it is often straightforward to recognize life, 
it is difficult to provide a satisfying set of boundary conditions from an experimental 
point of view. Therefore in the literature the question “what is life” has extensively 
been debated.[2] Most provided definitions contain at least the following three 
qualifications that a system has to fulfil to be alive; it has to be able to 1) transmit 
heritable information (replication); 2) capture energy and material resources, to stay 
at a far from equilibrium state (metabolism); 3) form a boundary between itself and 
the environment (compartmentalization).[3] An example that is often used to indicate 
the difficulty in defining life is the mule. Even though this animal would be considered 
alive by most people, since it cannot reproduce by most definitions of life it is not a 
living entity. 
One of the essential molecules known to life on earth today is Deoxyribo Nucleic 
Acid.[4] The molecular structure of DNA consists of a phosphate sugar backbone, the 
sugars are connected to one of four different nucleic acids (Figure 1.1). These nucleic 
acids, adenine, thymine, guanine and cytosine form hydrogen bonds with one of the 
other three, thereby binding two DNA strands together that then form a double helix. 
DNA is the carrier of our genetic information and carries the information necessary to 
form proteins. Proteins are made out of amino acids and fulfil many of the essential 
functions in cells. They are capable of catalyzing reactions, enable DNA replication 
and providing cells with the proper nutrients.[5] 
Due to the crucial role that DNA and proteins fulfil in life today, the formation of 
their building blocks, has received much attention. Initial experiments to investigate 
the origin of life focused on obtaining these building blocks, amino acids, sugars and 
nucleic acids under reaction conditions that could have been present on the early 
earth. These conditions are referred to as prebiotically viable conditions. One of the 
most famous initial experiments is the Urey-Miller experiment.[7] In this experiment a 
mixture of basic compounds, methane, water, ammonia and hydrogen are allowed to 
react in the presence of an electric discharge. Analysis of the resulting mixture showed 
that some of the essential building blocks such as small amino acids,[8] organic acids 
and urea are formed under these conditions.[7] 
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A reaction that provides sugars (or sugar fragments) starting from the simple 
building block formaldehyde is the formose reaction (Scheme 1.1). This reaction was 
first described by Butlerow in 1861.[9] The formose reaction has since then received 
much attention and many have contributed to increase the yield and direct the 
selectivity towards ribose. This has been achieved by using minerals to stabilize the 
desired sugars[10-12] and by investigating the mechanism.[13, 14] However, due to the 
extensive amounts of products that are formed and the low selectivity towards the 
desired sugars,[15] it is not generally accepted that the formose reaction played an 
important role in the origin of life.[16, 17]
Scheme 1.1: The formose reaction.[13]
The sugars formed via the formose reaction can subsequently react with a 
nucleobase to form nucleotides, the building blocks of DNA. However, so far no 
prebiotically viable reaction conditions have been found under which this coupling 
proceeds.[18] The group of Sutherland has played an important role in developing 
prebiotic viable routes to several biological building blocks such as nucleotides 
(Scheme 1.2). The extensive transformations shown in scheme 1.2 started from the 
concept, that nature does not necessarily follows the reactions pathways that are 
logical to chemists. Furthermore a general nucleotide precursor, that is intrinsically 
stable[19] but also contains reactive sites to form the four different nucleobases, 
could have played an important role. This concept was inspired by the formation of 
compound A from aldehyde B and aminoacetonitrile C (box in Figure 1.X).[20] It was 
hypothesized that A could be this general precursor in the formation of nucleobases. 
A proof of concept was given in 2009 by showing that intermediate A can react with 
aldehyde D leading to the formation of activated sugar intermediates E and F.[21] 
Especially important is that this reaction methodology is prebiotically viable and 
compatible with the phosphate chemistry providing pyrimidine ribonucleotides 
G and H.[21, 22] This was subsequently shown by performing the synthesis of these 
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compounds in one pot in aqueous media. [22] The exact product distribution of this 
one pot reaction can be adjusted by changing the pH of the solution.[22] Additionally 
this one pot reaction, also provided other interesting products. The approach of 
starting from several precursors that lead to multiple products in varying distributions 
adds complexity to the system. The presence of a large variety of compounds and 
reactions will be a better resemblance of the primitive earth and the origin of life than 
a single directed reaction in a flask. This complex way of approaching the origin of life 
falls in the field of “systems chemistry” and will be further discussed at the end of this 
section.[23]
Another problem in the synthesis of nucleotides is the incompatibility between 
the oxygenous sugar chemistry and the nitrogenous chemistry needed to make 
the nucleobases. The problem arises because oxygen-carbon and nitrogen-carbon 
compounds can often exchange in the presence of water. As a consequence it is 
highly unlikely that the nitrogen based nucleic acids and the oxygen based sugars 
are formed together. Therefore the synthesis of nucleotides would require strict 
separation of the sugar and nucleic acid synthesis.[18] This problem was solved by the 
use of nitrogen chemistry to make sugars. It was found that HCN, which was likely to 
be present on early earth,[24] could be used as carbon fragment to synthesize sugars in 
the presence of copper under prebiotically viable conditions (Scheme 1.2, formation 
of B from I and J via K).[25, 26] This discovery paves the way for a prebiotically viable one 







































































































































































































Scheme 1.2:  Prebiotic viable reaction pathways leading to several amino acids and nucleotides 
starting from simple general starting materials as developed by the group of 
Sutherland.[27]
Research dedicated to find prebiotic plausible routes to nucleotides and amino 
acids is often considered part of the “RNA world” hypothesis.[28-31] RNA, ribose nucleic 
acid, is a biological compound structurally related to DNA, it differs from DNA in that 
it has a different sugar in its backbone, ribose instead of deoxyribose. Additionally 
RNA uses uracil as nucleobase instead of thymine to bind to adenine. Another 
difference is that DNA forms a double helix whereas RNA, although it has the same 
complexation sites, usually occurs as a single strand species. The hypothesis of an RNA 
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world preceding our DNA world, is based on the idea that a simpler form of life existed 
prior to the DNA based life we know now.[32] The hypothesis of an RNA world, was 
inspired by the discovery that RNA catalyzes several biologically relevant reactions.[33-
35] Additionally, RNA is capable of forming the same base-pairs via hydrogen bonding, 
that are present in our DNA. Therefore it was hypothesized that before DNA became 
the main genetic code carrier, a world existed in which RNA played this role, the so 
called RNA-world.[31] 
Another hypothesis to the origin of life is the metabolism first hypothesis.[36-38] This 
hypothesis is based on the assumption that life started from continuous reaction 
cycles, that use fuel or food. This hypothesis is based on the fact that it is not likely that 
the reactions performed in the lab to obtain RNA building blocks, ever occurred so on 
the primitive earth.[36] Additionally, the mentioned reactions so far do not show a form 
of continuation. Additional problems with the RNA world, namely that many of these 
reactions are low yielding, do not show selectivity for the desired product and that the 
desired products are not stable points in to the direction of a metabolism first world. 
Literature is full of examples and arguments in favor of the RNA-world hypothesis or 
the Metabolism first hypothesis.[38-40] However so far no metabolic cycles that could 
have contributed to the origin of life have been published.[36]
More recently, Addy Pross has developed a more general hypothesis to the origin 
of life. Pross has defined a driving force for the origin of life and formulated processes 
that are at the basis of the formation of “chemical” life and the subsequent evolution 
of this initial “life”.[23, 41, 42] Many are familiar with biological evolution and terms like 
fitness and survival of the fittest. In an effort to develop a general terminology for both 
the well-known biological evolution described by Darwin[43] as well as the “chemical 
evolution” that preceded it, the term dynamic kinetic stability is introduced.[44, 45] This 
term is used to describe the stable state of life or other complex chemical organizations 
under kinetic control. Often stability, especially in chemistry, coincides with the lack 
of reactivity and thus this stability usually implies a static state.[46] However, the 
constant uptake of food or fuel and emission of waste is a dynamic process, but if 
this process is continuous it is stable in its own dynamic kinetic way. Hence the term 
dynamic kinetic stability (DKS). The drive towards a greater DKS, has the potential to 
both explain chemical evolution as well as biological evolution (Table 1.1).[41, 42, 47, 48] 
Additionally, it is hypothesized that the drive towards a greater DKS could be a basis 
for homochirality on earth (Section 1.1). In a homochiral environment recognition 
between replicators will be more selective and therefore more favorable than in an 
achiral or racemic situation. Therefore the drive towards a greater DKS corresponds 
with the kinetic selection for homochiral replicators.[41]
CHAPTER 116
Biological Term Underlying Chemical Term
Natural selection Kinetic selection
Fitness Dynamic Kinetic Stability
Survival of the fittest Drive toward greater dynamic kinetic stability
Table 1.1: Key Darwinian concepts and their underlying chemical equivalent.[44]
In this line of transcending thinking, a new field called systems chemistry focusses on 
understanding more complex chemical systems.[49, 50] Generally in organic chemistry a 
reaction mixture only contains reagents that are deemed necessary for the reaction to 
proceed. All reagents are added with a specific purpose leading to a desired product. 
This conventional approach to chemistry is a linear approach.[51] Another, nonlinear 
approach, is to start from various similar starting materials and let these starting 
materials react in a reversible manner. In such a system the reaction determines the 
most stable product. This type of chemistry is called Dynamic Combinatorial Chemistry 
(DCC), defined as combinatorial chemistry under thermodynamic control.[52] The 
compounds present in such a reaction form a dynamic combinatorial library (DCL). 
A DCL is unique in that the thermodynamic stability of its members determines the 
composition of the library.[52, 53] As a result DCL’s are complex and difficult to analyze. If 
such a chemical system changes from being under thermodynamic control to being 
under kinetic control different reaction conditions can result in different product 
distributions. The study of such complex systems, that start to resemble the complexity 
of metabolic cycles, are referred to as systems chemistry.[54] In systems chemistry, 
the library members demonstrate self-organization, often through non covalent 
interactions, providing the system with functionalities that it’s separate members do 
not contain. Since the development of life has been described in terms of dynamic 
kinetic stability,[42] the investigation and selection[55] of kinetically stable chemical 
systems i.e., systems chemistry, is extremely relevant in the search for the origin of life. 
This is especially if the chemistry occurs under prebiotically viable conditions, in water 
at not to extreme pH values and temperatures. Systems chemistry is relevant to both 
the RNA-world hypothesis as well as the metabolism first hypothesis. Once multiple 
chemical pathways can coexist and influence each other, as presented by Sutherland 
et al.,[27] they become so complex that they can be viewed as systems chemistry, which 
in turn can be viewed as a form of metabolism.[42, 56] 
When assuming that life originated from chemical cycles, a new challenge presents 
itself. Namely that these complex replicating chemical cycles need to be separated and 
protected from their environment, a process known as compartmentalization.[57-59] It is 
likely that a, bilayer membrane fulfilled this task. Membranes consist of amphiphiles, 
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molecules which contain a polar headgroup and one or two long apolar tail(s). Due to 
hydrophobic interactions the tails will pack together, to reduce contact with the polar 
surroundings. The polar head groups on the other hand will remain on the outside so 
they can interact with the polar surroundings (Figure 1.2). A membrane is capable of 
providing a boundary and therewith protect the initial chemical replicators from their 
environment.[60] Membranes, especially phospholipid based, are a logical choice to 
achieve compartmentalization, because they are semi-permeable so they are capable 
of letting small organic molecules (food) in and waste out and they are still present 
in life now.[61] The formation of bilayers and bilayer based vesicles is further discussed 





Figure 1.2: A single amphiphile (left) and a bilayer formed from multiple amphiphiles (right).
1.2 Origin of homochirality
Besides the synthesis of nucleotides and amino acids under prebiotically viable 
conditions, another major challenge in this synthetic field is the introduction of 
homochirality.[1, 62, 63] Molecules that contain a carbon center with four different 
substituents are chiral.[64] Like a left and right hand, chiral molecules have a mirror 
image that is not superimposable on the original molecule. Two chiral molecules that 
are each other’s mirror are enantiomers (Figure 1.3). A feature of chiral molecules 
is that they exhibit optical activity, meaning that these molecules are capable of 
turning polarized light clockwise (dextrorotatory), or anti-clockwise (levorotatory). 
Depending on in which direction a molecule is able to turn the light, the molecule 
is designated l or d. This characteristic was first discovered by Jean-Baptiste Biot in 
1815. Thirty three years later, Louis Pasteur found that some crystals of tartaric acid, 
would turn polarized light to the left and while the other crystals would turn it to 
the right.[65, 66] That carbon centers with four different substituents could be the cause 
of this phenomenon, due to the specific three-dimensional structure, was proposed 
by Jacobus Van’t Hoff and Jacques Le Bell.[67, 68] With the discovery of the underlying 
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molecular structure another designation, besides l and d, came in to use namely 
the Cahn-Ingold-Prelog rules. These rules use the molecular structure to determine 
whether a molecule has an R or S absolute configuration.[64] Except for proteinogenic 
amino acids, in this thesis the R or S designation will be used.
Figure 1.3:  Two mirror images, enantiomers, of an amino acid structure, on the left the  
S enantiomer and on the right the R enantiomer.
Most of the key molecules in biology discussed in the previous section, sugars, 
amino acids and nucleic acids are chiral molecules. Surprisingly, in nature only 
one enantiomer of the two possible enantiomers is present. Considering that it 
would be thermodynamically more favorable to have a racemic, fifty-fifty, mixture 
of enantiomers, the presence of only one preferred chirality in nature, so called 
homochirality, poses a big mystery.[1, 62, 63, 69-72] Because the building blocks, amino 
acids and sugars, are chiral, the structures that are based on these building blocks, 
such as proteins and DNA are therefore chiral. One of the functions of proteins is to 
catalyze chemical reactions and proteins with this function are called enzymes. Since 
enzymes are chiral proteins they are capable of maintaining the homochirality of 
life. If by accident a molecule of the wrong chirality would be present it will not be 
selected by the enzyme, because it does not fit the homochiral enzymes. One can 
imagine these enzymes to be left gloves that have a pocket that fits a left hand. If a 
right hand would be present it will not fit in to this left glove and would therefore not 
be selected to react. 
However, before life emerged no enzymes were present to select the right 
enantiomer. This makes the origin of homochirality comparable to the chicken and 
egg problem, which was first homochirality or life? Generally it is assumed that 
homochirality emerged before life,[73] it has even been mentioned as a prerequisite for 
life.[63] This is supported by the idea that homochiral enzymes could not have come in 
INTRODUCTION 19
to existence without at least some excess, a small bias, of one of the two enantiomers. 
Since both enantiomers are energetically exactly the same, a racemic mixture is the 
lowest energy state.[74] It could be possible that two chemical cycles of opposite 
chirality co-exist. Because these cycles are thermodynamically the same, there has 
to be an external driving force to tip the balance in one way or the other. Disruption 
of the, thermodynamically favored, racemic situation is called symmetry breaking, 
and would result in a small excess of one of the enantiomers over the other. This 
small excess subsequently needs to be amplified. This could occur if for instance the 
homochiral replicator has a greater dynamic kinetic stability (DKS) than the racemic 
replicator.[41]
Therefore two challenges exist in the origin of homochirality, namely the initial 
symmetry breaking and subsequent amplification of this initial enantiomeric excess 
both in a prebiotic environment.[75] Energy sources that could have played a role in the 
preference for one or the other enantiomer are well studied. It has been suggested 
that a weak electronic forces based on the principle of parity violation could be 
responsible for the symmetry breaking.[76, 77] However, it has often been suggested 
that this force is too small to be effective.[78] Another source of symmetry breaking 
is circular polarized light (CPL). CPL is capable of activating one enantiomer more 
than the other resulting in faster deterioration of this enantiomer, resulting in a small 
enantiomeric excess. In the universe large area’s exist where CPL is present.[79] This 
might be the origin of a small enantiomeric excesses in organic compounds present 
on meteorites.[80, 81] 
These described processes of initial symmetry breaking lead to a small 
enantiomeric excess in a specific area, this is however not likely to be sufficient to 
induce homochirality in all living systems. Therefore these small initial enantiomeric 
excesses need to be amplified. One of the earliest hypothesis is that asymmetric 
autocatalysis[82-85] (Scheme 1.3) played an important in the amplification of chirality. A 
reaction is classified as an autocatalytic reaction if the product acts as a catalyst for its 
own formation (Scheme 1.3). If the product of an autocatalytic reaction is chiral and a 
selective catalyst, meaning that (S)-product catalyzes the formation of (S)-product, an 
asymmetric autocatalytic reaction is obtained. 
Scheme 1.3: General scheme for (asymmetric) autocatalysis.
Many non-assymetric autocatalytic reactions are known, most of them are 
destruction reactions as for instance the acid catalyzed hydrolysis of an ester.[82, 86] As 
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a greater amount of ester gets hydrolyzed more free acid is present in the solution to 
catalyze the hydrolysis, providing an autocatalytic reaction.[86] Additionally there have 
been a wide range of autocatalytic reactions to amplify an initially small signal.[87] It is 
widely assumed that (asymmetric) autocatalytic reactions have played an important 
role in the origin of life. Autocatalysis provides a tool to obtain relevant compounds 
in sufficient amounts. Furthermore an autocatalytic reaction can be viewed as one 
of the most simple chemical metabolic cycles. Additionally as mentioned above, the 
asymmetric variant provides a tool to amplify not only the relevant compounds but 
also its chirality. 
In systems chemistry autocatalysis has been observed when the product is capable 
of binding, usually via hydrogen bonding, its own monomers thereby facilitating 
its own formation (Figure 1.4). One of the first such systems entailed the formation 
of a hexaeoxynucleotide from two trideoxynucleotides, was discovered by von 
Kiedrowski.[88, 89] Von Kiedrowski’s system was based on the oligonucleotide templating 
reported by Inoue and Orgel.[90] These initial replications where often inefficient due 
to a to strong binding between the product dimer, resulting in catalyst inhibition.[50] 
Exponential growth has been obtained by attaching the oligonucleotides to a solid 
surface and subsequently manually melting and annealing the strands, thereby 
avoiding product inhibition.[91] Ghadiri et al. have shown that also peptides exhibit 
this autocatalytic behavior.[92] There are many other autocatalytic replicators, that are 
well reviewed by Fletcher and Bissette.[82]
Figure 1.4:  General scheme for autocatalysis in replications. Recognition between product C and 
starting materials A and B facilitate the formation of product C.[82]
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The idea of asymmetric autocatalysis was first proposed by Frank in 
1953.[84] It subsequently took over four decades before Soai published the first proof 
of concept.[83] The reaction published by Soai is the addition reaction of diisopropyl 
zinc to a pyrimidine aldehyde (Scheme 1.4). Subsequently Soai and coworkers have 
shown that besides an initial enantiomeric excess also other chiral factors such as 
quartz crystals,[93] sodium chlorate salts,[94] CPL,[95, 96] helicenes[97] and even carbon,[98] 
oxygen[99] and hydrogen[100] isotopes are capable of directing the chirality of the 
Soai reaction.[101] Once a small enantiomeric excess has been established, as small as 
0.0005%, it has been shown that performing several cycles of the reaction using the 
product as catalyst for the subsequent cycle, ee’s of up to 99.5% can be achieved.[102] 
Being the perfect example of asymmetric autocatalysis, it is often mentioned that 
the Soai reaction, or an equivalent, played an important role in the origin of 
homochirality.[70, 103, 104] However, the use of diisopropyl zinc makes the Soai reaction 
highly reactive towards water and therefore not very likely to have occurred under 
prebiotic conditions. The strength of the Soai reaction, in synthetic chemistry, was 
demonstrated by Carreira who used the reaction to produce the drug Efivarenze. By 
applying an autocatalytic reaction, the reaction is not only catalyzed but because the 
catalyst is also the product the purification of the product becomes more facile.[105]
Scheme 1.4: The Soai reaction, the addition of diisopropyl zinc to pyrimidine aldehyde.
Initially it was thought that the Soai reaction shows such an high selectivity due to 
the formation of homochiral and heterochiral dimers. If only the homochiral dimers 
would be capable of catalyzing the reaction, all racemic product would be inactive, 
thereby explaining the perfect selectivity observed in the Soai reaction (Scheme 
1.X).[106, 107] Additionally it was shown via DFT calculations that both dimers have 
similar reactivity, therefore proving that de dimer formation does not sufficiently 
explain the selectivity.[108] Additional kinetic and H1 NMR experiments have shown 
the formation of a tetrameric transition structure.[109, 110] The formation of a tetrameric 
structure that consists of the homochiral dimer and the starting material explains 
the exceptional selectivity observed in the Soai reaction. The interactions are strong 
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enough to provide the selectivity, but on the other hand weak enough to prevent 
catalyst poisoning, the plagues many of the autocatalytic replicators. 
Besides (asymmetric) autocatalysis other processes exist through which 
homochirality can be obtained. Most of these processes depend on the different 
physical properties of the racemate versus the enantiopure compound.[111] For 
instance, the preferential sublimation of enantiomeric enriched serine results in 
enhancement of ee.[112, 113] It is also known that a racemate can possess a different 
solubility than the enantiopure compound.[114] If the difference is large enough 
in favor of the enantiopure compound a small enantiomeric excess present in the 
solution can be “extracted” in to the solution phase.[115] Blackmond et al. have found 
that most amino acids exhibit this behavior, resulting in ee’s up to 99 percent in the 
solution state.[116, 117] For a more detailed introduction the reader is referred to the 
introduction to chapter 5. 
The last of these physical processes is the emergence of homochirality through 
crystal grinding. At the basis of this process is the behavior of larger crystals to grow 
at the expense of smaller crystals, a process known as Ostwald ripening.[118] Therefore 
if these crystals are of a single chirality, in the solid phase it is theoretically possible 
to achieve homochirality. To achieve this, there has to be a pool of compound with 
this chirality so that the crystals can keep on growing. This can be achieved by 
racemizing the compound in the solution phase. Additionally the compound needs 
to crystalize as enantiopure crystals. Compounds that exhibit this behavior are known 
as conglomorates.[114] It has been shown that complete homochirality can be achieved 
in the solid phase of amino acid 1 (Figure 1.5).[119] This is achieved by taking a super 
saturated solution of a chiral compound and racemizing this compound by adding a 
base, like DBU to the solution. The process is significantly accelerated by grinding the 
crystals with glass beads. The grinding provides a larger crystal surface accelerating 
the crystallisation, solubilizing process.[120-122] For a more thorough explanation and 
list of examples the reader is referred to the introduction of chapter 4 and a mini 
review on this topic.[123]
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Figure 1.5: Atrition enhanced deracemisation of amino acid derivative 1.[123]
In addition to the search for the origin of homochirality, efforts have been directed 
to find out how, once homochirality was established in some key building blocks, it can 
be transferred to other essential building blocks.[69, 124-126] An example is the selective 
catalysis by the amino acid L-proline, in the glyceraldehyde reaction (Scheme 1.5).[69, 
124, 125, 127] 
Scheme 1.5:  Selective catalysis of L-proline in the formose reaction leading to an excess 
D-Glyceraldehyde over L-Glyceraldehyde.
1.3 Compartmentalization
As mentioned in the first section another important factor considered key to 
the origin of life is compartmentalization.[28, 57] Compartmentalization is a means 
to separate, compartmentalize, initial replicators or building blocks from their 
environment. The reason for this is that the initial replicators of life had to be protected 
from dilution and pollution from other compounds. Especially dilution comprises a 
great risk for the origin of life. To form larger molecules such as DNA or small proteins, 
a large concentration of building blocks needs to be established. In this process 
compartmentalization is essential.
CHAPTER 124
A way of achieving compartmentalization is by forming a membrane around the 
replicator, a so called liposome. Besides protection the membrane would provide a 
way to selectively allow different compounds to move in or out the compartment. 
Another advantage is that membranes can grow and divide, providing two shielded 
replicators. Such a replicating system could be viewed as the first cell.[59]
Liposomes consist of amphiphiles, which are molecules that contain a hydrophobic 
tail and a hydrophilic head group. These different parts repel each other, but are 
attracted to the same part of a neighbouring molecule. Due to these intramolecular 
hydrophobic-hydrophilic interactions amphiphiles self-assemble. Amphiphiles can 
self-assemble in to various phases (micellar, lamellar, cubic, hexagonal see Figure 1.6), 
which can in some cases exhibit multiple colloidal assemblies. Lamellar phases can for 
instance occur as long sheets or as liposomes. How amphiphiles assemble depends 
mainly on their size and shape (Figure 1.6). A good descriptor of the shape of the 
amphiphile that allows predictions of the type of aggregate formed is the packing 
parameter.[128] This parameter was introduced by Ischraelachvelli and is formulated as 
P = V / a0 x l. V is the volume of the hydrophobic chains, a0 is the cross sectional surface 
area of the hydrophilic headgroup and l is the length of the all trans hydrophobic tail. 
Therefore P effectively describes the ratio between the effective size of the hydrophilic 
headgroup of the amphiphile and the hydrophobic tail (Figure 1.7).[128] 
Additionally to compartmentalization, self-assembly can play an important role in 
the amplification of chirality.[129] For instance the use of self-assembled systems can 
result in large scale chiral structures, which can subsequently select for chirality.[130] 
It has been shown that sometimes only a small amount of enantiopure compound 
can result in large structures of one preferred chirality, thereby providing a large 
amplification of the chirality.[131] Sometimes the chirality of one molecule attached to 
a polymer can determine the helical chirality of the polymer.[132] 
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Figure 1.6:  Different ranges of the packing parameter and the molecular shape, phase and 
aggregated structures associated with that packing parameter. Adapted from ref[133]
Figure 1.7: Amphiphile and a schematic explanation of the parameters a0, V and l.
Much is known about amphiphiles and how they form larger aggregated structures. 
However special non-invasive techniques are required to visualize the aggregates 
that form. In this thesis mainly two techniques are used to visualize the aggregation 
behaviour. The first is transmission electron microscopy at low temperatures as 
discussed in the next section. This technique can directly visualize the formed 
aggregates. The second technique consists of the use of a solvatochromic probe, 
for instance Nile Red. Nile Red is a fluorescent probe of which the wavelength of the 
fluorescence varies with varying environments. This way Nile Red provides information 




In Electron Microscopy (EM) an electron beam is used to analyse a sample. Since the 
wavelength of an electron beam is much smaller than of a light beam, it is possible to 
resolve samples to a few nm.[134] With the introduction of Cryo Transmission Electron 
Microscopy (Cryo TEM) it became possible to obtain nm resolved images of soft 
matter in solution.[135, 136] The sample preparation for cryoTEM involves placing a small 
drop of the sample on a holey carbon film on a copper grid and removal of excess 
liquid by filter paper. In this way a thin film, usually up to 500 nm, spans the holes of 
the grid. The grid is subsequently dropped in liquid ethane at 100 K. This cools the 
sample so fast (10-2 ms)[137] that the water has no time to form crystals and the sample 
is frozen in its “native” liquid state (this process is called vitrification).[138] Due to the 
high resolution and the possibility to visualize aggregates in their native solution form 
without adding stains, cryo TEM is the technique of choice to visualize aggregates 
present in dilute aqueous dispersions. 
Besides these clear advantages CryoTEM also has several limitations. The size of 
the sample film (< 500 nm) limits the technique to smaller aggregates. For instance 
inverted phases, that usually aggregate in macroscopic structures, are difficult to 
observe via cryo TEM.[139] The electron beam used to visualize the sample can also 
damage the sample, resulting in the appearance of bubbles or the loss of sample 
mass.[140] Furthermore during cryo TEM imaging, images are taken of small areas of 
the total sample. Especially when the solution is not homogenous a single cryo TEM 
image could be unrepresentative for the bulk solution. Therefore it is difficult to make 
definite conclusions over the bulk sample solely based on Cryo TEM images. 
Besides practical limitations the correct interpretation of cryo-TEM images is 
crucial.[141] There are several artifacts that are commonly observed in cryo-TEM images 
like ice crystals. Even though there is only a few seconds between the preparation of 
the film and the vitrification, evaporation of the solvent does occur, yielding a varying 
concentration over the grid. The grid itself induces size sorting effects because the 
film that spans the holes is thicker at the edges than in the center of the hole.[138] Also 
the vitrification process itself can cause morphological changes of the aggregates. 
Thorough understanding of and experience with cryo-TEM are crucial to interpret the 
2D images of the 3D aggregates in the thin film. Making cryo-TEM a useful method 
that can give detailed information of the aggregation behavior of molecules in 
solution, it should be supported by other methods where possible. 
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1.3.2 The use of Nile Red as a fluorescent probe
Nile Red (Figure 1.8) is a fluorescent molecule that can be used as a solvatochromic 
probe.[142] When Nile Red is added to an aggregate, it will intercalate into the apolar 
part of these aggregates because of its apolar structure. However, when Nile Red is 
excited it will become charged and therefore much more polar. If Nile Red is excited 
whilst being in a polar environment, the energy needed to excite the molecule will 
be less and thus of a higher wavelength than when Nile Red is excited in an apolar 
environment.[143] As a result the wavelength of the emission maximum of Nile Red’s 
fluorescence (λmax) will be higher in polar solvents than in apolar solvents (see Figure 
1.9).[142] 
Figure 1.8: Nile Red
Figure 1.9:   Fluorescence spectra of the shift in λmax of Nile Red when changing from a less polar 
solvent (t-butanol) to water. Adapted from ref.[142]
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Not only the λmax of Nile Red shifts depending on the environment, this shift is 
accompanied by a shift in the excitation wavelength. The shift in excitation wavelength 
makes it possible to selectively excite the Nile Red population that is in a specific (a)
polar surrounding. Additionally it is possible to determine change in polarity over 
a pH or a temperature gradient, by measuring the emission maximum of the probe 
(λmax) while changing the pH or temperature. This way insight is gained in to how the 
packing changes as a result of a change in pH or temperature.
1.4 Thesis outline
In this thesis several topics regarding the origin of homochirality and in a broader 
sense, the origin of life are investigated. After this introduction chapter, chapter 
two will focus on the development of an asymmetric autocatalytic reaction using 
simple readily available starting materials, maleic anhydride and amines, under 
prebiotically viable conditions, in water at elevated temperatures. The third chapter 
continues in the search for an asymmetric autocatalytic reaction. As starting point 
a known autocatalytic reaction is taken, that furnishes a chiral β-amino ester. An 
enantiomerically enriched sample of the chiral β-amino ester is obtained and used to 
investigate the chiral induction in the reaction. 
Subsequently the research described in this thesis focusses on other methods 
to obtain and amplify chirality. In the fourth chapter the use of attrition enhanced 
deracemisation is investigated for a pyrolidinone that was found to be a conglomorate. 
The next chapter, chapter 5, focusses on the difference in solubility between a 
racemate and the corresponding enantiopure compound to obtain high ee’s of 
N-phospho amino acids in water. In chapter 6 the use of asymmetric copper catalysis 
to obtain β-substituted amides is described. 
The last two chapters of this thesis focus on the aggregation of N-phospho amino 
acid amphiphiles. In chapter 7 a β-alanine based amphiphile is synthesized and the 
vesicles formed are tested for their use in drug delivery. The last chapter investigates 
the tunable aggregation behavior of an N-phospho amino acid amphiphile based on 
carnosine. It shows that depending on the pH and the temperature vesicles, tubes or 
chiral twisted ribbons are formed. 
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Chapter introduction
In the following chapter we focus on developing an asymmetric autocatalytic reaction 
that forms biologically relevant compounds under prebiotically viable conditions. As 
a model we use the ring opening of maleic anhydride by an amine nucleophile. This 
reaction provides an α-amino acid core and proceeds in water at elevated temperatures. 
Furthermore the reaction starts from simple starting materials and forms multiple new 
functional groups in addition to a stereogenic centre. 
First, benzyl amine is explored as a nucleophile, as this reaction provides a protected 
asparagine core. Following the reaction steps and identification of the intermediates 
enabled us to propose a reaction mechanism for this transformation. Subsequently an 
ethyldiamine was probed as nucleophile. This reaction furnishes a cyclic β-amino acid 
that resembles one of the most successful organocatalysts, proline. Furthermore kinetic 
studies are performed that provide insight in to the course of the reaction. The lack of a 
sigmoidal kinetic profile allowed us to dismiss the possibility of a autocatalytic reaction. 
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2.1 Introduction
As mentioned in the introduction chapter chirality is an important aspect of life 
and homochiral molecules probably existed before life emerged.[1] The concept of 
amplifying chirality by means of asymmetric autocatalysis was introduced by Frank 
in 1953.[2] A proof of concept was delivered by Soai et al. more than 40 years later 
when they published what is now known as the Soai reaction (Scheme 2.1).[3, 4] The 
Soai reaction (Scheme 1.X) is a perfect asymmetric autocatalytic reaction. By seeding 
the reactionmixture with product that contains as little as 0.00005% ee, after several 
cycles, the product can be obtained in >99.5% ee (Scheme 2.1).[5] Even though this 
reaction is an unique example of chiral amplification, the Soai reaction is not very 
likely to have contributed to the origin of homochirality on earth. Several reasons 
underline this. One is that the reaction uses diisopropyl zinc, which reacts fiercly 
with water, and therefore rigorously dry conditions are needed for the reaction to 
proceed. As water was already present on the prebiotic earth, it is unlikely that the 
conditions needed for the Soai reaction to proceed could have been met on the early 
earth. Secondly the product of this reaction, 5-pirimidinealcohol 2, is not considered a 
biologically relevant compound, therefore the likelihood of this compound being one 
of the building blocks of life is very small. 
Scheme 2.1: The Soai reaction.
It would therefore be interesting to develop an asymmetric autocatalytic reaction 
which uses simple building blocks that could have been available on the prebiotic 
earth and which might have occurred under prebiotically viable conditions to form 
biologically relevant molecules like amino acids or sugars. This chapter focusses 
on our efforts towards developing asymmetric autocatalytic reactions that follow 
these criteria. The key point in developing an asymmetric autocatalytic reaction is to 
envision a product that has several functionalities capable of catalyzing the reaction 
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and directing the starting materials to induce selectivity in the product. In this way a 
stereoselective reaction and as a consequence an asymmetric autocatalysis might be 
obtained. 
2.1.1 The ring opening of Maleic anhydride by Amines
Acid-Base catalysis is one of the simplest forms of catalysis[6] and proceeds readily 
in aqueous media. We began our studies towards developing an asymmetric 
autocatalytic reaction based on a simple concept. This concept entailed a reaction 
in which an carboxylic acid would be formed, which would then act as a catalyst to 
accelerate its own formation. One process that is capable of doing this, is the addition 
of a nucleophile to maleic anhydride (Scheme 2.2). The nucleophilic addition opens 
the anhydride and yields a carboxylic acid. As the opening of maleic anhydrides can 
potentially be acid catalysed this would lead to an autocatalytic reaction (Scheme 
2.2).[7] 
Scheme 2.2: Opening of maleic anhydride.
This reaction is especially interesting if the nitrogen nucleophile used can also 
perform a 1,4-addition to the conjugated double bound also present in the molecule 
since this would lead to the formation of an amino acid core structure (Scheme 2.3). 
Already in 1886 this method was used to synthesize the amino acid asparagine from 
maleic anhydride by stirring it in liquid ammonia (Scheme 2.3).[8, 9] In this synthesis a 
new assymetric carbon centre is formed when the ammonia performs the conjugate 
addition to the double bond of maleic anhydride. This reaction is the perfect 
example of what we had in mind, it starts from two simple achiral starting materials 
readily available on the prebiotic earth[10-12] and yields a chiral, biologically relevant 
compound: the natural occurring α-amino acid, asparagine. 
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Scheme 2.3:  General scheme for the synthesis of an amino acid core structure from maleic 
anhydride.[8, 9]
McMillan and Albertson reported in 1948 the addition of benzyl amine to maleic 
anhydride to form (N2,N4)-dibenzylasparagine 1 (Scheme 2.4).[13] In the formation of 
asparagine, a conjugate addition to the double bond occurs in parallel to a 1,2-addition 
to one of the two carbonyl functionalities and the latter results in the opening of the 
maleic anhydride ring and the formation of a carboxylic acid functionality. 
Scheme 2.4: Synthesis of aspartic acid derivatives from maleic anhydride and benzylamine.[13]
2.2 Goal
With the aim of developing a novel asymmetric autocatalytic reaction we 
decided to investigate the addition of benzyl amine to maleic anhydride based on 
McMillan’s and Alberton’s results. The reasons for this are the following. First, the 
starting materials are simple compounds that could have been present on the early 
earth.[10] Furthermore the reaction conditions, water and heat are equally likely to have 
occurred in a prebiotic environment.[RW.ERROR - Unable to find reference:370] Therefore this reaction 
is prebiotically viable. Second, an α-amino acid core structure is formed, which is a 
biologically relevant motif. Third, the formed amino acid core is potentially capable 
of accelerating the reaction by activating the anhydride, either by protonation or by 
iminium formation (Scheme 2.5). Iminium formation is a well-known way of activating 
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carbonyl functionalities and this is the main activation mode of proline catalysis.[14, 
15] Fourth, the product contains several functionalities which are capable of forming 
hydrogen bonds, therefore the product could control the selectivity during the 
1,4-addition taking advantage of multiple non-covalent interactions between the 
chiral product and the achiral substrates. This might result in an enantioselective 
reaction provided the product has an excess of one enantiomer. 
Scheme 2.5:  Two possible pathways of activation of the maleic anhydride by the amino acid 
core; acid catalysis and iminium formation.
The idea to have a chiral acid or secondary amine playing a role in the activation and 
the enantioselective opening of cyclic anhydrides is supported by literature precedent.
[7] For instance the selective ring opening of disubstituted dihydrofurandiones by 
methanol is known to be catalysed by secondary and tertiary amines, acids, cinchona 
alkaloids, phosphoramidates, thioureas and sulphonamides (Scheme 2.6). 
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Scheme 2.6: Selective ring opening of maleic anhydride type structures.[7]
Therefore we choose the addition of benzyl amine over the addition of ammonia 
as our model reaction, as the large excess of ammonia present in the reaction would 
counteract any acid based catalytic activity the product might exhibit. Additionally, 
the use of benzylamine, as opposed to ammonia, furnishes a secondary amine instead 
of a primary amine. 
2.3 Results and discussion
2.3.1 Reaction of maleic anhydride with benzylamine
We began our study of this reaction by reproducing the results published by 
McMillan and Albertson. The addition was performed by stirring maleic anhydride (1 
equiv) and benzyl amine (2 equiv) overnight in water at reflux temperature (Scheme 
2.7). Recrystallization from ethanol yielded benzyl diprotected asparagine 1 as a 
white solid in 60% yield. 
Scheme 2.7: Synthesis of N2,N4-dibenzylasparagine
To better understand the reaction between maleic anhydride and benzylamine and 
to identify which intermediates could be present in the reaction mixture, with the aim 
of rendering this transformation enantioselective, we varied the reaction solvent and 
temperature (Table 2.1). As can be seen from entries 1 to 6, when the temperature is 
lowered no amino acid product 1 is formed is water as a solvent. Even after stirring 
the reaction mixture for 16 h at 75 °C no 1,4-addition is observed. Depending on 
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time and temperature a mixture between starting material and a compound which is 
identified to be α,β-unsaturated imine 5 can be observed. The α,β-unsaturated imine 
5 is a known literature compound[16, 17] and has been reported to form from maleic 
anhydride with the corresponding amine in the presence of an activating agent such 
as an acid or DCC.[18] In all entries where water is used as the solvent (entries 1 to 6) α,β-
unsaturated imine 5 is formed. This suggests that α,β-unsaturated imine 5 might be 
an intermediate in the formation of α-amino acid 1. The importance of the formation 
of α,β-unsaturated imine 5 is further discussed in section 2.3.1.1. 
In all initial experiments only one compound, namely α-amino acid 1, was observed 
when maleic anhydride and benzylamine were allowed to react in water at reflux 
temperature. However when, at a later point in time, it was tried to reproduce the 
reaction to obtain more of the α-amino acid 1, the reaction showed β-amino acid 2 
as a side product.
Entry Solvent T (°C) Time Ratio determined by 
1H NMR
1 H2O 100 16 h 1
2 H2O 100 3 h 1 : 4 : 5 = 2 : 1 : 1
3 H2O 75 16 h 5 : sm = 4 : 1
4 H2O 50 16 h 5 : sm = 3 :1 
5 H2O 50 21 h 5 : sm = 5 : 1
6 H2O r.t. 16 h. 5 : sm = 1 : 3
7 Dioxane 75 16 h 1 : 2 : 4 = 1 : 1 : 2
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8 Dioxane 50 16 h 1 : 2 : 4 : 5 = 1 : 1 : 
2 : 2
9 Dioxane 50 21 h 1 : 2 : 4 = 1 : 0.5 : 1
10 Dioxane r.t. 3 d 3
11 MeOH 65 16 h 5 (+ decomposition)
12 MeOH 50 16 h 4 : 5 = 2 : 9
13 MeOH r.t. 3 d 3 : sm = 4 : 1
14 Acetone r.t. 3 d 3 (+ decomposition)
15 DMSO r.t. 3 d 1 : 4 : 5 = 20 : 7 : 4
Table 2.1:  Outcomes of the reaction of maleic anhydride with benzylamine starting from  
1.02 mmol anhydride and 2.04 mmol amine in 5 mL solvent.
When the reaction is performed in dioxane (entries 7 to 10), the 1,4-addition occurs 
at lower temperatures. Usually amine 5 is not observed, except for entry 8, but the 
1,2-addition products amides 3 and 4, are observed in all cases. Furthermore besides 
the desired α-amino acid a very similar compound is observed which we hypothesized 
to be β-amino acid 2. When α-amino acid 1 and β-amino acid 2 are formed together 
they are usually present in a 1 to 1 ratio. We believe that this mixture of products 
could arise when a different mechanistic pathway is favoured. The possible reaction 
pathways that would lead to this mixture of amino acids is discussed in section 2.3.1.1. 
When the reaction is performed at room temperature (entry 10) only 1,2-addition 
product amide 3 is observed. Therefore we can conclude that this temperature is too 
low to obtain double bond isomerisation. Also the observation of amides 3 and 4 
in dioxane, but not in water, hint that the reaction between maleic anhydride and 
benzylamine favours a different reaction mechanism in water then in dioxane. 
Subsequently we performed the reaction in MeOH (entries 11 to 13). At r.t. only 
1,2-addition occurs and amide 3 is the only product (entry 13). At 50 °C the α,β-
unsaturated imine 5 is the major product. A minor product observed is amide 4, which 
is formed from amide 3 followed by double bond isomerisation. Surprisingly at room 
temperature and 50 °C no solvolysis is observed, either in methanol or in water. When 
the reaction is performed at reflux temperature in methanol α,β-unsaturated imine 5 
is observed together with various minor products. Since in the 1H NMR spectra several 
singlets are observed around 3 ppm, it is likely that at reflux temperature solvolysis 
does occur to a small extent. In acetone already at room temperature minor side 
products are observed alongside amide 3. 
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It can be concluded from the results in table 2.1 that at room temperature only 
the 1,2-addition or imine formation occurs, depending on whether the reaction 
is performed in an aprotic or protic solvent. It seems that the imine formation is 
favoured in polar protic solvents, such as water and to a lesser extent in methanol at 
temperatures below 100 °C. When the reaction temperature is 50 °C or higher double 
bond isomerisation starts to occur and instead of Z-α,β-unsaturated amide 3 the 
thermodynamically favourable E-α,β-unsaturated amide 4 is observed. The reactions 
to form either α,β-unsaturated imine 5 or Z-α,β-unsaturated amide 3 are highly 
exothermic since an elevation of the temperature of the reaction vials is observed 
following the addition of the reagents. 
2.3.1.1  Possible mechanistic pathways towards the formation of α-amino 
acid 1 and β-amino acid 2.
Scheme 2.8: Possible pathways to α-amino acid 1 and its regioisomer β-amino acid 2.
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The results from Table 1 served as the basis to differentiate between the two 
different mechanistic pathways that we proposed (Scheme 2.8). Pathway A starts 
with an 1,2-addition to form Z-α,β-unsaturated amide 3. At elevated temperatures 
we know E-α,β-unsaturated amide 4 is formed as the main product via double bond 
isomerisation. It is unlikely that 1,4-addition would occur on unsaturated amides 3 or 
4 because α,β-unsaturated amides and acids are difficult substrates for 1,4-additions 
and often require stronger activation conditions than present here.[19, 20] From entries 
2 versus 1 and 9 versus 8, it seems that compound 4 is consumed. Since 1,4-addition is 
not likely on unsaturated amides 3 or 4 we hypothesise the formation of imide 7. Once 
imide 7 is formed it can undergo 1,4-addition leading to imide 8. The subsequent 
ring opening by water would then determine which of the two regioisomers, 1 or 2, 
is formed. Of the intermediates present in pathway A only α,β-unsaturated amides 
3 and 4 are observed. Since the ring closing of 3 to 7 is not obvious and neither 
compounds 7 or 8 are observed there is no strong evidence that pathway A is a viable 
mechanistic pathway for this reaction. 
In Pathway B the first step is imine formation leading to α, β-unsaturated imine 
5. α,β-Unsaturated imine 5 can undergo 1,4-additon in the α- or β-position and this 
1,4-addition will determine which regioisomer of the product is formed. Attack on the 
β position corresponds to a 1,4-addition to an α,β-unsaturated imine, whereas attack 
on the α position corresponds to an attack on an α,β-unsaturated lactone. If the 
1,4-addition occurs on the α carbon imine 9 is formed which would lead to β-amino 
acid 2. A 1,4-addition on the β carbon would lead to imine 10 which would after ring 
opening by water result in α-amino acid 1. 
In water we observe the formation of α,β-unsaturated imine 5 in all entries. Water 
being a protic solvent it most likely activates the imine more strongly than the lactone 
thereby steering the reaction towards 1,4-addition at the β carbon, which results in 
the formation of α-amino acid 1 via imine 10. Since α-amino acid 1 is indeed the 
major product in water we propose that under these conditions pathway B is favoured 
over pathway A. 
When the reaction is performed in dioxane mainly α,β-unsaturated amides 3 and 4 
are formed. Therefore it would be tempting to assume the reaction follows pathway 
A in aprotic solvents. Especially because here the regio-discrimination is determined 
in the final ring opening by a water molecule. Since water is a small molecule there 
will most likely not be any significant steric effect and therefore no regio-selectivity. 
A 1 to 1 mixture of both regio-isomers is indeed observed when the reaction is 
performed in dioxane. However, imide 7 is not observed, which argues against what 
we would expected if pathway A is favoured, since imide 7 is assumed to be a stable 
intermediate in the reaction. 
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In pathway B the regioselectivity arises from the 1,4-addition. It could very well be 
that when the reaction is performed in an aprotic solvent the reactivity of the imine 
and lactone become similar. This would lead to approximately equal attack on the α 
and β carbon of α,β-unsaturated imine 5, yielding both regioisomers of the product in 
a roughly 1 to 1 ratio. Because imide 7 is not observed but α,β-unsaturated imine 5 is 
observed in dioxane and the lack of regioselectivity could be explained by the change 
in solvent, we believe that also in dioxane pathway B is favoured over pathway A. 
In none of the reactions performed are cyclic imines 8, 9 or 10 observed. This can 
potentially be explained by the fact that as the 1,4-addition has already occurred, 
these imines no longer possess an extended conjugated system making them more 
prone to ring opening than α,β-unsaturated imine 5. 
In water where the α,β-unsaturated imine 5 is suggested to be activated by the 
solvent, the 1,4-addition occurs at higher temperatures than in dioxane, where no 
such activation is possible. We hypothesize that when water is used as a solvent 
the benzylamine is less nucleophilic due to excessive hydrogen bonding with the 
solvent.[6, 21] Therefore the reaction needs more heating to proceed in water than in 
dioxane. The proposed reduction of nucleophilic character of the benzylamine and 
potential activation of the imine also helps to explain the remarkable regioselectivity 
that is observed when the reaction is performed in water. 
2.3.1.2  Attempted determination of the precise structure of regioisomers 
1 and 2 
Although compound 1 and its regioisomer 2 are known literature compounds,[13, 
22] both articles that describe their synthesis predate the NMR era. Therefore no 
comparison can be made to determine which regioisomer is which. To prove beyond 
a doubt that we formed α-amino acid 1 we turned to Heteronuclear Multiple Bond 
Coherence NMR (HMBC) measurements. To reduce signals artefacts a gradient version 
of the HMBC was used (gHMBC). With this technique it is possible to visualize long 
range heteronuclear bond couplings. The idea was to see whether the CH2 or CH 
protons of position y would interacted with carbon z, or vice versa to see an interaction 
between the benzylic protons of position z with the carbon of position y (Figure 2.1). 
This would allow us to differentiate between the two regioisomers 1 and 2. 
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Figure 2.1:  Expected long range couplings to be seen with GHMBC for α-amino acid 1 and 
β-amino acid 2.
Regardless of the amounts of scans no crosspeaks between the benzylic protons 
connected to the amide and the “core” carbons were observed. In both cases we 
hoped to visualize a 1H-13C correlation through 4 bonds, including two carbon-
nitrogen bonds. The intensity of the correlation signal decreases with the number of 
bonds through which it has to be measured. Also when carbon-heteroatom bonds 
are present the signal intensity decreases due to the fact that these bonds are more 
strongly polarized. It is therefore not unreasonable that in this case the correlation is 
too weak to be observed. This technique could therefore not be used to prove beyond 
a doubt that we obtained pure α-amino acid 1 as product and not its regioisomer 
β-amino acid 2. Another way to prove which regioisomer was formed would have 
been to obtain an X-ray structure of the compound. However we were not able to 
obtain crystals of an high enough quality to obtain such a structure. 
Since full characterisation of compound 1 was obtained and it was synthesized 
following a literature protocol we believe that regioisomer 1 was obtained. However 
to ascertain that the assignment is indeed correct, one could try to crystalize the 
corresponding salts of the acids.
2.3.2 Reaction between maleic anhydride and ethylenediamine
Due to uncertainty of which regioisomer was formed and problems with the 
reproducibility of the initial reaction of maleic anhydride with benzylamine in water 
at reflux, it was decided to change to a slightly different system. We kept the maleic 
anhydride but shifted to a diamine so that we would form a cyclic β-amino acid. We 
envisioned that if, instead of using two equivalents of a single amine, a diamine was 
used to open the maleic anhydride a cyclic amino acid could be obtained (Scheme 
2.9). This would also bring new insight on the possible mechanism of the reaction as 
it was expected that the second reaction step, which is now intramolecular, would 
occur more easily. 
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Scheme 2.9: Formation of cyclic β-amino acid 9.
Furthermore cyclic β-amino acid 11 contains multiple functionalities, that are not 
present in the starting materials, that could play an important role in the selective 
catalysis of the reaction. As in the reaction with benzylamine a carboxylic acid is formed 
that could activate the starting materials via protonation (Figure 2.2). Additional to the 
ring structure an amide functionality is present, which is an excellent hydrogen bond 
forming motif. For instance, the secondary structure of proteins, is largely determined 
by the hydrogen bonding between the amides that comprise the protein backbone.[23] 
Moreover, cyclic β-amino acid 11, contains a secondary amide that resides next to 
the chiral carbon atom. Two of these features, namely the carboxylic acid and the 
chiral secondary amide, are essential parts of proline, which is one of the best known 
and most simple organocatalysts.[24, 25] Another similarity between β-amino acid 11 
and proline is that both their cores consist of a cyclic structure. Since cyclic structures 
are more constrained, it is more likely to form a more rigid transition state between 
substrate and catalyst which, in turn, could lead to a higher enantioselectivity. 
Figure 2.2:  Functionalities of cyclic β-amino acid 11 and (L)-proline, one of the best known 
enantioselective organocatalysts. 
We attempted to obtain compound 11 following the previous protocol, namely 
stirring maleic anhydride and 1 equivalent of ethylene diamine overnight in water at 
reflux. This produced a complicated mixture of compounds. In an attempt to identify 
if compound 11 was indeed formed it was synthesized via a literature procedure 
(Scheme 2.10).[26] This synthesis starts from dimethyl maleate and ethylene diamine, 
which are stirred overnight at 50 °C in isopropanol yielding ester 12 in quantitative 
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yield. Subsequent hydrolysis of the ester by sodium hydroxide gives product 11 in 
98% yield. Comparing the 1H NMR spectra of compound 11 to the spectra obtained 
from the reaction of maleic anhydride and ethylene diamine showed that cyclic 
compound 11 was not formed. 
Scheme 2.10: Synthesis of compound 11
Since we were unsuccesful in obtaining compound 11 we tried to use N-methyl 
ethylenediamine instead with maleic anhydride. In this case we were able to obtain 
product 13 in 32% yield after recrystallization from ethanol (Scheme 2.11). X-ray 
crystallography of compound 13 proved that it is indeed this regioisomer which is 
formed and not the regioisomer in which the methyl group is on the lactam nitrogen 
(Figure 2.3). Since the secondary amine is more reactive than the free amine it is no 
surprise that the more reactive amine undergoes the 1,4-addition. 
Scheme 2.11:  Formation of cyclic β-amino acid 13 from maleic anhydride and N-methyl 
ethylene diamine.
 Figure 2.3: X-ray structure of a single cyclic β-amino acid 13.
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The full X-Ray structure of cyclic β-amino acid 13 shows that in the solid phase 
extensive hydrogen bonding occurs (Figure 2.4). One of the hydrogen bonds is 
intramolecular, and occurs between the carboxylic acid and the tertiary nitrogen in 
the ring. Therefore compound 13 appears to be bicyclic in figure 2.4. Additionally 
hydrogen bonding occurs between the carboxylic acids of two molecules of compound 
13. These intermolecular hydrogen bonds, are presented by the black dotted lines 
running horizontally in figure 2.4. Furthermore two distinct water molecules, in green 
and red, are trapped inside the crystal lattice. These two water molecules are bound 
by three molecules of compound 13. There are hydrogen bonds with the amide bond 
of one 13, the amide bond of a second 13 and finally with the carboxyl group of the 
carboxylic acid of a third molecule 13. 
The extensive hydrogen bonding found in compound 13 agrees well with our 
hypothesis. It is clear that indeed all present functionalities play a role in the hydrogen 
bonding in the crystal lattice. Moreover compound 13, proves to be even more 
structurally constrained than expected due to the formation of a bicyclic structure in 
the crystal phase. 
Figure 2.4: X-ray structure of the extensive hydrogen bonding in solid phase β-amino acid 13.
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To test if any enantioselectivity occurs in this reaction we needed a sample of 
enantioenriched compound to seed the reaction mixture. First we tried to obtain 
an enantioenriched sample via resolution,[27] by forming the diastereomeric salt of 
compound 13 (Scheme 2.12). It was expected that when compound 13 was treated 
with an equimolar amount of (R)-1-phenylethan-1-amine, two diasteriomeric salts 
(S,R)-14 and (R,R)-14 would form. The two diastereoisomers are expected to have 
different physical properties,[28, 29] therefore the solubility of the salt can differ between 
the isomers. This offers the possibility of selectively crystallizing one diastereoisomer 
over the other. However, crystallisation of both diastereomeric salts of 14 from either 
methanol or acetone yielded both product diastereoisomers. Subsequently quinine 
was used as enantiopure amine to obtain diastereomeric salt formation.[30, 31] In this 
case, as indicated by 1H NMR, both diastereomers were obtained in a one to one ratio 
in the solid phase. The principle of chiral resolution is based on difference in solubility 
between the two diastereoisomers, this difference in solubility arises when the two 
salts have a different crystal packing. It is possible that the stereogenic centre in the 
acid is too far away from the stereogenic centre in the amine to have an influence 
on the crystal packing, resulting in a similar crystal packing and therefore a similar 
solubility. 
Scheme 2.12: Formation of diastereomeric salt 14.
To test if bringing the asymmetric centre closer, and thereby enhancing the 
structural difference, by forming a covalent bond instead of an ionic bond the 
menthol ester of ester 16 was synthesized. Acid 13 and menthol 15 were coupled 
via a 4-dimethylaminopyridine catalysed N,N’-dicyclohexylcarbodiimide coupling. 
Crystallization of 16 from various solvents did not yield an excess of one of the 
diastereoisomers, as determined by 1H NMR.
Scheme 2.13: Synthesis of the menthol ester 16.
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Subsequently we tried to obtain enantiomerically pure 13 via an adaptation of a 
known asymmetric synthesis.[26] The synthesis starts from the commercially available 
β-benzyl protected (L)-aspartic acid 17. Boc protection of the amine yields acid 
18 in quantitative yield. Coupling acid 18 to 2,2-dimethoxyethanamine using EDC 
as coupling agent, hydroxybenzotriazole as additive to prevent racemisation and 
diisopropylethylamine as base yielded amide 19 in 83% yield (Scheme 2.14). However 
subsequent deprotection of the acetal and N-Boc functionalities under acidic 
conditions did not yield cyclic amide 20. Other conditions were tried but in none of 
these product mixtures any signals belonging to alkene protons where observed in 
the 1H NMR spectrum. 
Scheme 2.14: Attempted asymmetric synthesis of chiral β-amino acid 13
In the meantime we also focused on the kinetics of the reaction. As stated in the 
introduction chapter a distinctive S curve can be seen when an autocatalytic reaction 
is followed over time. Due to the release of more catalyst during the reaction, the 
reaction rate of an autocatalytic reaction is highest at around 50% yield whereas a 
normal reaction has a maximum reaction rate at the beginning of the reaction when 
the concentration of starting materials is highest.[32] To investigate if the reaction 
between maleic anhydride and N-methylethylene diamine is autocatalytic we 
followed this reaction over time. Taking samples at set time intervals did not give a 
clear insight in the intermediates present. At lower temperatures other products are 
present in the reaction mixture then at higher temperatures. This was also observed 
during our initial experiments with maleic anhydride and benzyl amine (Table 2.1). 
Therefore we searched for a method that would give us the opportunity to follow 
the reaction in situ. At the start we opted to monitor the reaction by Raman[33] 
spectroscopy. The reasons for using Raman spectroscopy are as follows. First it is 
easy to follow a reaction in situ with Raman spectroscopy, it is possible to completely 
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reproduce the experimental set up and insert the Raman probe in to the reaction 
mixture. Secondly, since many polar molecules are formed and the intensity of the 
Raman signal depends on the polarizability of the molecule, clear signals for both the 
starting materials and the product are expected. The last reason is that water is a good 
solvent for Raman spectroscopy since it is silent in the regions where most compound 
signals appear.[34] 
Initial experiments were performed to see which signals could be assigned to the 
product and which to the starting maleic anhydride. Subsequently different mixtures 
where made of both the starting material and the product and spectra were taken 
to produce a calibration curve. These initial experiments were promising (Graph 2.1). 
Product (13) shows two distinctive signals at 450 and 680 nm and the starting maleic 
anhydride gives a clear signal around 880 nm. 
Graph 2.1:  Raman spectra of pure maleic anhydride (MA), pure 13 and mixtures of these two 




100 to 0 14785 226
90 to 10 11310 347
50 to 50 826 3332
10 to 90 1098 6127
0 to 100 145 6541
Table 2.2:  Calibration of the maleic anhydride peak at 880 cm-1 vs integration of the product 
peak at 680 cm-1. 
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When the measured intensities of maleic anhydride and β-amino acid 13 are 
plotted against the percentage product present in the mixture it can be seen that the 
response of maleic anhydride is not linear (Graph 2.2). Especially the measuring point 
presenting the 1 to 1 ratio deviates strongly. The calibration curve of the β-amino acid 
13 is linear. The calculted R2 of 0.995, indicates that the linear trendline fits the data 
almost perfectly. Therefore it was decided to follow the reaction progress by following 
the increase of the β-amino acid 13 signal at 680 cm-1. 
Graph 2.2: Calibration curve based on the intensities from Table 2.2
When the reaction was followed in situ this product signal at 680 cm-1 was not 
observed by Raman spectroscopy. Furthermore the large amount of intermediates 
yielding various new unidentified signals made it difficult to follow the progress of the 
reaction via Raman spectroscopy. 
Therefore we shifted to follow the reaction by 1H NMR in a sealed NMR tube at 
100 °C in D2O, where acid 21 was added as internal standard (Figure 2.5). Acid 21 
was added to the reaction mixture directly and while isolated in a sealed capillary. 
We observed that the kinetics of the reaction were not influenced by the use of a 
capillary, indicating that the acid of the internal standard has no effect on the rate 
of the reaction. However, the quality of the shimming decreased significantly when 
a capillary was used. Therefore in the following experiments 10 mol% of internal 
standard 21 was dissolved in the solution. 
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Figure 2.5: Structure of internal standard 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) 21.
Graph 2.3:  Kinetic profile of the addition reaction of N-methyl ethylenediamine to maleic 
anhydride to form β-amino acid 13. Intensities are normalized and compared to 
Internal Standard 21.
As can be seen from graph 2.3 no sigmoidal behaviour is observed therefore 
no asymmetric autocatalysis is occurring. To verify this the experiment was also 
performed with 10 mol% of product present in the NMR tube. As can be seen, adding 
the product does not significantly increase the reaction rate (Graph 2.4)
Graph 2.4:  Kinetic profile of the addition reaction of N-methyl ethylenediamine to maleic 
anhydride in the presence of 10 mol% of product 13. Intensities are normalized and 
compared to Internal Standard 21.
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From the kinetic experiments it can be concluded that the reaction between maleic 
anhydride and N-methyl ethylenediamine is not autocatalytic. Therefore no further 
experiments towards this reaction were performed. 
2.4 Conclusion and outlook
In this chapter we focused on developing an asymmetric autocatalytic reactions 
that form biologically relevant compounds under prebiotically viable conditions. We 
chose the ring opening and 1,4-addition of maleic anhydride by an amine nucleophile, 
since this reaction provides an α-amino acid core and proceeds in water at elevated 
temperatures. Furthermore the reaction starts from simple starting materials and 
forms various new functional groups as well as a stereogenic centre. 
First we used benzyl amine as nucleophile, since this reaction would provide a 
protected asparagine core and was already known in the literature. It was shown that 
various intermediates were present during the reaction depending on the solvent. 
Based on the intermediates and the regioselectivities a mechanism for this reaction 
was proposed. 
Due to difficulties with reproducibility, the fact that we could not prove beyond 
a doubt which regioisomer was formed and to simplify and facilitate the reaction, 
the system was changed to using a diamine instead of two amines. We envisioned 
this approach to be more successful since the first addition would now facilitate the 
second, since the second addition would now proceed intramolecular. Furthermore 
the product would be a cyclic β-amino acid resembling one of the most successful 
organocatalysts, proline. To test the potential enantioselective catalysis of the product 
the synthesis of enantiomerically enriched product was attempted, although so far 
no procedure to obtain optically enriched 13 was found. Subsequently the kinetics of 
the reaction were investigated by following the reaction by 1H NMR with an internal 
standard. The kinetic profile of the reaction was not sigmoidal which would be 
expected for an autocatalytic reaction. Therefore it was concluded that the reaction 
between maleic anhydride and N-methylene diamine is not an autocatalytic reaction. 
In the following chapter we continue our search for an asymmetric autocatalytic 
reaction that might provide biologically relevant compounds. 
2.5 Experimental section
All chemicals and reagents were purchased from commercial suppliers (Acros, TCI 
and Sigma-Aldrich) and used without further purification. Dry solvents were taken 
from an MBraun solvent purification system (SPS-800). Thin layer chromatographic 
(TLC) analysis was performed on Merck silicagel 60/Kieselguhr F254, 0.25 mm TLC 
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plates and spots were visualized by UV and staining with KMnO4 stain. Column 
chromatography was performed using silica gel (P60, 230 – 400 mesh). 
1H-NMR-, 13C-NMR-, 31P-NMR-, were recorded on a Varian AMX400 (400 and 100.59 
MHz, respectively) using CDCl3 as a solvent (CDCl3: δ 7.26 for 1H-NMR, δ 77.16 for 
13C-NMR). Data are reported as follows: chemical shifts, multiplicity (s= singlet, 
d= doublet, t= triplet, q= quartet, qi= quintet, br= broad, m= multiplet) coupling 
constants J (Hz) and integration.
High resolution mass spectrometry (HRMS) was carried out on a LTQ ORBITRAP XL 
spectrometer (Thermo Scientific) employing electron impact ionization in positive ion 
mode (EI+) and negative ion mode (EI-). 
Optical rotations were measured on a Schmidt + Haensch polarimeter (Polartronic 
MH8) with a 10 cm cell (concentration c given in g/100 mL). Melting points were 
measured on a Büchi B-545 and recorded in °C. 
Kinetic studies
Method A:
In a round bottom flask 200 mg (2.04 mmol) maleic anhydride and 180 μL (2.04 
mmol) N-methylethane-1,2-diamine were dissolved in 10 mL water. At certain 
intervals 0.45 mL aliquots of the reaction mixture were taken and mixed in an NMR 
tube with 0.05 mL of D2O. 1H NMR’s were measured on a 400 MHz NMR using solvent 
suppression to suppress the H2O peak. 
Method B:
In a temperature controlled 500 MHz NMR, that was set at 100 °C, a sample was 
prepared consisting of 10 mg (0.1 mmol) maleic anhydride in 0.50 mL D2O, with or 
without 4,4-dimethyl-4-silapentane-1-sulfonic acid as internal standard. The sample 
was locked and an initial 1H NMR spectra was taken before 180 μL (2.04 mmol) 
N-methylethane-1,2-diamine was added to the NMR tube. Spectra were recorded 
automatically every 5 minutes. 
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N2,N4-dibenzylasparagine (or 3,4-bis(benzylamino)-4-oxobutanoic acid) (1) 
In a round bottom flask equipped with a reflux condenser and a stirring bar, 500 mg 
(5.10 mmol) maleic anhydride and 1.11 mL (10.20 mmol) benzyl amine where dissolved 
in 5 mL H2O and stirred while heated at reflux for 17 h. After cooling the white solid 
was filtered and recrystallized from ethanol yielding 955 mg (3.06 mmol, 60%) of the 
pure product as a white solid. Mp 201.9-202.5 °C; 1H NMR (400 MHz, DMSO-d6) δ 8.62 
(t, J = 6.0 Hz, 1H), 7.44 – 7.07 (m, 10H), 4.27 (dd, J = 6.0, 2.0 Hz, 2H), 3.94 (d, J = 13.1 Hz, 
1H), 3.83 (d, J = 13.2 Hz, 1H), 3.47 (dd, J = 7.7, 5.0 Hz, 1H), 2.65 (dd, J = 15.3, 5.1 Hz, 1H), 
2.51 (dd, J = 15.7, 7.8 Hz, 1H). 13C NMR (101 MHz, DMSO) δ 179.88 (C), 172.38 (C), 139.72 
(C), 137.51 (C), 129.07 (CH), 128.80 (CH), 128.66 (CH), 127.97 (CH), 127.65 (CH), 127.16 
(CH), 57.82 (CH), 50.57 (C H2), 42.52 (C H2), 37.50 (CH2); HRMS (APCI+, m/z): calculated 
for C18H21N2O3 [M + H+]: 313.1547, found: 313.1545; Anal. Calcd. for C18H20N2O3.1/2 H2O: 
C, 67.27; H, 6.59; N, 8.72. Found: C, 67.03; H, 6.39; N, 8.80.
(Z)-4-(benzylamino)-4-oxobut-2-enoic acid (3) 
In a round bottom flask 20 mg (0.2 mmol) maleic anhydride and 45 µL (0.4 mmol) 
benzylamine where dissolved in 5 mL of dioxane and the resulting mixture was stirred 
at r.t. over 65 h. Evaporation of the solvent and excess amine yielded the product as 
a white solid in quantitative yield. 1H NMR (400 MHz, DMSO-d6) δ 9.39 (t, J = 6.0 Hz, 
1H), 7.44 – 7.16 (m, 5H), 6.43 (d, J = 12.4 Hz, 1H), 6.25 (d, J = 12.4 Hz, 1H), 4.38 (d, J = 
5.9 Hz, 2H).[35] 
TOWARDS THE DEVELOPMENT  OF ASYMMETRIC AUTOCATALYSIS BASED ON THE RING OPENING OF MALEIC ANHYDRIDE 59
(E)-4-(benzylamino)-4-oxobut-2-enoic acid (4)
When maleic anhydride and benzylamine, in various solvents (summarized in table 
2.1,) where stirred for a given period of time the following NMR signals where assigned 
to compound 4. 1H NMR (400 MHz, DMSO) δ 8.87 (t, J = 6.0 Hz, 1H), 7.37 – 7.17 (m, 5H), 
6.83 (d, J = 15.3 Hz, 1H), 6.54 (d, J = 15.5 Hz, 1H), 4.35 (d, J = 6.0 Hz, 2H).[36]
(E)-5-(benzylimino)furan-2(5H)-one (5) 
When maleic anhydride and benzylamine, in various solvents (summarized in table 
2.1) where stirred for a given period of time the following NMR signals where assigned 
to compound 5. 1H NMR (400 MHz, DMSO) δ 7.43 – 7.24 (m, 5H), 6.12 (d, J = 13.2 Hz, 
1H), 5.70 (d, J = 13.6 Hz, 1H), 4.32 (s, 2H).[17]
methyl 2-(3-oxopiperazin-2-yl)acetate 12[26, 37]
In a roundbottom flask 0.43 mL (3.47 mmol) dimethyl maleate and 0.23 mL (3.47 
mmol) ethane-1,2,-diamine were dissolved in 10 mL IPA. The reaction mixture was 
stirred at 50 °C for 15 h. Evaporation of the solvent yielded the product as a white solid 
in quantitative yield (598 mg, 3.48 mmol). 1H NMR (400 MHz, Chloroform-d) δ 5.92 (s, 
1H), 3.80 – 3.72 (m, 1H), 3.70 (s, 3H), 3.49 (td, J = 11.1, 4.4 Hz, 1H), 3.29 (ddd, J = 11.2, 
4.0, 3.7 Hz, 1H), 3.20 – 3.11 (m, 1H), 3.09 – 3.00 (m, 1H), 3.01 (dd, J = 8.2, 4.6 Hz, 1H), 
2.78 (dd, J = 17.3, 8.7 Hz, 1H).
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sodium 2-(3-oxopiperazin-2-yl)acetate 11[26]
In a roundbottom flask 744 mg (4.32 mmol) methyl 2-(3-oxopiperazin-2-yl)acetate 
was dissolved in 5 mL 2 M aq. Sodium Hydroxide. The reaction mixture was stirred for 
16 h. The solvent was removed in the Freeze dryer yielding the salt of the product in 
quantitative yield. 1H NMR (400 MHz, CD3OD) δ 3.37 (dd, J = 8.5, 4.5 Hz, 1H), 3.30 (p, J 
= 1.7 Hz, 2H), 2.76 – 2.63 (m, 2H), 2.58 (dd, J = 23.0, 4.7 Hz, 1H), 2.41 (dd, J = 15.4, 8.5 
Hz, 1H).
2-(1-methyl-3-oxopiperazin-2-yl)acetic acid 13
In a roudbottom flask equipped with a reflux condenser and a stirring bar, 1.0 g 
(10.2 mmol) maleic anhydride and 0.9 mL (10.2 mmol) N-methylethane-1,2-diamine 
where dissolved in 50 mL water and heated at reflux for 16 h. Recrystallization from 
ethanol gave 563 mg (3.26 mmol, 32%) of the product as a white solid. Mp mixture of 
two confomers (A:B; 1:1.8) 1H NMR (400 MHz, D2O) δ 4.02 (t, J = 4.7 Hz, CHA ), 3.89 (t, J 
= 4.0 Hz, CHB), 3.75 – 3.32 (m, NHCH2A, NHCH2B, N(CH3)CH2A, N(CH3)CH2B), 2.96 (ddd, 
J = 18.2, 4.0, 1.5 Hz, CHHACOOH), 2.91 (s, CH3B), 2.88 (s, CH3A), 2.84 (m, CHHACOOH, 
CHHBCOOH) 2.64 (ddt, J = 18.0, 3.9, 1.3 Hz, CHHBCOOH); 13C NMR (50 MHz, DMSO) δ 
173.80 (CA=O), 173.30 (CB=O), 169.80 (CB=O), 169.10 (CA=O), 63.82 (CAH), 56.15 (CBH), 
50.36 (CAH2), 49.83 (CBH2), 43.08 (CAH3), 41.34 (CAH2), 37.55 (CBH2), 39.55 (CAH2), 35.73 
(CBH2), 34.43 (CBH3); HRMS (APCI+, m/z): calculated for C7H13N2O3 [M + H+]: 173.0921, 
found: 173.0925; Anal. Calcd. for C7H12N2O3.11/2 H2O: C, 42.21; H, 7.59; N, 14.06. Found: 
C, 42.34; H, 7.38; N, 14.87.
TOWARDS THE DEVELOPMENT  OF ASYMMETRIC AUTOCATALYSIS BASED ON THE RING OPENING OF MALEIC ANHYDRIDE 61
(R)-4-(benzyloxy)-4-oxo-2-((pivaloyloxy)amino)butanoic acid 18[26]
A sample of 500 mg (2.24 mmol) (R)-2-amino-4-oxobutanoic acid was dissolved in 
a mixture of 2.5 mL water and 6 mL dioxane and cooled to 0 °C. Subsequently 0.62 
mL (4.48 mmol) trimethylamine and 590 mg (2.69 mmol) Boc anhydride were added 
to the solution. The reaction mixture was stirred for 20 h at 50 °C. After the mixture 
cooled to r.t. the solution was extracted 3 times with DCM. The combined organic 
layers where washed with 10% aq. citric acid solution, dried with MgSO4 and the 
solvent evaporated in vacuo. Giving the product in quantitative yield (725 mg 2.25 
mmol) of the product as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.29 (m, 5H), 
5.54 (d, J = 8.4 Hz, 1H), 5.15 (dd, J = 14.2, 2.1 Hz, 2H), 4.62 (s, 1H), 3.07 (dd, J = 17.3, 4.6 
Hz, 1H), 2.89 (dd, J = 17.2, 5.0 Hz, 1H), 1.45 (s, 9H).
Benzyl (R)-4-((2,2-dimethoxyethyl)amino)-4-oxo-3-((pivaloyloxy)amino)
butanoate 19[26]
In an oven dried Schlenk vessel 250 mg (0.77 mmol) (R)-4-(benzyloxy)-4-oxo-2-
((pivaloyloxy)amino)butanoic acid was dissolved in 5 mL dry THF. To this solution 125 
mg (0.93 mmol) HOBt, 178 mg (0.93 mmol) EDC.HCl, 0.34 mL (1.93 mmol) DIPEA and 
84 μL (0.77 mmol) 2,2-dimethoxyethanamine were added. The reaction mixture was 
stirred for 20 h at r.t.. The reaction was quenched with sat. aq. NH4Cl and the resulting 
solution was extracted 3 times with DCM. The combined organic layers were dried 
with MgSO4 and the solvent evaporated in vacuo yielding 260 mg (0.64 mmol, 83% 
yield) of the crude product. 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.29 (m, 5H), 6.61 (br s, 
NH), 5.64 (br d, J = 8.8 Hz, NH), 5.15 (d, J = 12.3 Hz, 1H), 5.10 (d, J = 12.3 Hz, 1H), 4.57 – 
4.42 (m, 1H), 4.33 (t, J = 5.4 Hz, 1H), 3.42 – 3.30 (m, 8H), 3.06 (dd, J = 17.1, 4.6 Hz, 1H), 
2.71 (dd, J = 17.1, 6.0 Hz, 1H), 1.45 (s, 9H).
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In this chapter, the conjugate addition of LDA to an α,β-unsaturated ester, which 
has been reported to be an autocatalytic reaction, is investigated for its potential 
enantioselectivity. Literature studies showed that during the addition reaction a mixed 
aggregate consisting of the β-amino ester and LDA is formed. It is hypothesized that if the 
LDA, aggregated to the chiral β-amino ester product, would play a role in the conjugate 
addition the reaction would likely show enantioselectivity. To investigate the possible 
asymmetric auto-induction, an enantiomerically enriched sample of the β-amino ester 
was prepared. Subsequently the conjugate addition was performed in the presence 
of of the enantioenriched product, as a selective catalyst. The degree of enantiomeric 
enrichment in the product of this reaction showed that although the β-amino ester acts 
as a catalyst, it does not show enhanced enantioselectivity. This result indicates that the 
LDA present in the mixed product LDA aggregate does not play a role in the conjugate 
addition.
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3.1 Introduction 
As introduced in chapter 1.X asymmetric autocatalysis is an extremely interesting 
process that could have played an important role in the origin of homochirality 
which is an important prerequisite for life to emerge.[1] The addition of dialkyl zinc 
to 5-pyrimidinecarboxyaldehyde, as described by Soai and coworkers,[2] is the 
only uncontested example that unequivocally proofs the principle of asymmetric 
autocatalysis as proposed by Frank in 1953.[3] As mentioned in chapter 2, the Soai 
rection in itself is highly interesting, however, the transformation does not yield 
compounds of biological relevance. Therefore it would be highly challenging to 
explore autocatalytic reactions that do yield biologically relevant compounds, and to 
investigate if these autocatalytic reactions show enantioselectivity. 
In 2010 the group of Collum et al.[4] published a paper regarding the autocatalytic 
behaviour of the addition of lithium diisopropylamine (LDA) to unsaturated ester 1 
(Scheme 3.1). The conjugate addition of LDA, first reported by Schlessinger et al.,[5] 
under standard conditions (LDA/THF/ -78 °C) shows a decay that is neither first- nor 
second- order in the ester (Figure 3.1). The almost linear decay of the ester is most 
akin to zeroth-order dependence in the ester. This prompted the authors to start a 
thorough kinetic investigation of this reaction. 
Scheme 3.1: Addition of LDA to α,β-unsaturated ester 1.
Figure 3.1:  Plot of IR absorbance vs time in THF (6.10 M) for 1,4-addition of ester 1 (0.004 M) with 
LDA (0.10 M) at -78 °C in the presence of various amounts of LiCl: (A) no LiCl; (B) 0.01 
mol% LiCl; (C) 0.4 mol% of LiCl.[4] Adapted from reference.[4]
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When performing the conjugate addition reaction a large difference in reaction 
rate was observed when either commercially available LDA or LDA prepared in situ 
from diisopropylamine and n-butyl lithium was used. This prompted Collum et al. to 
study the effect of LiCl[4, 6] on the reaction rate. This salt is present in commercially 
available n-butyl lithium and therefore in in situ prepared LDA. Kinetic experiments 
have shown that LiCl, accelerates the 1,4-addition reaction (Scheme 3.1). Even as little 
as 0.01 mol% of LiCl is capable of accelerating the 1,4-addition reaction 70 fold. This 
result motivated Collum et al. to use LDA prepared from metallic lithium, to obtain 
rigorously LiCl free LDA, for all further kinetic studies. 
To obtain a thorough understanding of the kinetics of the conjugate addition 
reaction, 6Li NMR was used to follow various intermediates. Figure 3.2a presents the 
concentration of starting materials and intermediates formed during the reaction 
when starting from a 1:1 mixture of α,β-unsaturated ester 1 and LDA dimer (A2). In 
figure 3.2b the progress of the reaction is presented when an excess of LDA dimer 
(A2) to α,β-unsaturated ester 1 (ratio 2:1) is used as the starting point of the reaction.[4]
 Figure 3.2:  Time-dependent concentrations measured by 6Li NMR spectroscopy. α,β-
Unsaturated ester 1, A2 = LDA dimer; E2 = enolate dimer; AE= mixed dimer consisting 
of one LDA and one enolate; starting from a) 0.05 M LDA dimer (A2) and 0.05 M 
α,β-unsaturated ester 1 in THF at -78 °C. b) 0.05 M LDA dimer (A2) and 0.025 M α,β-
unsaturated ester 1 in THF at -78 °C. Adapted from reference.[4]
From the two kinetic profiles presented in figure 3.2 four key points became 
clear. 1) There is a linear decay of the starting material (α,β-unsaturated ester 1); 2) 
The coincident formation of dimers AE (LDA, enolate) and E2 (enolate dimer) at the 
start of the reaction, indicates that these two aggregates form autonomously and 
independently from each other; 3) After some time a large concentration of E2 exists 
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relative to the equilibrium concentration. This indicates that during the reaction full 
equilibration is not reached; 4) Two distinct phases exist during the reaction. In the 
first phase there is simultaneous formation of AE and E2. In the second phase the 
formation of AE occurs from E2.[4] 
Based on kinetic experiments leading to the mentioned key observations, in 
combination with DFT calculations, a mechanism for the conjugate addition was 
proposed (Scheme 3.2). The proposed mechanism indicates that the reaction has 
a different rate limiting step depending on the presence or absence of LiCl. When 
the LiCl salt is present in the reaction mixture, the salt facilitates the breakup of the 
A2 dimers. Therefore the 1,4-addition is the rate limiting step when LiCl is present in 
the reaction. When LiCl is not present in the reaction mixture the first step, breaking 
up the LDA dimer, becomes the rate limiting step. Here autocatalysis arises since the 
product is capable of assisting the deaggregation of the A2 dimer. The free LDA can 
now add in a conjugated fashion to the α,β-unsaturated ester yielding the product. 
Scheme 3.2:  Proposed mechanism of the LDA addition to α,β-unsaturated ester 1, in the case 
that LiCl is present the first step, deaggregation, is catalysed by the LiCl. Adapted 
from reference.[4]
The mechanism presented in Scheme 3.2 corresponds well with the known 
coordination behaviour of lithium compounds.[7-10] Lithium amides, but also other 
lithium compounds, can be present as salts, monomers, dimers or cyclic trimers.[8] 
Whether monomers, dimers or higher aggregated structures are the major aggregates 
present in solution depends largely on the R groups and the solvent.[8-10] In 1988, 
Seebach has reviewed the X-Ray data of supramolecular Li compounds.[10] In this 
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review the structure of the LDA dimer (A2) is shown, but also X-Ray data of nitrogen 
containing enolates are presented that show the same dimeric aggregation behaviour 
as suggested by Collum et al.[4] for AE.[10] 
Figure 3.3: Four different types of aggregation of lithium amides.
3.2 Goal
Our interest was triggered by the before mentioned paper of Collum et al..[4] Since 
in this manuscript an autocatalytic reaction is presented that yields a β-amino ester 
product that contains a chiral carbon centre. We hypothesised that the conjugate 
addition reaction could occur in an enantioselective fashion, thereby providing 
an asymmetric autocatalytic reaction. Our reasoning is based on the 6Li NMR 
spectroscopy studies of the reaction mixture that shows a large presence of the mixed 
LDA-enolate dimer. If this dimer were to add to the α,β-unsaturated ester, the addition 
would occur in a chiral environment and could therefore lead to enantioselectivity. 
Furthermore, the product of this reaction is a β-amino ester that upon hydrolysis 
would furnish a β-amino acid. These are biologically highly relevant structures[11] and 
could therefore be interesting building blocks in the context of the origin of chirality. 
To study the potential chiral induction of β-amino ester 2 on the 1,4-addition (Scheme 
3.3), we required a sample of compound 2 with a known enantiomeric excess. The 
enantiomerically enriched β-amino ester 2 will then be used to seed the conjugated 
addition reaction and in this way the chiral inductive effect of the product on the 












Scheme 3.3:  a) General scheme for an asymmetric autocatalytic reaction; b) (asymmetric) 
autocatalytic reaction of 1,4-addition of LDA to ester 1, catalysed by product 2.
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3.3 Results and discussion
First α,β-unsaturated ester 1 was synthesized following a protocol from the 
Davies group,[12] using methylmagnesiumbromide as a base in the Horner-
Wadsworth-Emmons reaction between cyclohexanecarbaldehyde and tert-butyl-2-
(diethoxyphosphoryl)acetate (Scheme 3.4). The corresponding β-amino ester was 
made by in situ preparation of LDA from diisopropyl amine and butyl lithium at -78 °C, 
followed by addition of α,β-unsaturated ester 1 as described by Collum et al. yielding 
the desired β-amino ester 2 in 71% yield (Scheme 3.5). 
Scheme 3.4: Synthesis of ester 1
Scheme 3.5: Synthesis of β-amino ester 2.
The lack of sufficient chromophores in β-amino ester 2 limits the use of a standard 
HPLC apparatus, equipped with an UV detector, to determine the ee of β-amino 
ester 2. This problem could be overcome by employing an ELSD detector. However 
no enantiomeric separation could be obtained on the available chiral columns. 
Subsequently it was tried to achieve chiral separation by using a chiral GC-FID system. 
Due to a high flight temperature of β-amino ester 2 no chiral separation was obtained. 
Therefore derivatization of the product was used to obtain chiral separation.
β-Amino ester 2 was reduced to the corresponding alcohol in the presence of 3 
equivalents of LiAlH4. Alcohol 3 has a lower molecular weight than ester 2, an amine 
next to the stereogenic centre and an alcohol adjacent to the chiral carbon centre, 
therefore attempts were made to obtain chiral separation of alcohol 3 using GC. Since 
no baseline separation could be found, alcohol 3 was further functionalised to the 
benzoyl ester 4 (Scheme 3.6). For the benzoylester chiral separation was found on a 
HPCL system, equipped with a UV detector, using a Chiraldex AD-H column. 
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Scheme 3.6: Synthesis of β-amino benzoyl ester 4 for ee determination.
With a method in hand to determine the ee of β-amino ester 2, an enantiomerically 
enriched sample of β-amino ester 2 was desired to perform the seeding experiment. 
Tomioka en coworkers published a method in 2003 to prepare chiral β-amino esters 
from the corresponding α,β-unsaturated esters, using Li amides in the presence of 
chiral ligand 5 (Scheme 3.6).[13] Various R3 groups were used and in the case of phenyl 
as R3 and LDA as nucleophile, 68% ee could be obtained. Based on the similarities 
between our desired β-amino ester 2 and β-substituted ester 6 published by Tomioka 
et al., this methodology was selected to obtain enantiomerically enriched β-amino 
ester 2. 
Scheme 3.7:  General reaction scheme for the enantioselective addition of Lithium amides to 
α,β-unsaturated esters as reported by Tomioka et al.[13]
Ligand 5 was synthesized starting from enantiopure R,R-benzoin 7.[14] The chiral 
diol was converted to a dimethyl ether via deprotonation with NaH and subsequent 
methylation using dimethylsulfide. This procedure provided ligand 5 in 70% yield 
(Scheme 3.8).[14] Next diether 5 was used as chiral ligand in the conjugate addition 
of LDA to α,β-unsaturated ester 1, providing β-amino ester 2 in 12% yield and 74% 
ee after purification by column chromatography (Scheme 3.9). In the crude mixture, 
the α,β-unsaturated ester starting material is visible, which is a result of a less active 
system due to the addition of a ligand and the change to a less coordinating solvent 
or indicates that a retro Michael addition occurs. Considering that the work up 
conditions used are the same as for the reaction depicted in scheme 3.6, it is expected 
that the low yield is due to the fact that this system is less reactive. Additionally 
Tomioka reports that ligand 5 can be reused after it is recovered after column 
chromatography.[13] Even though it was possible to obtain ligand 5 pure according 
to 1H NMR, reusing the ligand drastically lowered the ee of β-amino ester 2 to 12%. 
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Scheme 3.8: Synthesis of chiral ligand 5 as described by Tamioka et al..[14]
Scheme 3.9: Asymmetric synthesis of β-amino ester 2.
Now that enantiomerically enriched β-amino ester 2 was successfully obtained, this 
could be used as a, potentially enantioselective, catalyst for the 1,4-addition reaction. 
To be able to induce chirality the product would need to play a catalytic role in the 
rate determining step. As discussed before, the product only increases the rate of the 
reaction, i.e. acts as a catalysts, when LiCl free LDA is employed. To obtain rigorously 
LiCl free LDA, Li shavings were used as lithium source. In the presence of isoprene 
and diisopropyl amine the metallic lithium is converted to lithium ions. The reaction 
conditions are equal to the conditions used by Collum et al.,[4] which is an adaptation 
of existing literature.[15-18] The reaction was carried out in a double Schlenk flask with 
a P3 glass frit to later remove the remaining Li shavings. The lithium shavings and 
diisopropyl amine were brought into the Schlenk flask and dry dimethylethylamine 
(DMEA) was added as a solvent. A solution of isoprene in DMEA was slowly added over 
the course of 1h, taking care the temperature did not exceed 35 °C. To obtain the pure 
LDA the crude product was precipitated from DMEA, providing LDA, rigorously free of 
LiCl, in 71% yield (Scheme 3.10). 
Scheme 3.10: Synthesis of LiCl free LDA.
With the LiCl free LDA and an enantiomerically enriched sample of β-amino ester 
2 in hand it was possible to test if the conjugate addition of LDA to α,β-unsaturated 
ester 1 proceeds, besides in an autocatalytic way, also in an enantioselective manner. 
To this end the 1,4-addition was performed in the presence of 20 mol% of the product 
with 74 % ee and using LiCl free LDA (Scheme 3.11). 
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Scheme 3.11:  1,4-Addition of LDA to α,β-unsaturated ester 1, in the presence of product 2 
containing 74% ee.
Since enantiomerically enriched β-amino ester 2 is added to the reaction mixture as 
a catalyst, even if no enantioselectivity occurs it is expected that the product contains 
some ee. Assuming the reaction goes to full completion, the 20 mol% β-amino ester 
2, added as catalyst, would make up 17% of the total product. Considering that 17% 
of the total product would be of 74% ee, one would expect that the product possesses 
at least 11% ee, even if the addition of enantiomerically enriched product 2 has no 
enantioselective effect on the reaction. 
After purification of the product, β-amino ester 2, followed by derivatisation to 
benzoyl ester 4, ester 4 displayed an ee of 12% (Figure 3.4). Since this is within the 
error margin of the 11% ee calculated if no selectivity occurs, it can be concluded 
that that no asymmetric autocatalysis takes place. Additionally the reaction was also 
performed in toluene but this change in solvent did not have an effect on the ee found. 
When one takes in to consideration the proposed mechanism (Scheme 3.2), and 
the obtained results, which indicates that no enantioselective catalysis occurs, it 
seems likely that the mixed aggregate, of product 2 and LDA (AE), plays no role in 
the enantiodiscriminating step of the conjugate addition. Most probably the catalytic 
effect of β-amino ester 2, arises solely from breaking up the dimer of the LDA (A2), 
thereby forming the reactive free LDA and the mixed AE aggregate. If only free LDA 
participates in the conjugated addition no chiral environment is present that could 
induce selectivity when the addition occurs. Therefore no enantioselectivity is 
observed when enantiomerically enriched β-amino ester 2 is used as catalyst in the 
conjugate addition reaction. 
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Figure 3.4:  HPLC trace of benzoyl ester 4, from the conjugate addition of LDA to α,β-unsaturated 
ester 1 in the presence of 20 mol% of the 74% ee containing product 2, showing an 
ee of 12%. Chiralcel AD-H column, n-heptane–i-PrOH 99.9 : 0.1, 40 °C, 0.5 mL min-1, 
223 nm.
3.4 Discussion and conclusions
The investigations described in this chapter, were based on the hypothesis that 
the conjugate addition of LDA to α,β-unsaturated ester 1, as reported by Collum et 
al.,[4] would be autocatalytic as well as enantioselective. It was envisioned that the 
mixed aggregate consisting of β-amino ester 2 and LDA (AE, Scheme 3.12), would 
play a role in the conjugate addition. If this is the case, the chiral β-amino ester 2, 
present in the aggregate would provide a chiral environment and therefore render 
this autocatalytic reaction enantioselective. To investigate the possible asymmetric 
induction, an enantiomerically enriched sample of β-amino ester 2 was prepared, as 
well as rigorously LiCl free LDA. Subsequently the conjugate addition was performed 
in the presence of 20 mol% of enriched product and LiCl free LDA. The product 
obtained from this reaction showed 12% ee. If no enantioselective catalysis takes 
place 11% ee is expected, resulting from the addition of enantiomerically enriched 
product 2 as catalyst. It was therefore concluded that the product does not play a 
selective role in the enantiodiscriminating step. 
This result indicates that the product most probably only plays a catalytic role in 
breaking up the LDA dimer (A2), forming free LDA (A) and the mixed AE aggregate, 
see Scheme 3.12. Subsequently only the free LDA (A), and not the AE aggregate, 
participates in the conjugated addition so that no chiral environment is present when 
the addition occurs. Therefore no chiral induction is observed when enantiomerically 
enriched product is used to catalyse the conjugate addition reaction, proving that this 









































Scheme 3.12: Mechanistic pathway of the LDA (A) addition to ester 1 (E).
3.5 Experimental section
3.5.1 Materials and Methods
All chemicals and reagents were purchased from commercial suppliers (Acros, TCI 
and Sigma-Aldrich) and used without further purification. Dry solvents were taken from 
an MBraun solvent purification system (SPS-800). Thin layer chromatographic (TLC) 
analysis was performed on Merck silicagel 60/Kieselguhr F254, 0.25 mm TLC plates 
and spots were visualized by UV and staining with KMnO4. Column chromatography 
was performed using silica gel (P60, 230 – 400 mesh). 
1H-NMR- and 13C-NMR-spectra were recorded on a Varian AMX400 (400 and 
100.59 MHz, respectively) using CDCl3 as a solvent (CDCl3: δ 7.26 for 1H-NMR, δ 77.16 
for 13C-NMR). Data are reported as follows: chemical shifts, multiplicity (s= singlet, 
d= doublet, t= triplet, q= quartet, qi= quintet, br= broad, m= multiplet) coupling 
constants J (Hz) and integration.
tert-butyl (E)-3-cyclohexylacrylate 1[12]
To a solution of 2.32 mL (9.91 mmol) tert-butyl-2-(diethoxyphosphoryl)acetate 
in 15 mL dry THF was dropwise added, 3.3 mL 3 M MeMgBr in hexane (9.91 
mmol). The mixture was stirred for 15 min at r.t. after which 1.31 mL (10.9 mmol) 
cyclohexanecarbaldehyde was added dropwise. Subsequently the reaction mixture 
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was heated at reflux for 2.5 h. The reaction was quenched with aq. sat. NH4Cl, and the 
product extracted with Et2O (3 times). The combined organic layers where washed 
with brine, dried over MgSO4 and concentrated in vacuo. Purification by column 
chromatography (SiO2, pent/EtOAc, 97/3) Rf= 0.9, yielded 1.86 g (8.8 mmol, 89%) of 
the product as a colorless oil. 1H-NMR (CDCl3, 400 MHz): δ (ppm) = 6.81 (dd, J = 15.8, 
6.7 Hz, 1H), 5.68 (dd, J = 15.8, 1.5 Hz, 1H), 2.18 – 2.05 (m, 1H), 1.83 – 1.71 (m, 4H), 1.69 
– 1.61 (m, 2H), 1.48 (s, 9H), 1.38 – 1.22 (m, 2H), 1.22 – 1.03 (m, 2H); 13C NMR (75 MHz, 
CDCl3) δ 166.53 (C=O), 153.01 (CH), 120.45 (CH), 79.89 (C(CH3)3), 40.20 (CH), 31.69 (CH2), 
28.07 (CH3), 25.90 (CH2), 25.69 (CH2).
tert-butyl 3-cyclohexyl-3-(diisopropylamino)propanoate 2[19]
Method A (racemic):
In a dry Schlenk flask, 133 μL (0.95 mmol) diisopropylamine was dissolved in 2.5 
mL dry THF at -20 °C, subsequently 594 μL n-BuLi (0.95 mmol, 1.6 M in hexanes) 
was added to the mixture and the temperature was lowered to -78 °C. Then 100 mg 
(0.48 mmol) ester 1 was added and the reaction mixture was stirred for 30 min, after 
which the reaction was quenched with water. From the resulting aq. solution the 
product was extracted with ether (3 times). The combined organic layers were dried 
over MgSO4 and concentrated in vacuo. Purification of the crude product by column 
chromatography (SiO2, pent/EtOAc, 7/3, Rf = 0.95) yielded 106 mg (0.34 mmol, 71%) 
2 as a white solid. 1H-NMR (CDCl3, 400 MHz): δ (ppm) = 3.09 (hept, J = 6.7 Hz, 2H), 2.96 
(td, J = 8.3, 3.4 Hz, 1H), 2.46 (dd, J = 15.1, 3.4 Hz, 2H), 2.33 (dd, J = 15.1, 8.7 Hz, 1H), 2.04 
(m, 1H), 1.79 – 1.65 (m, 2H), 1.66 – 1.55 (m, 2H), 1.44 (s, 9H), 1.35 – 1.25 (m, 2H), 1.21 – 
1.06 (m, 2H), 1.02 (d, J = 6.6 Hz, 6H), 0.99 (d, J = 6.7 Hz, 6H), 0.94 – 0.79 (m, 2H); 13C NMR 
(75 MHz, CDCl3) δ 172.84 (C=O), 79.78 (C(CH3)3), 56.46 (CHN), 45.27 (CH(CH3)2), 43.07 
(CH), 40.44 (CH2), 31.68 (CH2), 30.28 (CH2), 28.04 ((CH3)3), 26.97 (CH2), 26.88 (CH2), 26.65 
(CH2), 23.81 ((CH3)2), 21.73 ((CH3)2).
Method B (chiral):
To a solution of 1.65 mL (11.59 mmol) diisopropylamine in 10 mL dry toluene at -20 
°C, 6.93 mL (11.09 mmol) n-BuLi in hexanes (1.6 M) was slowly added. The solution 
was stirred for 30 min after which 2.7 g (12.6 mmol) (1R,2R)-1,2-dimethoxy-1,2-
diphenylethane was added to the mixture. After another 3 min, 1.06 g (5.04 mmol) 
tert-butyl-(E)-3-cyclohexylacrylate was added and the reaction mixture was stirred for 
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1 h at -20 °C. The reaction was quenched with sat. aq. NH4Cl. The resulting mixture 
was extracted with Et2O (3 times), the combined organic layers where washed with 
sat. aq. NaHCO3, dried over MgSO4 after which the solvent was concentrated in vacuo. 
Purification by column chromatography (SiO2, pent/EtOAc, 7/3, Rf = 0.95) yielded 182.4 
mg (0.59 mmol, 11.62%) of the product as a white solid. Subsequent derivatization to 
3-cyclohexyl-3-(diisopropylamino)propyl benzoate showed an ee of 74 %; Chiralcel 
AD-H column, n-heptane–i-PrOH 99.9 : 0.1, 40 °C, 0.5 mL min-1, 223 nm, retention 
times (min) t1: 15.70 (major) and t2: 17.42 (minor).
Method C (with product as catalyst and LiCl free LDA):
In a dry Schlenk flask at -78 °C under N2 atmosphere 103 mg (0.96 mmol) LiCl free 
LDA was dissolved in 2.4 mL THF. To this solution a solution of 30 mg (0.096 mmol) 
tert-butyl-3-cyclohexyl-3-(diisopropylamino)propanoate (74% ee) and 101 mg (0.48 
mmol) tert-butyl-(E)-3-cyclohexylacrylate in 0.5 mL dry THF was slowly added. The 
reaction mixture was stirred at -78 °C for 1h. Subsequently the reaction was quenched 
with H2O and the resulting reaction mixture was extracted 3 times with Et2O. The 
combined organic layers where dried over MgSO4 and concentrated in vacuo yielding 
the crude product 178 mg (0.6 mmol, 97%) of the product as a white solid. The yield is 
based on theoretical yield of the reaction plus the added product. 
3-cyclohexyl-3-(diisopropylamino)propan-1-ol 3
In a dry Schlenk tube under N2 atmosphere at 0 °C, 37 mg (0.96 mmol) LiAlH4 
was brought. Subsequently 100 mg (0.32 mmol) tert-butyl 3-cyclohexyl-3-
(diisopropylamino)propanoate 2 was dissolved in 20 mL THF and dropwise added to 
the LiALH4. The reaction mixture was stirred overnight and allowed to warm to r.t.. 
The reaction was subsequently quenched with H2O and the resulting reaction mixture 
was extracted with Et2O (3 times), the combined organic layers where dried with 
MgSO4 and concentrated in vacuo. 1H NMR (201 MHz, CDCl3) δ 3.78 – 3.58 (m, 2H), 3.28 
(hept, J = 6.6 Hz, 1H), 2.70 – 2.56 (m, 1H), 1.92 – 1.44 (m, 8H), 1.43 – 1.17 (m, 5H), 1.07 
(dd, J = 6.6, 2.8 Hz, 12H); 13C NMR (50 MHz, CDCl3) δ 63.99 (CH2), 61.07 (CH), 45.55 (CH), 
44.42 (CH), 42.96 (CH), 32.82 (CH2), 29.27 (CH2), 28.73 (CH2), 27.45 (CH2), 26.93 (CH2), 
26.54 (CH2), 23.19 (CH3), 21.93 (CH3); GC-MS HP5, calculated mass C9H20NO [M - cHex]: 
calculated 158.15 found: 158.2.
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3-cyclohexyl-3-(diisopropylamino)propyl benzoate 4
In a dry Schlenk tube under N2 atmosphere at 0 °C, 152 mg (4.01 mmol) 
LiAlH4 was brought. Subsequently 250 mg (0.8 mmol) tert-butyl-3-cyclohexyl-3-
(diisopropylamino)propanoate 2 was dissolved in 20 mL dry THF and dropwise 
added to the LiAlH4. The reaction mixture was stirred overnight and allowed to warm 
to r.t.. The reaction was quenched with H2O and the resulting reaction mixture was 
extracted with Et2O (3 times), the combined organic layers where dried over MgSO4 
and concentrated in vacuo. The crude alcohol was dissolved in 10 mL THF to which 
0.2 mL (2.4 mmol) pyridine and 0.14 mL (1.2 mmol) benzoylchloride were added. The 
reaction mixture was stirred for 2 d at r.t., after which the reaction was quenched 
with H2O. The water layer was extracted with Et2O (3 times), the combined organic 
layers where washed with a sat. aq. CuSO4 solution until all pyridine was removed, 
then the organic layers were dried over MgSO4 and concentrated in vacuo. Purification 
by column chromatography (SiO2, pent/Et2O, 9/1) yielded 93 mg (0.27 mmol, 34%) 
of the product as a white solid. 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 7.0 Hz, 1H), 
7.55 (t, J = 7.4 Hz, 1H), 7.44 (dd, J = 8.3, 7.0 Hz, 2H), 4.52 – 4.21 (m, 2H), 3.20 (hept, J 
= 6.6 Hz, 2H), 2.62 (ddd, J = 7.8, 5.7, 3.4 Hz, 1H), 1.90 – 1.79 (m, 2H), 1.79 – 1.69 (m, 
3H), 1.70 – 1.62 (m, 1H), 1.56 – 1.45 (m, 1H), 1.38 – 1.06 (m, 4H), 1.03 (d, J = 6.6 Hz, 
6H), 1.01 (d, J = 6.6 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 166.65 (C=O), 132.67 (CH), 
130.65 (C), 129.46 (CH), 128.28 (CH), 64.30 (CH), 55.67 (CH2), 45.09 (CH(CH3)2), 43.70 
(CH(CH3)2), 32.00 (CH, cHex), 29.96 (CH2,cHex), 28.60 (CH2), 27.35 (CH2,cHex), 27.05 
(CH2,cHex), 26.69 (CH2,cHex), 23.24 (CH3), 23.05 (CH3); GC-MS HP5 column retention 
time: 18.9 min, calculated mass C22H36NO2 [M - cHex]: calculated 262.2 found: 262.1; 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel AD-H column, 
n-heptane/i-PrOH 99.9 : 0.1, 40 °C, 0.5 mL min-1, 223 nm, retention times (min) t1: 15.70 
and t2: 17.42.
(1R,2R)-1,2-dimethoxy-1,2-diphenylethane 5[14] 
In a round bottom flask, 560 mg (11.60 mmol) of NaH (60% in mineral oil) was 
washed 3 times with pentane before it was dissolved in 15 mL dry THF. To this solution 
1.00 g (4.7 mmol) of (R,R)-benzoin was added and the resulting mixture was heated 
until reflux for 30 min. Subsequently the mixture was cooled to 0 °C and 1.12 mL (9.8 
mmol) dimethylsulfite was added. The reaction mixture was stirred for 15 h at r.t., after 
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which the reaction was quenched with aq. sat. NH4Cl, the resulting water layer was 
extracted with Et2O (3 times). The combined organic layers where washed with sat. 
aq. NaHCO3 and brine, dried over MgSO4 and concentrated in vacuo. Purification by 
recrystallization form hexane yielded 636 mg (2.26 mmol, 51%) product as colourless 
crystals. 1H-NMR (CDCl3, 400 MHz): δ (ppm) = 7.20 – 7.13 (m, 6H), 7.04 – 6.97 (m, 4H), 
4.31 (s, 2H), 3.27 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 138.20 (C), 127.83 (CH), 127.82 (CH), 
127.60 (CH), 87.69 (CHOMe), 57.14 (CH3).
lithium diisopropylamide 6 (LiCl free)[19]
A 250 mL double Schlenk flask with an attached P3 fine-mesh glass frit was charged 
with 550 mg (79 mmol) lithium shavings, 11.14 mL (79 mmol) diisopropylamine and 
40 mL dimethylethylamine. The flask was submerged in a water bath at 25 °C while 8 
mL (79 mmol) isoprene in 15 mL dry dimethylethylamine was added over the period 
of 1h. The resulting reaction mixture was filtered and the solvent was removed under 
reduced pressure, yielding the crude LDA as a white solid. The LDA was transferred, 
in a glovebox, and 100 mL of hexane was added to the solid, the resulting slurry 
was stirred for 2h at 60 °C after which most of the LDA was dissolved. The solution 
was filtered and the filtrate was slowly cooled to – 78 °C. At this temperature the 
product slowly precipitated from the solution over a period of 7 days. In a glove box 
the resulting white precipitate was filtered off and washed 3 times with hexane and 
subsequently dried in vacuo yielding 5.6 g (52 mmol, 66%) of the pure product. 1H 
NMR (400 MHz, DMSO-d6) δ 2.74 (hept, J = 6.2 Hz, 2H), 0.88 (d, J = 6.2 Hz, 12H). ; 13C 
NMR (101 MHz, DMSO) δ 44.82 (CH), 23.62 (CH3).[20]
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In this chapter attrition enhanced deracemization of a chiral pyrrolidinone is 
investigated. After successful synthesis of the pyrrolidinone it is confirmed that this 
compound indeed crystallizes as a conglomerate. Having a conglomerate crystallization is 
one of the prerequisites of attrition enhanced deracemization. Subsequently racemization 
conditions are sought, because racemization in solution is the second requirement to 
obtain attrition enhanced deracemization via crystallization. Due to similarities of the 
pyrrolidinone to hydroxyfuranone, which racemizes under ambient conditions in the 
presence of acid or base as a result of tautomerisation, first acid and base catalyzed 
racemization was investigated. As none of the tested acids and bases were able to achieve 
racemization it is concluded that the γ-proton of pyrrolidinone is much less prone to 
tautomerization than the γ-proton of hydroxyfuranone. Subsequently racemization via 
Pd-allyl formation was explored. Analysis of the reaction mixture, following attempted 
Pd-catalyzed racemization, shows that different side reactions occur leading to a complex 
product mixture. 
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4.1 Introduction
The previous two chapters focused on developing asymmetric autocatalytic 
reactions, as these type of reactions can amplify homochirality. Besides via asymmetric 
autocatalysis, homochirality can be obtained in the solid phase via attrition enhanced 
deracemization. That enantiomerically pure crystals can be obtained from a racemic 
mixture was first discovered by Kondepudi et al..[1] They found that when NaClO3 
crystals are stirred over time in a super saturated solution, homochirality emerges 
in the solid phase (Figure 4.1a). NaClO3 is an enantiomorphous material, meaning 
that in solution it is achiral but it crystalizes as two enantiomeric crystals. First it was 
hypothesized that the symmetry breaking occurs due to the formation of a chiral 
“mother crystal”. Stirring would break the homochiral mother crystal into multiple 
small daughter crystals, which all contain the same chirality. It was hypothesized 
that these daughter crystals grow more rapidly than the crystals of the opposite 
enantiomer. In this way, in the solid phase only a single enantiomer is observed. 
More than a decade later this theory was discarded by Viedma.[2-4] By following the 
deracemization of NaClO3 crystals over time, he found that in the beginning the solid 
phase is nearly racemic. This observation provided evidence that the homochiral 
solid phase arises via another process than the mother crystal theory.[2, 3] The mother 
crystal theory was also theoretically discarded by Blackmond.[5] She introduced the 
term “chiral amnesia” to emphasize that as soon as a the NaClO3 crystals are dissolved, 
no chiral memory is present. Since in a saturated solution there is an equilibrium 
between the compound in solution and in the solid phase, another driving force 
is required to obtain a homochiral solid phase other than a “mother crystal”.[5] It is 
now generally accepted that Ostwald ripening,[6] a process that describes the growth 
of larger crystals at the expense of smaller crystals, is the driving force behind the 
formation of a homochiral solid phase.[4, 5, 7] 
To obtain single chirality in the solid phase via attrition enhanced deracemization, a 
system needs to fulfill two requirements. First a compound has to be able to form two 
distinct enantiomerically pure crystals, as a conglomerate does. Second, in solution 
an equilibrium between both enantiomers (racemization) needs to be obtained. 
Enantiomorphic materials such as NaClO3 fulfill these requirements automatically, 
since as soon as they dissolve, they become achiral and therefore they “racemize” in 
solution. 
When these requirements are met, the overall system works as follows. In a 
supersaturated solution there are several equilibria present between the solid phase 
and the solution phase and between both enantiomers in solution phase (Figure 
4.1). As soon as the surface area of one enantiomeric crystal is slightly larger than the 
surface area of its mirror image, this enantiomeric crystal will grow faster (Ostwald 
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ripening). This is in principle an autocatalytic process, since as one enantiomer grows 
faster due to a larger surface area, the surface area of this enantiomer will increase 
even further and thereby accelerate its own formation. However, the enantiomeric 
crystal with a larger surface area can only keep on growing if this enantiomer is 
present in the solution. Therefore racemization needs to occur in solution to ascertain 
the presence of both enantiomers in solution at all time. In situ racemization also 
provides a way to obtain yields well above the theoretical 50%.[8, 9] 
Figure 4.1:  Schematic representation of a) NaClO3 that crystalizes as two separate enantiomeric 
crystals but is achiral in solution, b) two enantiomers that racemize in solution and 
crystalize as enantiopure crystals.
Noorduin et al.[10] provided the first proof of concept that attrition enhanced 
deracemization could be used, besides on enantiomorphous materials, on 
conglomerates (Figure 4.1b). Conglomerates are chiral compounds of which the 
enantiomers crystalize separately as two enantiomerically pure crystals.[11] They were 
able to obtain a homochiral solid phase of amino acid derivative 1 in water by stirring 
1 in the presence of glassbeads and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) as a 
base. DBU is capable of deprotonating the α-carbon and thereby racemizing amide 
1 (Scheme 4.1). The glassbeads are added to grind the crystals to increase the crystal 
surface area, as this accelerates the deracemization process. 
Scheme 4.1: Racemization of 1.
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Subsequently other amino acid derivatives[12] and isoindolinones[13] have 
successfully been used in attrition enhanced deracemization. In 2014 Steendam et 
al. reported the possibility of forming the chiral β-amino ketone 2 in situ from achiral 
starting materials (Scheme 4.2), thereby providing a system capable of obtaining 
homochirality, in the solid phase, from achiral building blocks.[14] 
Scheme 4.2: Attrition enhanced deracemization of 2 formed in situ from achiral building blocks.
When several attrition enhanced deracemization experiments are performed, the 
enantiomeric outcome should be a statistic distribution. The statistical distribution 
arises from the fact that the enantiomeric crystal which has the largest surface area is 
randomly formed. This results in half the time the formation of one enantiomer and 
the other half the formation of its mirror image. The stereochemical preference of the 
experiment can be directed by starting with a slight excess of one of the enantiomers, 
by adding an additive or even by changing the order of addition.[15] In 2009 Noorduin 
et al. reported that circular polarized light (CPL) can be used to direct the outcome 
of the attrition enhanced deracemization.[16] The use of CPL to direct the chirality is 
especially interesting since in several regions of the universe CPL is present (Section 
1.1).[17] Therefore CPL is one of the agents capable of directing chirality in our universe, 
CPL is for instance considered responsible for the enantiomeric excess found in certain 
compounds present on meteorites.[18-20] 
4.2 Goal
As described in the introduction, attrition enhanced deracemization is an effective 
way of obtaining homochirality in the solid phase. The challenge of this method 
lies in the pre-conditions that need to be fulfilled, since this system only works 
for conglomerates, because only conglomerates form enantiopure crystals. It is 
estimated that only 10% of all solids form conglomerates, which is a limiting factor for 
this method.[11] Furthermore it is necessary to be able to racemize the conglomerate 
under conditions that are compatible with the crystallization conditions.
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Figure 4.2: Pyrrolinone 3.
Pyrrolinone 3 was, during previous projects in our group, discovered to be a 
conglomerate (Figure 4.2).[21] Furthermore it was shown that a comparable compound, 
hydroxyfuranone 4 racemizes upon standing in solution (solvent), probably due to 
an extended keto-enol tautomarization which makes the γ-proton relatively acidic. 
Deprotonation of the γ-carbon therefore occurs readily, leading to the racemization 
of hydroxyfuranone 4 (Figure 4.3).[22, 23] We envisaged that the γ-proton of pyrrolinone 
3 would also be relatively acidic and that therefore pyrrolinone 3 could be racemized 
under basic conditions. If base catalyzed racemization of pyrrolinone 3 could be 
obtained, the two requirements for attrition enhanced deracemization would be 
fulfilled: i) a conglomerate ii) that can be racemized under conditions compatible with 
crystallization.






Figure 4.3: Racemisation mechanisms of hydroxyfuranone 4.
4.3 Results and discussion
4.3.1 Synthesis of pyrrolinone 3 
To allow the screening of racemization conditions for pyrrolinone 3, the 
compound first needed to be synthesized as a racemate and as a single enantiomer. 
For the synthesis we relied on a synthetic method previously reported from our 
laboratory.[24, 25] In the first step freshly distilled furfural is photo-oxidized to form 
ultimately hydroxyfuranone 4, according to the mechanism depicted in scheme 
4.3. The mechanism revolves around a photo-oxidation induced 4 + 2 cycloaddition 
between the diene moiety of the furfural and the singlet oxygen, providing 
intermediate peroxide 5.[26] Subsequently the aldehyde can be eliminated once hemi-
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acetal 6 is formed with methanol, which is present as solvent. Now that an alcohol 
functionality is obtained, a shift of the lone pair of the oxygen of the hydroxyl group 
occurs, leading to the breakage of the bond between the aldehyde carbon and the 
endoperoxyde ring formation. The subsequent opening of the strained peroxide 
















Scheme 4.3:  Mechanism of the photo-oxidation of furfural in the presence of singlet oxygen in 
methanol.
This reaction was first published in 1953 by Schenck, however the reactionwas 
performed in ethanol to provide ethoxyfuranone 7 (Figure 4.4).[29] This is most likely 
the result of insufficient cooling during the photo-oxidation reaction. The subsequent 
step in the reaction, the acetal formation, proceeds while heating the hydroxyfuranone 
in methanol or ethanol and can therefore occur during the photo-oxidation, if the 
reaction mixture exceeds the temperature at which the acetal forms. It is necessary 
to keep the temperature below 20 °C during the work up if hydroxyfuranone 4 is the 
desired product.[25, 26] 
Figure 4.4: 5-Ethoxyfuran-2(5H)-one 7.
Since in our case the synthesis of methoxyfuranone 8 was the subsequent reaction 
step, it was decided to evaporate the methanol under reduced pressure at 40 °C 
(Scheme 4.4). This led to a mixture of the hydroxyfuranone 4 and the methoxyfuranone 
8. Column chromatography was used to separate the two compounds. Starting 
from 65 g furfural we were able to obtain 8.4 g of hydroxyfuranone 4 (13%) and 
25.5 g of methoxyfuranone 8 (33%). Literature reports yields varying from 42%[30] to 
quantitative[24] for this reaction. When the acetal formation was performed starting 
from hydroxyfuranone 4, 88% yield of methoxyfuranone 8 could be obtained. 
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Scheme 4.4: Synthesis of pyrrolinone 3.
Subsequently, methoxyfuranone 8 was stirred for 1 h at 0 °C in saturated aqueous 
ammonia yielding pyrrolinone 9 as a yellow solid. Keeping compound 9 open to air 
quickly deteriorates the compound, turning it from a yellow solid in to an insoluble 
brown sticky oil. Further purification of pyrrolinone 9 was therefore avoided by using 
the crude pyrrolinone 9 immediately in the subsequent acetylation step.[22, 25] The 
desired pyrrolinone 3 was obtained in 52% yield over the final two steps. 
4.3.2 Screening racemization conditions for pyrrolinone 3
To allow screening of racemization conditions, a sample of the chiral compound 
needed to be obtained. When crystalizing pyrrolinone 3 from toluene, crystals 
could be obtained of high ee (> 90%), the ee was determined via chiral GC using 
methods previously reported from our laboratories.[22] It is only possible to obtain 
enantioenriched crystals through a simple crystallization if the compound is a 
conglomerate, because, by definition, a conglomorate crystalizes as separate 
enantiopure crystals instead of a racemic crystal. Therefore the fact that enantiopure 
crystals were obtained from racemic 3, confirmed our previous finding that 
pyrrolinone 3 is indeed a conglomerate. The obtained enantiopure crystals could 
subsequently be used for the screening of racemization conditions. However, due 
to the small quantitities of enantiopure compound that could be obtained via this 
method, we chose to perform a kinetic resolution[31] of pyrrolinone 3 with immobilized 
Candida antartica lipase B (CALB).[32, 33] CALB is capable of selectively hydrolysing (R)-
3, as a result enantioenriched (S)-3 is obtained, together with racemic 10 (Scheme 
4.5). The absolute stereochemistry of pyrrolinone 3 was previously determined in our 
laboratories.[25] By treating 3 with CALB we were able to obtain (S)-3 in 56% yield and 
76% ee. The obtained ee is significantly lower than the ee reported in literature (>95%). 
This difference is most likely due to the use of an deteriorated enzyme batch. For the 
purpose of screening the racemization conditions the obtained ee was sufficient to 
proceed with this material. 
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Scheme 4.5: Kinetic resolution by transesterification of pyrrolinone 3 using CALB.
Based upon the hypothesis that the γ-proton is relatively acidic, racemization 
of the pyrrolinone 3 was first attempted using various bases (Scheme 4.6 B). To 
obtain our end goal of attrition enhanced deracemization, it is necessary for the 
racemization conditions to be compatible with the crystallization conditions. 
Therefore all racemization experiments were performed in acetone and toluene. 
First diazabicycloundecene (DBU) was tested, since this base was also used in 
the racemization of 2-(benzylideneamino)-2-phenylacetamide 1.[7] After 7 days 
no racemization was observed, therefore subsequently stronger alkali bases, like 
NaOH and KOtBu were examined. However these alkali bases also did not yield any 
detectible racemization after 3 days. Subsequently we tried heating the reaction 
mixture to 40 °C, but after 3 days still no racemization occurred in the presence of any 
of the previously named bases. 
Scheme 4.6: Acid and base catalyzed pathway of racemization of pyrrolinone 3.
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Since protonation of the carbonyl functionality could also promote racemization, 
via the hydropyrrole intermediate, we therefore switched to acids as racemization 
agents (Scheme 4.6 A). Trifluoroacetic acid (TFA), citric acid (CA), and para toluene 
sulfonic acid (pTSA) were screened as racemization agents in acetone and toluene 
as solvents. TFA and CA did not show any racemization. After stirring the reaction 
mixture, in acetone or toluene, for 3 days, no decrease in ee was observed. When pTSA 
was used, especially at elevated temperatures, racemization did occur albeit slowly. 
However the observation of multiple unknown signals in the GC-chromatogram 
indicates that, besides racemization, degradation takes place. Since the degradation 
proceeded faster than the racemization of pyrrolidone 3 this method of racemization 
was abandoned. 
Finally, palladium catalyzed racemization was investigated. The mechanism for 
palladium catalyzed racemization is based upon the formation of Pd-allyl species 
11 (Scheme 4.7).[34] Pd-allyl complex are chiral, however when no nucleophile is 
present to trap the Pd-allyl species the palladium can migrate to the other π-face of 
the molecule. This migration occurs via the formation of a σ-species where the Pd is 
bound to oxygen, which has previously been described for furanones by the group of 
Trost.[35, 36] We hypothesized that racemization of 3 could occur by forming the σ-Pd 
species from the π-species (Figure 4.7). It is expected that the racemization would 
occur readily since only the eliminated acetate is present as a nucleophile providing 
time for the racemization to occur. If 11 would racemize in solution, subsequent re-
addition of the acetate group would occur on both faces of the molecule providing 
























Scheme 4.7: Racemization with Palladium, by forming the Pd-allyl species.
As palladium source Pd(PPh3)4 was chosen. Initial experiments at room temperature 
did not show any racemization. Subsequently heating of the reaction mixture led to 
multiple unidentified products. It is likely that at elevated temperatures the acetate 
group does not only adds to the γ-carbon, which is desired, but also to other positions 
once that Pd-allyl species 11 is formed. Since higher molecular weight compounds are 
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found in the GC-MS spectra it is likely that besides re-addition of the acetate, coupling 
or polymerization occurs. It was therefore concluded that palladium catalyzed 
racemization was not a viable method to obtain racemic pyrrolidinone 3. Since 
no racemization conditions could be found that did not show degradation of the 
product, this project was stopped and our efforts focused on obtaining homochirality 
via a different process. 
4.4 Conclusions
In this chapter attrition enhanced deracemization of pyrrolidinone 3 was 
investigated. After successfully synthesizing pyrrolidinone 3 it was confirmed via 
crystallization that this compound forms indeed a conglomerate. Subsequently 
racemization conditions where sought, so that attrition enhanced deracemization 
could be obtained. First, acid and base catalyzed racemization of pyrrolidinone 3 
was investigated, since it was known that a similar compound hydroxyfuranone 
4 racemizes upon standing, due to the high acidity of its γ-proton. The γ-proton of 
pyrrolidinone 3 proved to be much less acidic than the γ-proton of hydroxyfuranone 
4. None of the investigated bases were capable of achieving racemization. In the 
case of acid catalyzed racemization only pTSA showed racemization. However, in 
this case also significant degradation was observed. Finally, obtaining racemization 
via Pd-allyl formation was investigated. Also palladium catalyzed racemization 
proved inadequate since many side reactions occurred during the process. Since no 
effective racemization conditions could be found in the solution phase, no attrition 
enhanced deracemization could be obtained in the solid phase at this stage. Perhaps 
racemization of pyrrolidinone 3 could be obtained via a Pd-allyl species when the 
ligands coordinating to the palladium are less sterically bulky, to facilitate the η3-η1 
isomerisation. 
4.5 Experimental
Dry solvents were taken from an MBraun solvent purification system (SPS-800). Thin 
layer chromatographic (TLC) analysis was performed on Merck silicagel 60/Kieselguhr 
F254, 0.25 mm TLC plates and spots were visualized by UV and staining with KMnO4 
stain. Column chromatography was performed using silica gel (P60, 230 – 400 mesh). 
1H-NMR- and 13C-NMR spectra were recorded on a Varian AMX400 (400 and 100.59 
MHz, respectively) using CDCl3 as a solvent (CDCl3: δ 7.26 for 1H-NMR, δ 77.16 for 
13C-NMR). Data are reported as follows: chemical shifts, multiplicity (s= singlet, 
d= doublet, t= triplet, q= quartet, qi= quintet, br= broad, m= multiplet) coupling 
constants J (Hz) and integration.
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High resolution mass spectrometry (HRMS) was carried out on a LTQ ORBITRAP XL 
spectrometer (Thermo Scientific) employing electron impact ionization in positive ion 
mode (EI+) and negative ion mode (EI-). 
Optical rotations were measured on a Schmidt + Haensch polarimeter (Polartronic 
MH8) with a 10 cm cell (concentration c given in g/100 mL). Melting points were 
measured on a Büchi B-545 and recorded in °C. All chemicals and reagents, were 
purchased from commercial suppliers (Acros, TCI and Sigma-Aldrich). The immobilized 
enzyme CALB was purchased from Sigma-Aldrich. 
4.5.1 General procedure for the racemization experiments
A) Acid/Base racemization
A sample of 2-5 mg of (S)-3 was dissolved in 2 mL acetone or toluene to this solution 
+/- 0,01 mmol of base or acid was added. The reaction mixture was stirred for at least 3 
d while the progress of the reaction was followed via GC-FID (Chiraldex G-TA capillary 
column, at 140 °C) retention time (S): 10.56 min (R): 13.86 min
B) Pd catalyzed racemization
In a dried flask 5 mg of (S)-3 was dissolved in 5 mL toluene. To this solution a spatula 
tip of tetrakis(triphenylphosphine)palladium (0) was added. The solution was left 
at r.t. or heated to 60 °C while the progress of the reaction was followed via GC-FID 
(Chiraldex G-TA capillary column, at 140 °C) retention time (S): 10.56 min (R): 13.86 
min.
5-hydroxyfuran-2(5H)-one 4[24]
In a large container 56.5 mL (676 mmol) freshly distilled furfural was dissolved in 
390 mL methanol together with 10 mg methylene blue. The starting material was 
photooxygenated using an in house build set up, in which oxygen was added through 
a glass filter (P2) in to the reaction vessel, kaptan 500 H was used as UV filter and 
a Hanau Q 700 lamp was used as the light source. Evaporation of the solvent at 40 
°C and subsequent column chromatography (SiO2, pent/acetone, 3/1) yielded 8.4 g 
(13%) of hydroxyfuranone 4 as a white solid and 25.5 g (33%) methoxyfuranone 8 as a 
pale yellow oil. Caution: prior to work-up check for peroxides using standard peroxide 
tests. 1H NMR (300 MHz, CDCl3) δ 7.31 (d, J = 7.0 Hz, 1H) , 6.13 (d, J = 7.0 Hz, 1H), 5.83 
(s, 1H), 5.41 (br.s, 1H); 13C NMR (125 MHz, CDCl3) δ 171.3 (C), 152.0 (CH), 124.6 (CH), 
98.7 (CH).
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5-methoxyfuran-2(5H)-one 8[24]
In a round bottom flask 1 g (10 mmol) of 5-hydroxyfuran-2(5H)-one was dissolved 
in 5 mL methanol and the solution was stirred while heated at reflux for 3 d. 
Evaporation of the solvent gave the crude product, which was purified using column 
chromatography (SiO2, pent/acetone, 3/1) yielding 1.00 g (8.8 mmol, 88%) of the 
product as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.20 (dd, J = 5.7, 1.2 Hz, 1H), 
6.24 (dd, J = 5.7, 1.2 Hz, 1H), 5.86 (t, J = 1.2 Hz, 1H), 3.58 (s, 4H); 13C NMR (100 MHz, 
DMSO-d6) δ 170.21 (C), 150.62 (CH), 124.40 (CH), 103.92 (CH), 56,31 (CH3). 
5-hydroxy-1,5-dihydro-2H-pyrrol-2-one 9[25]
To 60 ml ice cold sat. aq. NH3, 5.0 g (44 mmol) 5-methoxyfuran-2(5H)-one was added 
slowly. The reaction mixture was allowed to stir at 0 °C for 1h. The reaction mixture was 
concentrated in vacuo, ensuring the temperature did not exceed 25° C. Subsequently 
the water was removed by freeze drying the solution. This provided 4.35 g (38 
mmol, 86%) of the crude product as a pale yellow solid. Due to the instability of this 
compound it was always freshly prepared and immediately used in the subsequent 
reaction step. 1H NMR (400 MHz, DMSO-d6) δ 6.97 (dt, J = 5.7, 1.5 Hz, 1H), 5.96 (dt, J 
= 5.7, 1.3 Hz, 1H), 5.43 (s, 1H); 13C NMR (100 MHz, DMSO-d6) δ 171.99 (C), 149.58 (CH), 
127.50 (CH), 80.17 (CH). 
1-acetyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl acetate 3[25]
In a round bottom flask 4.35 g (38 mmol) 5-hydroxy-1,5-dihydro-2H-pyrrol-2-one 
was dissolved in 5.5 mL pyridine at 0 °C. To this solution 10.4 mL (110 mmol) acetic 
anhydride was added slowly and the reaction mixture was stirred overnight at r.t.. The 
reaction mixture was diluted with Et2O and the resulting mixture was washed several 
times with sat. aq. CuSO4. The organic layer was dried with MgSO4 and the solvent 
was evaporated in vacuo, while maintaining the temperature below 25 °C. The crude 
product was dissolved in DCM and filtered over silica. After evaporation of the DCM, 
the resulting crude solid was recrystallized from acetone yielding 4.42 g (23.1 mmol, 
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52 % over 2 steps) of the product as clear crystals. 1H NMR (400 MHz, CDCl3) δ 7.17 (dd, 
J = 6.0, 1.8 Hz, 1H), 7.11 (d, J = 2.0 Hz, 1H), 6.24 (d, J = 6.0 Hz, 1H), 2.54 (s, 3H), 2.11 (s, 
3H); 13C NMR (100 MHz, CDCl3): δ 169.24 (C), 168.60 (C), 168.01 (C), 144.90 (CH), 128.53 
(CH), 80.03 (CH), 24.25 (NCOCH3), 20.29 (OCOCH3).
(S)-1-acetyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl acetate (S)-3
Method A, crystallization:
In a roundbottom flask 1 g racemic 3 was stirred with a small amount of toluene 
and heated at reflux. While heating toluene was added until 3 is completely dissolved. 
The hot solution was filtered over a pre-warmed filter that was wetted with toluene 
in to a pre-warmed Erlenmeyer. The Erlenmeyer with the warm solution was slowly, 
on, cooled to r.t.. After cooling crystallization has taken place and small enantiopure 
crystals (both R and S) can be obtained.
Method B, enzymetic hydrolysis: 
In a grinder tube 500 mg (2.73 mmol) racemic 3 was dissolved in 5 mL n-butanol and 
to this solution 50 mL of a 3/1 mixture of n-butanol/n-hexane was added. Immobilized 
candida antartica B was added to the mixture, which was subsequently rotated at 
r.t. for 60 h. The mixture was filtrated over a P3 glass filter to remove the enzyme, 
which after washing with acetone, could be reused. The filtrate was concentrated in 
vacuo securing that the temperature did not exceed 25° C. The resulting solids were 
separated via column chromatography (SiO2, EtOAc/pent; 1/1) yielding 140 mg (0.76 
mmol, 56%) of (S)-3 as white clear crystals with an ee of 76%, and 185 mg (1.31 mmol, 
96%) of the racemic 1-acetyl-2,5-dihydro-2H-pyrrol-2-one. 1H NMR (400 MHz, CDCl3) δ 
7.17 (dd, J = 6.0, 1.8 Hz, 1H), 7.11 (d, J = 2.0 Hz, 1H), 6.24 (d, J = 6.0 Hz, 1H), 2.54 (s, 3H), 
2.11 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 169.24 (C), 168.60 (C), 168.01 (C), 144.90 (CH), 
128.53 (CH), 80.03 (CH), 24.25 (CH3), 20.29 (CH3).
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Chapter introduction
Difference in solubility between a racemic compound and its pure enantiomer is a 
simple, robust and prebiotically viable method to amplify a tiny chiral bias to obtain high 
ee’s in the solution phase. Here we show that phosphoramidites have an exceptionally 
large difference in solubility between racemate and pure enantiomers leading to ee’s in the 
aqueous phase of >98%, starting with nearly racemic compounds. X-ray crystallography 
was used to show a clear difference in packing between the racemate and the homochiral 
compound. The racemate is capable of forming a stable heterochiral dimer whereas the 
homochiral compound has a completely different and apparently less favorable packing 
enhancing solubility. A phosphoramidate derived from phenyl alanine also showed a 
large difference in solubility leading to high ee’s in the solution phase. This compound 
turned out to be prone to slow hydrolysis yielding the free amino acid in high ee’s in the 
aqueous phase. We will finally show that this phenomenon can be used to detect minute 
imbalances in ee, in compounds that are nearly racemic.
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5.1 Introduction
Homochirality of its essential molecules i.e. amino acids, sugars and DNA, is a 
characteristic of biological systems[1-6] and has been denoted a signature of life.[7, 8] The 
presence of single enantiomers is considered a prerequisite for the information transfer 
essential in the origin of life and several theoretical models[3, 9] and experimental 
approaches[1-3, 10] toward the emergence of biomolecular homochirality have been 
reported. The problem of the origin of single handedness in chiral molecules, 
which is considered to be highly significant to chemical evolution, presents two 
fundamental questions; first there needs to be a symmetry breaking event to yield an 
initial imbalance of enantiomers and subsequently an amplification mechanism[9] is 
required to sustain and propagate the chiral bias to provide a large set of homochiral 
building blocks[11] or induce chirality at different length scales.[12] 
Approaches to achieve amplification of homochirality include asymmetric 
autocatalysis pioneered by Soai,[13] physical models based on differences in solubility 
of enantiomers and racemates[14] or crystallization[15] and sublimation behavior[16, 
17] (conglomerates vs racemates)[18], and aggregation.[12, 19] Especially the attrition-
enhanced deracemization of conglomerates (involving Ostwald ripening)[20], 
pioneered by Viedma,[21] to obtain solid phase homochirality has recently received 
major attention.[22] To arrive at enantiomer-enriched compounds in solution, 
advantage is taken of the eutectic model,[23] with selective partitioning of enantiomers 
between liquid and solid phase and preferred crystallization of racemic (heterochiral) 
crystals. This mechanism for solution phase amplification was explored by Morowitz,[24] 
Breslow,[25] Hayashi[26] and Blackmond[23, 27] for a range of amino acids and applied 
in chirality transfer for instance in catalytic asymmetric aldol reactions.[23, 26] Taking 
advantage of the sensitivity of molecular composition in a co-crystallization process 
to additives, as elegantly demonstrated by Lahav,[28] methods were developed to 
modify eutectic ee values resulting in an increase of the solution phase enantiomeric 
enrichment of several amino acids. 
5.2 Goal
Major outstanding challenges are associated with the design of prebiotic relevant 
systems to achieve high enantiomeric enrichment in water, enhance eutectic ee values 
and change solubility and crystallization behavior (conglomerate vs racemate) by 
simple derivatization. As part of our continuous efforts towards chiral amplification[2, 
12, 16, 29, 30] we envisioned a key role for phosphorylation. Phosphorylation results in 
favorable water interactions which might enhances non-linear effects via aggregation 
and additionally phosphorylation changes the hydrogen bonding pattern and as 
a consequence the crystallization behavior. Here we show that the formation of 
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phosphoramidates of amines and amino acids result in exceptionally large difference 
in solubility between racemates and enantiomers. Both pentavalent phosphorus 
and water seem to play a key role in this chiral amplification whereas spontaneous 
hydrolysis delivers an enantiomeric enriched aqueous solution of free amino acid.  
5.3 Results and discussion
We started our investigations with phosphoramidates of simple chiral amines e.g. 
alpha-phenylethylamine (Figure 1a), envisioning that hydrogen bonding might lead 
among others to dimer formation and water binding with the potential of enhanced 
stereoselection through the diastereotopic alkoxy moieties at phosphorus. The 
phosphoramididates 1-5 where obtained either using an Atherton-Todd reaction in 
ethanol-water starting with the corresponding phosphite (Figure 1b) or alternatively 
using phosphoryl chloride in dichloromethane with trimethylamine as base (Figure 
1c). In preliminary experiments we observed that the racemate of phosphoramidate 
1 was obtained a white solid while enantiomerically pure 1 could only be isolated 
as a viscous oil. Furthermore addition of a few ml’s of water to scalemic 1 with low 
enantiomeric excess (ee =5%) resulted in dissolution of mainly a single enantiomer 
resulting in an aqueous solution of 1 with high ee (> 90%). 
Figure 1:  Chiral phosphoramidates. Top: synthesis of phosphoramidate via Atherton – Todd 
procedure from the diisopropyl phosphite; Bottom: Investigated phosphoramidites.
In order to obtain more precise information on the amount of 1 dissolved and 
the ee in water a ternary phase diagram (TPD) was constructed (Figure 2).[18, 23, 31] The 
ternary phase diagram includes three components, i.e. both enantiomers (base of 
triangle) and the solvent (apex), with the concentration expressed as mole fraction 
providing more informative insight in the amount of compound in solution and ee 
for all possible scalemic mixtures. For the construction of the ternary phase diagram 
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(TPD) of phosphoramidate 1, chiral HPLC (see SI) was employed to determine both 
the ee and the concentration of 1 in the aqueous phase in the presence of 1,1’-(1E)-
1,2-ethenediylbis-benzene as internal standard (Figure 2). The scalemic mixtures 
where dissolved in DCM and their ee was measured via HPLC. After evaporation of the 
solvent 20 mg of the scalemic mixture was brought into a glass vessel to which 2 mL 
doubly distilled water was added. The mixture was stirred for at least 30 h at 25 °C in 
a temperature controlled water bath. Next the samples where filtered before drying 
and dissolving in a heptane/ isopropanol mixture with internal standard in order to 
determine the concentration and the ee of the aqueous phase. The intial ee of the 
solid, the final ee of the aqueous solution and the amount of compound in mg/ mL 
are listed in table 1. 
It should be noted that from the TPD shown in figure 2 it is evident that for 
phosphoramidate 1 in water an eutectic point is not observed. This results in ee values 
higher than 97% for 1 in the solution phase almost irrespective of the starting ee. 
Figure 2: Zoom in of the TPD of diisopropyl (1-phenylethyl)phosphoramidate 1 in water.
sample 1 2 3 4 5 6
Initial ee[a] 1 4 5 17 50 98
Final ee[a] 2 90 91 97 97 98
mg/ mL[b] 0,27 1,24 1,51 2,37 2,19 2,97
Table 1.  Initial and final ee’s measured for several scalemic mixtures of phosphoramidate 1.[a] All 
ee’s where determined by chiral HPLC analysis using a Chiralcel AD column, n-heptane–
i-PrOH 90 : 10, 40 °C. [b] All concentrations where determined by HPLC analysis using 
1,1’-(1E)-1,2-ethenediylbis-benzene as internal standard
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To gain more information on the structure of the solid racemate of 1, which is not 
soluble in water, X-ray analysis was performed. The crystal structure of racemic 1 is 
composed of a dimer of the two enantiomeric forms (Figure 3). Hydrogen bonding 
between the P=O and the N-H moiety of the other enantiomer is observed, which 
stabilizes the heterochiral dimer. Unfortunately, all our attempts to obtain crystal 
structures of enantiopure phosphoramidite 1 were unsuccessful. We hypothesize, 
also based on X-ray analysis of phosphoramidate 4 (vide infra) that the enantiopure 
phosphoramidite 1 is not capable of forming a stable homochiral dimer due to steric 
interactions between the phenyl group and the isopropyl groups on the phosphonate. 
The absence of a stable crystal structure results in an increased solubility of the 
pure enantiomer compared to the racemate. Additionally 1H-NMR titration data of 
enantiomerically pure 1 with water shows a downfield shift of the NH proton upon the 
addition of water. This preliminary investigation indicates that water complexation is 
involved enhancing solubility of the homochiral compound.
a) b)
Figure 3:  a) X-RAY structure of racemic dimer DL-phosphoramidate 1 unit. The hydrogen-
bonding geometries of N1-H1···O3 (D-H [l], H···A [l], D···A [l], D-A···A [8]) are 0.816(16) 
[Å], 2.039(17) [Å], 2.8495(13) [Å] and 171.7(15) [°] respectively. b)X-ray structure of 
conglomerate crystal of racemic 4; The hydrogen-bonding of N1-H1···O1 (D-H [l], H···A 
[l], D···A [l], D-A···A [8]) are 0.879 [Å], 2.114 [Å], 2.869 [Å] and 143.31 [°]respectively. The 
halogen-bond length of Br1···O1is 3.245 [Å].
We reasoned that the nature of the alkoxy-substituents at phosphorus and structure 
of the benzylamine moiety could lead to distinct differences in steric effects, solubility 
and chiral aggregation. Unfortunately racemic phosphoramidates bearing methoxy- 
(6) and ethoxy- (7) substituents at phosphorus were oils, therefore no TPD can be 
constructed (Figure 4). We also synthesized cyclic phosphoramidate 8, which is a solid 
at room temperature and is sterically more constricted than phosphoramidites 1. In 
agreement with our hypothesis, phosphoramidite 8 showed a difference in solubility 
that was less pronounced than for compounds 1, and the TPD of compound 8 shows 
a eutectic point at 75% ee (Figure 4).
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Wang[32] and Blackmond[27] have derived a formula to determine the ee at the 
eutectic in an ideal case. Morgenstein et al. have pointed out that this approximation 
is only valid in ideal cases where the eutectic lies close to either the pure racemate 
or pure enantiopure compound.[33] Considering the high eutectic values found for 
N-phospho amines, close to an ideal case, justifi es the use of the simplifi ed formula 
as presented by Blackmond.[27] In this case the , with . 
From this equation it can be derived that if the racemate is insoluble [rac] equals 0, 
irrespective of the solubility of the enantiopure compound, this will lead to an α of 0. 
When α equals zero the eutectic the ee will be . Therefore it can be 
concluded that whether or not an eutectic composition is observed mainly depends 
on the insolubility of the racemate. If the racemate is practically insoluble, as is the 
case for these N-phospho amino acids, high ee’s can be obtained in the solution phase 
due to the absence of an eutectic composition. 
Figure 4: a) Structures of 6-8; b) Relevant part of TPD of phosphoramidate 8.
Modifying the amine moiety it was found that phosphoramidate 2, bearing a 
p-tolylethyl moiety, showed similar solubility behavior as phosphoramidate 1. 
An enormous diff erent in solubility was found between the homochiral and the 
heterochiral compound, providing ee’s exceeding 98% in solution phase and a TPD 
without an eutectic point (Figure 4a). It should be noted that the overall solubility of 
compound 2 in water is almost a factor lower than that of compound 1 (Figure 4a).
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a) b)
Figure 4: Ternary phase diagrams of a) phosphoramidate 2; b) phosphoramidate 3.
Phosphoramidate 3, bearing a m-chlorophenylethyl moiety, shows comparable 
behavior as phosphoramidates 1 and 2, furnishing also an TPD in water without an 
eutectic point (Figure 4b). However, the solubility diff erences between the homochiral 
and heterochiral compounds are slightly smaller than for phosphoramidates 1 and 2, 
providing ee’s around 88% in solution phase. Most scalemic solutions, provide an ee in 
solution of 88%, indicating this as the eutectic point. However the phase diagram does 
not show an eutectic point, so far we do not have an explanation for this observation.
We observed that phosphoramidites 4 and 5, bearing a p-bromo- or p-chloro- 
phenylethyl moiety, present a completely diff erent behavior than phosphoramidites 1 
to 3, showing no diff erence in solubility between the enantiopure compounds and the 
racemates. X-ray analysis of the racemic phosphoramidite 4 shows that it crystallizes 
as a conglomerate which implies enantiopure crystals (Figure 3b). Therefore, no 
diff erence in solubility can be obtained between the racemate and the enantiopure 
compound since they have the same crystal packing. The structure of conglomorate 
crystal 4 shows the presence of sheets where two non-covalent bonds are formed; 
the oxygen of the P=O moiety is involved in one hydrogen bond to the N-H proton. 
A remarkable feature is furthermore a halogen bond[34, 35] present between the Br and 
the oxygen of the P=O stabilizing the interactions between sheets in the crystal lattice. 
These additional interactions may be responsible for the formation of conglomerates 
in the case of phosphoramidites 4 and 5 since both have a halogen atom in the para 
position capable of forming this specifi c halogen bond with neighboring molecules. 
Inspired for the pronounced chiral amplifi cation of phosphoramidites 1-3 and 8, 
we performed some preliminary studies toward the eff ect of alkoxyphosphorylation 
of the amine moiety of phenylalanine as a model amino acid. This amino acid was 
studied both by the groups of Blackmond[27] and Breslow[25] to achieve enantiomeric 
enrichment and the eutectic composition lies at 83% ee in water. Phenylalanine 
derivative 9, bearing a diisopropylphosphoryl moiety at the N-terminus, indeed 
showed the amplifi cation earlier observed for compounds 1-3 (Figure 5a), typically 
88% or higher. Derivation at the N-terminus signifi cantly lowers the solubility of the 
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racemate, likely due to the formation of a stable dimer, as in the case of proline and 
N-phospho amine 1, opening the way to a high ee values of 9 in solution.
Figure 5: Alanine modified with diisopropylphosphoryl at amine moiety.
It is evident that for amino acid derivative 9 a distinct difference is observed 
in solubility for the racemate and enantiomerically pure form. It was established 
that the ee of remaining compound 9 in the water layer is always higher than 
90%. However, compound 9 is not stable in water over longer periods of and we 
observed slow hydrolysis yielding the free amino acid (Figure 5b). Interestingly, 
nearly enantiomerically pure (ee>95%) free amino acid phenylalanine was obtained 
after this spontaneous hydrolysis. This is especially noteworthy considering that the 
eutectic of free phenylalanine was found to be 83%.[27]
In view of the eutectic composition of phenylalanine in water (vide supra) it is 
intriguing to observe that N-phosphorylation followed by dissolution in water and 
subsequent spontaneous hydrolysis leads to enhancement of the enantiomeric 
excess beyond the eutectic value. These findings might point to a novel mechanism 
for chiral amplification of e.g. amino acids in water taking advantage of tailor-made 
derivatization mirroring enhanced conglomerate formation as pioneered by Lahav 
and co-workers.[28] Studies along these lines especially focusing on amino acids with 
low eutectic values or those that form conglomerates are in progress.
  
5.4 Conclusion
In this chapter we showed that phosphoramidites have an exceptionally large 
difference in solubility between racemate and pure enantiomers leading to ee’s in 
the aqueous phase of >98%, starting with nearly racemic compounds. Subsequently 
X-ray crystallography indicated a clear difference in packing between the racemate 
and the homochiral compound, this finding explains the observed difference in 
solubility. The racemate is capable of forming a stable heterochiral dimer whereas 
the homochiral compound has a completely different and apparently less favorable 
packing enhancing solubility. Finally a phosphoramidate derived from phenyl alanine 
was synthesized, this phosphoramidate also showed a large difference in solubility 
leading to high ee’s in the solution phase. It turned out that this compound is prone 
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to slow hydrolysis yielding the free amino acid in high ee’s in the aqueous phase. 




Chromatography: Merck silica gel type 9385 230-400 mesh, TLC: Merck silica gel 60, 
0.25 mm. Components were visualized by UV and cerium/molybdenum staining. Mass 
spectra were recorded on a LTQ Orbitrap XL (ESI+). 1H- and 13C-NMR were recorded on 
a Varian AMX400 (400 and 100.59 MHz, respectively) using CDCl3 as solvent. Chemical 
shift values are reported in ppm with the solvent resonance as the internal standard 
(CHCl3: δ 7.26 for 1H, δ 77.0 for 13C). Data are reported as follows: chemical shifts, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), 
coupling constants (Hz), and integration. Carbon assignments are based on APT 
13C-NMR experiments. Optical rotations were measured on a Schmidt + Haensch 
polarimeter (Polartronic MH8) with a 10 cm cell (c given in g/100 mL). Enantiomeric 
ratios were determined by HPLC analysis using a Shimadzu LC-10ADVP HPLC equipped 
with a Shimadzu SPD-M10AVP diode array detector. The 5,5-dimethyl-4-phenyl-1,3,2-
dioxaphosphinane-2-oxide was synthesized according to literature procedures.[36, 
37] Diisopropylphosphite, 1-(4-bromophenyl)ethanamine and 1-(4-methylphenyl) 
ethanamine, both the racemate and (R) compound, were purchased from TCI. The (R) 
and (S) 1-(3-chloroophenyl)ethanamine, the racemic and (R)-1-phenylethanamine, 
5,5-dimethyl-1,3,2-dioxaphosphinane-2-oxide and the CCl4 were purchased from 
Sigma Aldrich. Racemic and (R)-enantiomer of 1-(4-chlorophenyl)ethanamine and 
benzylamine were purchased from Acros. All solvents were standard laboratorium 
grade solvents purchased from Boom.
5.6 General procedure for the synthesis of phoshoramidates
The amine (9.10 mmol) and Et3N (2.2 mL, 13.2 mmol) were dissolved in ethanol (25 
mL) and cooled to 0 °C. A solution of diisopropylphosphite (0.91 mL, 6.06 mmol) in 
CCl4 (3 mL, 5 eq) was added to this solution with vigorous stirring. After the addition 
the reaction mixture was allowed to warm to r.t. and stirred for 2h. Subsequently 
the reaction was quenched with aq. 1 M HCl (20 mL) and the resulting mixture was 
extracted with DCM (3x 20 mL). The combined organic layers were dried with MgSO4 
and the solvent evaporated under reduced pressure. The crude mixture was purified 
by column chromatography (SiO2 rinsed with Et3N, with Et2O/ DCM 9:1) yielding the 
pure phosphoramidate. Basically all posphoramidates are rotamers therefore the 1H 
NMR spectra are more complicated than initially expected. 
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5.7  General procedure for the formation of the Ternary Phase 
Diagrams[18]
For the construction of the TPD’s 10 mg of compound was dissolved in 1 mL of 
doubly distilled water and stirred for at least 30 h at 25 °C. Subsequently the solution 
was filtered with a PTFE syringe filter. From this solution 500 µL was taken and the H2O 
was evaporated in a Freeze dryer. The resulting solid was dissolved in 600 µL of a 1/1 
isopropylalcohol/ heptane mixture. Of this 600 µL, 500 µL was pipetted in to a HPLC 
vial together with 100 µL of internal standard, usually 1,1’-(1E)-1,2-ethenediylbis-
benzene (10 mM) and 900 µL heptane. The contents of the vial were analyzed via 
HPLC using the column and methods described for the racemic compounds. Via HPLC 
both the enantiomeric excess and the concentration, based on a calibration curve 
against the internal standard, were calculated and the ternary phase diagram was 
constructed. 
diisopropyl (1-phenylethyl)phosphoramidate (1)
Phosphoramidate 1 was obtained starting from 1-phenylethanamine (2.4 mL, 18.2 
mmol) following the general procedure, after purification by column chromatography 
on silica gel that was basified with Et3N (Et2O/ DCM, 9:1) as a white solid in 62% yield 
(2.13 g, 7.5 mmol): mp 89.4-90.9 °C; 1H NMR (400 MHz, CHCl3) δ 7.30 (d, J = 4.3Hz, 4H), 
7.26 – 7.17 (m, 1H), 4.69 – 4.51 (m, 1H), 4.51 – 4.39 (m, 1H), 4.39 – 4.21 (m, 1H), 2.97 (br 
s, NH), 1.46 (d, J = 6.7 Hz, 3H), 1.30 (d, J = 6.2 Hz, 3H), 1.28 (d, J = 6.2 Hz, 3H), 1.24 (d, J 
= 6.2 Hz, 3H), 1.02 (d, J = 6.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 145.28 (d, J = 5.2Hz, 
C), 128.38 (CH), 126.94 (CH), 125.80 (CH), 70.70 (dd, J = 5.6, 2.8, CH), 51.39 (CH), 25.41 
(d, J = 6.4, CH3), 23.84 (d, J = 5.1, CH3), 23.78 (CH3) 23.78 (d, J = 7.2, CH3), 23.46 (d, J = 
5.7, CH3); 31P NMR (162 MHz, CDCl3) δ 5.52; HRMS (ESI-, m/z): calculated for C14H25NO3P 
[M + H+]: 286.1567, found: 286.1565; Anal. Calcd. for C14H24NO3P: C, 58.93; H, 8.48; N, 
4.91. Found: C, 59.11; H, 8.61; N, 4.93. Enantiomeric excess was determined by chiral 
HPLC analysis, Chiralcel AD column, n-heptane–i-PrOH 90 : 10, 40 °C, 1 mL min-1, 220 
nm, retention times (min) t1: 10.36 (S) and t2: 12.02 (R).
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(R,S)-diisopropyl (1-(p-tolyl)ethyl)phosphoramidate (2)
Phosphoramidate 2 was obtained starting from 1-(p-tolyl)ethanamine (1.31 g, 9.10 
mmol) following the general procedure, after purification by column chromatography 
on silica gel rinsed with Et3N (Et2O/ DCM, 9:1) as a white solid in 55% yield (1.0 g, 3.3 
mmol) mp: 90.5-91.8 oC; 1H NMR (400 MHz, CHCl3) δ = 7.15 (dd, J=8.1 Hz, 4H), 4.51 (m, 
2H), 4.29 (q, J=7.1 Hz, 1H), 2.92 (t, J=9.3 Hz, NH), 2.31 (s, 3H), 1.44 (d, J=7.1 Hz, 3H), 
1.31 (d, J = 6.0 Hz, 5H), 1.28 (d, J = 6.6 Hz, 6H), 1.25 (d, J = 6.5 Hz, 5H), 1.05 (d, J=6.2 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 142.33 (C), 136.49 (C), 129.01 (CH), 125.67 (CH), 70.73 
(CH), 70.62 (CH), 51.08 (CH), 25.36 (d, J = 5.5, CH3), 23.83 (d, J = 5.1, CH3), 23.78 (CH3), 
23.77 (d, J = 6.0, CH3), 23.49 (d, J = 5.8, CH3), 20.96 (CH3); 31P NMR (162 MHz, CDCl3) δ 
5.60; HRMS (ESI-, m/z): calculated for C15H25NO3P [M – H+]: 298.1567, found: 298.1589; 
Anal. Calcd. for C15H26NO3P: C, 60.18; H, 8.75; N, 4.68. Found: C, 59.79; H, 8.74; N, 4.69. 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel AD column, 
n-heptane–i-PrOH 90 : 10, 40 °C, 1 mL min-1, 220 nm, retention times (min) t1: 6.32 (S) 
and t2: 7.32 (R).
(R,S) diisopropyl (1-(3-chlorophenyl)ethyl)phosphoramidate (3)
Phosphoramidate 3 was obtained by mixing 500 mg of both enantiomers of 
phosphoroamidate 3 dissolved in Et2O in a one to one ratio. Evaporation of the 
solvent under reduced pressure yielded the product as a white solid in quantitative 
yield mp: 58.2-59.0; 1H NMR (400 MHz, CHCl3) δ 7.23 – 7.02 (m, 4H), 4.57 – 4.44 (m, 
1H), 4.44 – 4.31 (m, 1H), 4.29 – 4.13 (m, 1H), 3.18 (t, J = 9.7Hz, NH), 1.37 (d, J = 6.4, 1H), 
1.23 (d, J = 6.3, 1H), 1.21 (d, J = 6.4, 2H), 1.16 (d, J = 6.2, 1H), 0.96 (d, J = 6.2, 1H); 13C 
NMR (100 MHz, CDCl3) δ 147.50 (d, J = 4.5, C), 134.15 (s, CCl), 129.62 (CH), 126.99 (CH), 
126.22 (CH), 124.10 (CH), 70.79 (dd, J = 5.6, 0.8, CH), 51.02 (s, CH), 25.22 (d, J = 6.7, CH3), 
23.81 (d, J = 5.1, CH3), 23.75 (CH3), 23.74 (d, J = 7.7, CH3), 23.47 (d, J = 5.6, CH3); 31P NMR 
(162 MHz, CDCl3) δ 5.30; HRMS (ESI-, m/z): calculated for C14H24NO3PCl [M + H+]: 
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320.1177, found: 320.1178; Anal. Calcd. for C14H23NO3PCl: C, 52.59; H, 7.25; N, 4.38, 
Found: C, 52.67; H, 7.25; N, 4.39. Enantiomeric excess was determined by chiral HPLC 
analysis, Chiralcel AS column, n-heptane–i-PrOH 95 : 5, 40 °C, 1 mL min-1, 212 nm, 
retention times (min) t1: 5.529 (R) and t2: 7.01 (S).
(R)-diisopropyl (1-(3-chlorophenyl)ethyl)phosphoramidate (3)
Phosphoramidate 3 was obtained starting from 1-(3-chlorophenyl)ethanamine 
(1.27 gr, 9.1 mmol) following the general procedure, after purification by column 
chromatography on silica gel rinsed with Et3N (Et2O/ DCM, 9:1) as a thick clear oil in 
63% yield (1.22 g, 3.8 mmol). 
(R,S)-diisopropyl (1-(4-bromophenyl)ethyl)phosphoramidate (4)
Phosphoramidate 4 was obtained starting from 1-(4-bromophenyl)ethanamine 
(1.31 gr, 9.1 mmol) following the general procedure, after purification by column 
chromatography on silica gel rinsed with Et3N (Et2O/ DCM, 9:1) as a white solid in 58% 
yield (1.27 g, 3.51 mmol) mp: 87.5-89.3; 1H NMR (400 MHz, CHCl3) δ 7.43 (d, J = 8.5 Hz, 
2H), 7.19 (d, J = 8.3 Hz, 2H), 4.64 – 4.51 (m, 1H), 4.51 – 4.41 (m, 1H), 4.36 – 4.20 (m, 1H), 
2.91 (t, J = 9.5, NH), 1.43 (d, J = 6.8, 3H), 1.30 (d, J = 6.2, 3H), 1.28 (d, J = 6.2 Hz, 3H), 1.24 
(d, J = 6.2 Hz, 3H), 1.06 (d, J = 6.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 144.33 (d, J = 4.8, 
CBr), 131.42 (CH), 127.66 (CH), 120.66 (CH), 70.87 (dd, J = 5.4, CH), 50.88 (CH), 25.27 (d, 
J = 6.8, CH3), 23.80 (d, J = 6.76, CH3), 23.77 (CH3), 23.75 (d, J = 6.8, CH3), 23.55 (d, J = 5.6, 
CH3); 31P NMR (162 MHz, CDCl3) δ 5.31; HRMS (ESI-, m/z): calculated for C14H22NO3PBr 
[M – H+]: 362.0515, found: 362.0539; Anal. Calcd. for C14H23NO3PBr: C, 46.17; H, 6.37; N, 
3.85, Found: C, 46.06; H, 6.35; N, 3.87. Enantiomeric excess was determined by chiral 
HPLC analysis, Chiralcel AD column, n-heptane–i-PrOH 90 : 10, 40 °C, 1 mL min-1, 220 
nm, retention times (min) t1: 5.85 (S) and t2: 6.96 (R).
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(R,S)-diisopropyl (1-(4-bromophenyl)ethyl)phosphoramidate (5)
Phosphoramidate 5 was obtained starting from 1-(4-chlorophenyl)ethanamine 
(1.27 gr, 9.1 mmol) following the general procedure, after purification by column 
chromatography on silica gel rinsed with Et3N (Et2O/ DCM, 9:1) as a white solid in 48% 
yield (821 mg, 2.9 mmol) mp: 78.3-79.8; 1H NMR (400 MHz, CHCl3) δ 7.26 (dd, J = 8.7 
Hz, 4.8, 4H), 4.64 – 4.51 (m, 1H), 4.51 – 4.40 (m, 1H), 4.37 – 4.21 (m, 1H), 2.94 (t, J = 9.3 
Hz, NH), 1.43 (d, J = 6.8 Hz, 3H), 1.30 (d, J = 6.2 Hz, 3H), 1.28 (d, J = 6.2 Hz, 3H), 1.24 (d, 
J = 6.2 Hz, 3H), 1.06 (d, J = 6.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 143.87 (d, J = 5.0, 
C), 132.56 (CCl), 128.43 (CH), 127.29 (CH), 71.29 – 70.19 (m, CH), 50.82 (CH2), 25.31 (d, 
J = 6.3, CH3), 23.80 (d, J = 6.8, CH3), 23.77 (CH3), 23.75 (d, J = 6.8, CH3), 23.53 (d, J = 5.6, 
CH3); 31P NMR (162 MHz, CDCl3) δ 5.34; HRMS (ESI-, m/z): calculated for C14H22NO3PCl 
[M – H+]: 318.1020, found: 318.1040; Anal. Calcd. for C14H23NO3PCl: C, 52.59; H, 7.25; N, 
4.38, Found: C, 52.71; H, 7.31; N, 4.42. Enantiomeric excess was determined by chiral 
HPLC analysis, Chiralcel AD column, n-heptane–i-PrOH 90 : 10, 40 °C, 1 mL min-1, 220 
nm, retention times (min) t1: 5.72 (R) and t2: 6.80 (S).
5,5-dimethyl-2-((1-phenylethyl)amino)-1,3,2-dioxaphosphinane 2-oxide (8)
In a dry Schlenk tube equipped with stirring bar 5,5-dimethyl-1,3,2-
dioxaphosphinane-2-oxide (455 mg, 3.03 mmol) and CCl4 (3 mL, 30.3 mmol) were 
dissolved in 20 mL dry toluene at 0 °C. To this mixture NEt3 (1.5 mL, 10.7 mmol) was 
added slowly and after addition the reaction mixture was stirred for 30 min at 0 °C. 
Subsequently 1-phenylethanamine (0.58 mL, 4.5 mmol) was added and the mixture 
was stirred for 7 h at r.t. The reaction was quenched with aq. 1M HCl (15 mL) and the 
mixture extracted with Et2O (3x 20 mL). The combined organic layers were dried over 
MgSO4 and the solvent evaporated under reduced pressure. The pure compound was 
obtained via column chromatography on silica rinsed with NEt3 (Et2O/ DCM, 9:1) as a 
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white solid in 63% (511 mg, 1.90 mmol) yield. Mp 101.1-102.2 °C; 1H NMR (400 MHz, 
CHCl3) δ 7.31 – 7.21 (m, 4H), 7.21 – 7.13 (m, 1H), 4.48 – 4.29 (m, 2H), 4.18 (dq, J = 7.0 
Hz, 2.8 Hz, 2H), 3.80 – 3.54 (m, 2H), 1.44 (d, J = 6.8 Hz, 3H), 1.07 (s, 3H), 0.79 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 144.33 (d, J = 5.3, C), 128.47 (s, CH), 127.15 (s, CH), 125.81 
(s, CH), 76.15 (d, J = 4.0, CH2), 76.10 (d, J = 4.1, CH2), 51.27 (s, CH), 31.81 (d, J = 5.0, C), 
24.94 (d, J = 5.6, CH3), 22.00 (s, CH3), 20.77 (d, J = 0.8, CH3); 31P NMR (162 MHz, CDCl3) δ 
4.23; HRMS (ESI-, m/z): calculated for C13H21NO3P [M + H+]: 270.1253, found: 270.1254; 
Anal. Calcd. for C13H20NO3P: C, 57.98; H, 7.49; N, 5.2, Found: C, 57.03; H, 7.48; N, 4.98. 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel OD-H column, 
n-heptane–i-PrOH 90 : 10, 40 °C, 1 mL min-1, 254 nm, retention times (min) t1: 17.50 
(R) and t2: 19.07 (S).
(R,S)-2-((diisopropoxyphosphoryl)amino)-2-phenylacetic acid (9)
Phenylalanine (1.0 g, 6.06 mmol) and NEt3 (2.2 mL, 13.2 mmol) were dissolved 
in a mixture of 2 mL H2O and 2 mL EtOH at 0 °C. To this mixture a solution of 
diisopropylphosphite (0.98 mL, 5.27 mmol) in 1.5 mL (30 mmol) CCl4 was added while 
keeping the temperature below 0 °C. Subsequently the reaction mixture was stirred 
for 2 h at r.t. after which it was quenched with 10 mL aq. 1M HCl, extracted first with 
DCM (3x 15 mL), than with sat. aq. NaHCO3 (3x 15 mL) from the combined organic 
layers. The aq. NaHCO3 layers were subsequently acidified to pH 3 by slowly adding 
aq. 6M HCl. The resulting aqueous solution was extracted with DCM (3x 30 mL). After 
combining the DCM layers they were dried over MgSO4 and the solvent evaporated 
under reduced pressure. The crude solid was purified by washing with Et2O yielding 
the product as a white solid in 59% yield (1.17 g, 3.55 mmol) mp 123.5-124.5 °C; 1H 
NMR (400 MHz, CHCl3) δ 7.35 – 7.18 (m, 5H), 4.61 – 4.38 (m, 2H), 4.17 – 4.01 (m, 1H), 
3.71 (t, J = 10.3 Hz, NH), 3.13 (dd, J = 13.6 Hz, 5.5 Hz, 1H), 3.00 (dd, J = 13.7 Hz, 7.0 Hz, 
1H), 1.28 (d, J = 6.1 Hz, 3H), 1.27 (d, J = 6.1 Hz, 3H), 1.22 (d, J = 6.1 Hz, 1H), 1.19 (d, J = 
6.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 174.80 (C=O), 136.47 (C), 129.64 (CH), 128.39 
(CH), 126.82 (CH), 71.81 (d, J = 5.9, CH), 71.63 (d, J = 5.9, CH), 55.71 (CH), 40.10 (CH2), 
23.67 (CH3), 23.63 (CH3), 23.60 (CH3), 23.58 (CH3); 31P NMR (162 MHz, CDCl3) δ 5.55; 
HRMS (ESI+, m/z): calculated for C15H24NO5P [M + Na+]: 352.1284, found: 352.1288; 




Synthesized following the procedure for acid 9. Purification via column 
chromatography on C18 silica (H2O/ MeOH, 100:0 to 40:60) yielded the compound in 
25% yield (493 mg, 1.49 mmol) as a clear oil that slowly solidified upon standing [α]20D 
= +20.6 (c 1.0 in CHCl3).
(R,S)-methyl 2-((diisopropoxyphosphoryl)amino)-3-phenylpropanoate (10)
465 mg (3.03 mmol) of the HCl salt of phenylalaninemethylester was dissolved in 8 
mL THF at 0 °C. To this solution 1.1 mL of Net3 and 450 mg of diisopropylphosphite in 
0.75 mL CCl4 was added. The reaction mixture was stirred at r.t. for 5 h. The reaction 
was quenched with 10 mL aq. 1 M HCl. The solution was extracted with DCM (3x 
15 mL), the combined organic layers were dried with MgSO4 and the solvent was 
evaporated under reduced pressure. The resulting crude solid was recrystallized from 
heptane, yielding the product as a white solid in 30% (278 mg) ; mp 54.7-55.4 °C 1H 
NMR (400 MHz, CDCl3) δ 7.35 – 7.18 (m, 3H), 7.18 – 7.09 (m, 2H), 4.58 – 4.37 (m, 1H), 
4.22 – 4.02 (m, 1H), 3.66 (s, 3H), 3.06 (t, J = 10.0 Hz, NH), 3.00 (d, J = 6.1 Hz, 3H), 1.27 (d, 
J = 6.1 Hz, 1H), 1.26 (d, J = 6.1 Hz, 1H), 1.21 (d, J = 6.6 Hz, 3H), 1.19 (d, J = 7.2 Hz, 3H); 13C 
NMR (101 MHz,CDCl3) δ 173.08 (d, J = 5.7, C=O), 135.97 (C), 129.46 (CH), 128.43 (CH), 
126.97 (CH), 71.08 (t, J = 5.6, CH), 55.65 (d, J = 0.6, CH), 51.96 (CH3), 40.64 (d, J = 5.8, 
CH2), 23.75 (d, J = 4.3, CH3), 23.71 (d, J = 4.3, CH3), 23.69 (d, J = 5.5, CH3), 23.66 (d, J = 5.5, 
CH3); 31P NMR (162 MHz, CDCl3) δ 4.90; HRMS (ESI+, m/z): calculated for C16H26NO5PNa 
[M + Na+]: 366.1441, found: 366.1447; Anal. Calcd. for C16H26NO5P: C, 55.97; H, 7.63; N, 
4.08, Found: C, 55.95; H, 7.70; N, 4.11. Enantiomeric excess was determined by chiral 
HPLC analysis, Chiralcel AD column, n-heptane–i-PrOH 90 : 10, 40 °C, 1 mL min-1, 254 
nm, retention times (min) t1: 12.70 (R) and t2: 18.40 (S).
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For HPLC analysis the following derivatization method was used:
20 mg (0.8 mmol) of acid (9) was dissolved in 2 mL MeOH at 0 °C, subsequently 66 
µL 2M (diazomethyl)trimethylsilane in hexanes was added and the reaction mixture 
was stirred for 10 min after which the solvent was evaporated under reduced pressure 
while keeping the temperature below 20 °C yielded the ester as a white solid.
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In this chapter, a highly enantioselective one pot procedure for the synthesis of 
β-substituted amides starting from the corresponding α,β-unsaturated esters is 
developed. This new methodology is based on the previously reported copper catalyzed 
enantioselective conjugate addition of Grignard reagents to α,β-unsaturated esters 
and subsequent formation of the corresponding amides by quenching the intermediate 
enolate with an amine. This methodology proved to be compatible with a range of α,β-
unsaturated esters, Grignard reagents and amines, including primary and secondary 
amines bearing alkyl and aryl substituents. Importantly, it was found that this one pot 
two step process occurs without racemization. 
Additional experiments were performed to obtain insight into the reaction mechanism. 
These experiments combined with the substrate scope indicate that the nucleophilicity 
of the amine plays an important role in the conversion of the reaction, more so than the 
ability to form an anion. This observation led to the proposal of a mechanism based on 
Lewis Acid assisted activation/ deprotonation of the amine and direct addition to the ester. 
The developed one pot procedure to optically active β-substituted amides from simple 
starring materials renders this biologically interesting motive readily accessible, and 
therefore offers the prospect of the synthesis of new drug like molecules. 
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6.1 Goal and introduction
The catalytic asymmetric conjugate addition (CA) of organometallic reagents 
to α,β-unsaturated compounds is one of the most versatile methodologies for the 
formation of C-C bonds.[1-18] In 2004, a breakthrough in the catalytic enantioselective 
CA of Grignard reagents was reported from our laboratories (Figure 6.1 top).[19] The 
initial pioneering work was done by Lippard et al. and revolves around the use of 
copper as a catalyst in the conjugate addition reaction.[20] The transmetalation with 
copper provides an organo copper complex that favors the 1,4-addition over the 
1,2-addition. Initially high enantioselectivities could only be obtained with the use 
of alkyl zinc compounds. The publication by Feringa et al.[19] paved the way for the 
highly selective CA of Grignards reagents to α,β-unsaturated ketones,[20-23] esters[24-27] 
and thioesters[28, 29] using a catalytic system based on Josiphos (L1 or L2)[24] and 
various copper salts (Figure 6.1). The group of Loh reported an alternative for the 
enantioselective CA to α,β-unsaturated esters with a catalyst consisting of Tol-BINAP 
(L3)[25-27] and copper iodide (Figure 6.1). 
Figure 6.1:  General scheme for the 1,4-addition to α,β-unsaturated carbonyl compounds (top) 
and the chiral diphosphine ligands used in conjugate addition (bottom).
Despite the progress of asymmetric CA to carbonyl functionalities, few examples 
have been described that use α,β-unsaturated amides as electrophile. This paucity 
is attributed to the low intrinsic reactivity of α,β-unsaturated amides compared 
to esters and ketones.[30] The low reactivity is due to the partial double bond 
character between the nitrogen and the carbonyl carbon, making the amide a less 
potent electron withdrawing group and therefore the substrate less electrophilic 
(Figure 6.2). The tautomerization depicted in figure 6.2 is comparable to the keto-
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enol tautomerization of ketones. The low reactivity limited the formation of chiral 












if R = H
Figure 6.2: Resonance and tautomeric structures of an amide.
To the best of our knowledge only one method has been described, by Biswas 
and Woodward in 2008, for the enantioselective CA of Grignard reagents to α,β-
unsaturated amides.[35] In this example the authors use a N,N-dimethyl amide that 
limits the contribution of the undesired enol structure, since no proton is present at 
the nitrogen to facilitate the imine formation. Four examples were presented giving 
moderate to good yields and modest enantioselectivities (5-74% ee) (Scheme 6.1).[35]
Scheme 6.1: Copper catalyzed conjugate addition of Grignards to α,β-unsaturated amides.
Chiral β-substituted amides can be obtained with high stereoselectivities via the 
CA of Grignard reagents to α,β-unsaturated amides bearing (S,S)-pseudoephedrine 
as a chiral auxiliary.[35, 36] The addition proceeds both with[35] and without[36, 37] copper 
as catalyst. To obtain the desired chiral β-alkyl substituted amides via this route two 
additional steps are required: one to remove the auxiliary and one to obtain the 
corresponding amide.
Scheme 6.2:  Addition of Grignard reagents to α,β-unsaturated amides bearing (S,S)-
pseudoephedrine as a chiral auxiliary.[35, 36]
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An alternative method to form β-alkyl substituted amides consists of the 
enantioselective CA of boron compounds to enamides (including 5,6-dihydro-
2(1H)-pyridinones). This has been achieved with rhodium-catalyzed addition of 
arylboron[38-40] reagents and by the copper-catalyzed addition of dioxaborolanes[41] 
(Scheme 6.3). However, these methods do not allow the introduction of alkyl groups 
to furnish β-alkyl substituted amides. 
Scheme 6.3: The use of aryltrifluoroborates and dioxaborolane for the addition to enamides.[38-41]
In this context, the copper-catalyzed enantioselective CA of dialkyl zinc reagents 
to α,β-unsaturated N-acyloxazolidinones[42] has been reported by Hird and Hoveyda 
to provide the corresponding chiral β-alkyl compounds. In this publication by the 
Hoveyda group it was also demonstrated that the formed chiral β-alkyl substituted 
oxazolidinones can easily be transformed in good yields to the corresponding butyl 
ketone, the Weinreb amide and the acid in one additional step (Scheme 6.4).[42]
Scheme 6.4: Conjugate addition to N-acyloxazolidinones.[42]
The copper catalyzed enantioselective CA to α,β-unsaturated lactams has been 
described by our group with alkylzinc reagents and trialkylaluminium compounds 
using various protecting groups.[43] Subsequently the group of Alexakis expanded 
this method to the use of alkenylaluminium compounds.[44] Both procedures give rise 
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Scheme 6.5: Conjugate addition to lactams.[43, 44]
Despite these examples several key limitations remained, either a specific α,β-
unsaturated amide is needed for the CA or the scope of the amine partner is 
very limited. Often an additional electron withdrawing group is attached to the 
unsaturated amide to activate it. In the case of the oxazolidinones and the lactams, 
electron withdrawing protecting groups are used for this purpose. In the case of the 
Ru-catalyzed addition of boron compounds, a wide variety of aryl trifluoroboron 
compounds are allowed but only two different α,β-unsaturated amides were used. 
Both these α,β-unsaturated amides contain at most one methyl group attached to 
the double bond, hinting that there could be difficulties with more sterically hindered 
substrates. In the examples presented by the groups of Iwasawa[36] and Iza[37] (Scheme 
6.2), the CA occurs with α,β-unsaturated amides bearing (S,S)-pseudoephedrine as 
a chiral auxiliary. Since the auxiliary is removed in the subsequent step this is a less 
economical route to obtain β-substituted amides. The method described by Biswas 
and Woodward[35] is, to the best of our knowledge, the only way of directly introducing 
an alkyl group on the β position of an amide in an enantioselective manner. However 
for this method only 4 examples are described, with moderate yield’s (50 to 78%) 
and largely varying selectivity’s (5 to 74% ee). The limited scope, moderate yields 
and low selectivities, proved to be inefficient. In the same publication high yields 
and selectivities were obtained by combining their catalytic system with the use of 
(S,S)-pseudoephedrine as a chiral auxiliary. These limitations of know methods show 
that the formation of β-alkyl substituted chiral amides remains a challenging process. 
Furthermore these moieties are interesting targets as these structures are present in 
various pharmaceutically interesting compounds including Cyclotheonamide E5[45] 
and Orbiculamide A[46] (Figure 6.3).
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Figure 6.3:  Cyclotheonamide E5 and Orbiculamide A, two known drugs that contain the chiral 
β-alkyl substituted amide motif.
6.2 Results and discussion
6.2.1 Strategy
Recently, we discovered in our group that β-alkyl substituted amides could be 
obtained directly by intercepting the ester enolate, which was formed during the 
enantioselective CA of ethylmagnesiumbromide to coumarin, with propylamine. This 
first example showed that intercepting the coumarin enolate with propylamine gave 
the corresponding amide in good yield without compromising the ee of the product 
(Scheme 6.5).[47] 
Scheme 6.5: CA to coumarin and subsequent amide formation by quenching with propylamine.[47]
Inspired by this result, we envisioned a one pot procedure for the synthesis of 
β-alkyl substituted amides consisting of first the enantioselective CA of Grignard 
reagents to an α,β-unsaturated ester and subsequent in situ transamidation to obtain 
the corresponding amide (Scheme 6.7). The CA to α,β-unsaturated esters was first 
discovered and optimized in our group.[24] Therefore in this chapter the focus is on 
optimizing the second, transamidation, step and to explore the amine scope. We 
especially wondered whether the use of secondary amines would be allowed as well 
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as primary amines. First we investigated whether linear α,β-unsaturated esters would 
yield similar results as coumarin, which is a cyclic enolate, since this would enlarge the 
substrate scope significantly.
Scheme 6.6: Catalytic asymmetric CA to ester and amide formation. 
6.2.2  Synthesis and scope of the copper-catalysed enantioselective 
conjugate addition
We started by synthesizing the most successful substrates of the conjugated 
addition to α,β-unsaturated esters, E-methyl hex-2-enoate 1 and E-methyl 
5-phenylpent-2-enoate 2. These two compounds were chosen to represent substrates 
containing an alkyl chain or an aryl moiety. α,β-Unsaturated ester 1 was synthesized 
by an esterification of the corresponding acid in the presence of sulfuric acid, using 
methanol as solvent.[48] Aryl substrate 2 was obtained from 3-phenylpropanal and 
2-(dimethoxyphosphino)acetate via the Horner-Watsworth-Emmons reaction in the 
presence of 1,1,3,3-tetramethylguanidine as a base.[49]
Scheme 6.7: Synthesis of α,β-unsaturated esters 1 and 2.
With the substrates in hand for this one pot 1,4-addition-amidation procedure, we 
focused on the optimization of the amide formation after the enantioselective CA 
step. The latter was carried out in the presence of Josiphos L1 and copper bromide 
dimethylsulfide complex at -75 °C as previously reported.4 We therefore screened the 
reaction conditions of the quenching step using the one pot CA amidation reaction 
between substrate 1, EtMgBr and propylamine in t-BuOMe as model reaction. First the 
equivalents of propyl amine used in the reaction where lowered. When changing from 
5 to 3 equivalents no decrease in yield was observed. However, when 1 equivalent or 
CHIRAL AMIDES VIA COPPER-CATALYSED ENANTIOSELECTIVE CONJUGATE ADDITION 129
2 equivalents of amine where used the yield was compromised. Subsequently the 
reaction time was varied. It was found that, stirring the reaction mixture for a longer 
period of time, did not increase the yield. When the reaction was quenched after 4 h 
instead of 15 h the yield was significantly lower. It is likely that the reaction does not 
need a full 15 h to go to completion. However for practical reasons, stirring overnight 
(approximately 15 h) and using 3 equivalents of amine, were chosen as optimal 
reaction conditions.

































































































Table 6.1: Scope for the one pot two step procedure a Isolated yields. b Determined by chiral GC 
(entry 1) or chiral HPLC analysis. c Carried out on a 7.8 mmol (1.0 g) scale. d Using the Cu Tol-Binap 
catalyst system described by Loh.[25]
The enantioselective CA to substrates 1 and 2 was performed, with 
ethylmagnesiumbromide (1.5 equiv), copperbromide dimethylsulfide complex (5 
mol%) and Josiphos L1 (7.5 mol%) in methyl tert-butyl ether (MTBE).[22] Subsequently 
the intermediate enolate was quenched in situ with various amines and allowed to 
react under the optimized reaction conditions for the amide formation (Table 1). 
The reaction of α,β-unsaturated esters 1 and 2 with 3.0 equiv of aniline provided 
the corresponding amides 4 and 5 with good yields (65% and 73%, respectively) and 
excellent enantioselectivities (92% and 88%), revealing that no racemization occurs 
during the process (entries 1 and 2). The reaction using p-bromoaniline furnished 
amide 6 with good yields (77%) without compromising the ee (entry 3). The reaction 
was also carried out employing benzylamine giving similar results (entry 4). 
In order to broaden the amine scope, the reaction was carried out with the 
secondary N-methylbenzylamine giving rise to the corresponding amides 8 and 9 
with synthetically viable yields (32% and 40%, entries 5 and 6). Finally, the reaction 
was performed with the aliphatic propylamine, which yields amides 10 and 11 in 
moderate yields and excellent ee’s (entry 7 and 8).22 Increasing the temperature  or 
prolonging the reaction time did not improve the yields of the reaction. In addition, 
this method has been employed to obtain natural product amide 12[50] with 40% 
yield and 98% ee in a one pot, two step synthesis starting from commercially available 
materials (entry 9). 
Finally we tried commercially available cinnamylmethyl ester as substrate. This is 
a more challenging substrate for the enantioselective CA, and required additional 
equivalents of the Grignard reagent, a higher catalyst loading and dichloromethane 
as solvent to produce good results.[22] Besides using the optimized conditions for the 
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enantioselective CA described by our group also the TolBinap system reported by 
Loh et al.[25] was employed followed by subsequent quenching with 3 equivalents of 
propylamine yielded amide 13 in 13% and 21% yield and 94% or 91% ee, respectively 
(entry 10). 
To underline the synthetic utility of this method, we performed the one pot 
synthesis of amide 6 on a large scale (entry 3) starting from 1.0 gram (7.8 mmol) of the 
α,β-unsaturated ester 1. Amide 6 was obtained in a similar yield and selectivity as in 
the smaller scale reaction (1.8 gram; 75% yield and 92% ee). 
Finally, we employed different Grignard reagents including the challenging 
methylmagnesiumbromide (Figure 6.3). The reaction using hexylmagnesiumbromide 
and benzylamine furnished amide 14 with good yields (63%) and excellent ee’s (90%). 
In addition, the methyl group can be introduced employing the conditions of Loh et 
al..[27] The asymmetric CA followed by the addition of aniline afforded the amide 15 in 
moderate yield (47%) and excellent enantioselectivity (95%).
Figure 6.3: β-Substituted amides 14 and 15. 
6.2.3 Exploring the mechanism of the one-pot amide formation
After showing that this methodology allowed for the use of various substrates, 
amines and Grignard reagents, we investigated the mechanism by which the amide 
was formed. We hypothesized the mechanistic pathway shown in scheme 6.8. In 
the first CA step, which has been thoroughly investigated,[51] the enolate is formed. 
Subsequently the enolate reacts with the amine to form the deprotonated amine. It 
is hypothesized that the deprotonation of the amine is facilitated via the formation of 
a 6-membered transition state depicted in scheme 6.8. In the next step coordination 
of the magnesium ion to the carboxyl oxygen could subsequently activate the ester 
so that a nucleophilic attack of the deprotonated amine occurs readily. Subsequent 
loss of the methoxy group as the magnesium bromide salt yields the desired amide 
product (Scheme 6.8). 
The difficulty with this mechanism is that the pKa of the ester enolate (≈25)[52] 
is lower than that of the amine (≈30).[52] The pKa values would therefore favour 
the deprotonation of the enolate above the deprotonation of the amine. One can 
argue that the amine could be deprotonated by the excess of Grignard (pKa ≈ 50) 
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present in the reaction mixture. However to obtain the product from the enolate 
and the deprotonated amine, the amine anion needs to add to the enolate. Since the 
enolate is not an electrophile this is not a viable route. In the literature similar types of 
amidations are known starting from the acid, instead of the ester, using AlMe3, Boron 
compounds or other Lewis Acids as activating agents.[53] In this case the MgBr could 
act as an activating agent, to facilitate the amine addition. 
Scheme 6.8: Possible mechanism for the amide formation.
To further investigate the mechanism we started by performing the reaction in the 
absence of the copper salt and the Josiphos ligand to ascertain that these do not 
play a role in the amidation of the substrate. Therefore we dissolved β-substituted 
ester 16 in MTBE and added a solution of amine with the Grignard reagent. This one 
step reaction gave the desired product in near quantitative yield. The high yield 
suggests that the deprotonation of the amine facilitates the formation of the product. 
However, in this case only the amidation is performed since the CA product is used 
as starting material. Therefore the yield is also expected to be higher than when the 
CA and amidation are performed in one-pot. These results indicate that the catalytic 
Cu-Joshipos system does not play an essential role in the amidation.
Scheme 6.9: Addition of ethylmagnesiumbromide and benzylamine to a β-substituted ester.
The second approach to investigate the mechanism was to perform the 
enantioselective CA and subsequent amide formation on an ester bearing a better 
leaving group. It was expected that if the reaction occurred via a different mechanism 
the introduction of a better leaving group, by changing from a methoxy leaving 
group to a phenol or thiol, could increase the overall yield of the reaction. To test this 
hypothesis, phenol ester 17 was synthesized in 69% yield (Scheme 6.10). When ester 
17 was examined in the conjugated addition only the 1,2-addition product, the α,β-
unsaturated ketone, was observed by 1H NMR. Thereby making α,β-unsaturated ester 
17 an unsuitable substrate for the comparison to our one pot procedure to synthesize 
the corresponding β-substituted amide.
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Scheme 6.10: Formation of phenol ester 17
From previous studies in our group[28] we know that the conjugate addition to 
thiolesters is possible. We synthesized the corresponding thiolester following literature 
procedures.[28] By treating α,β-unsaturated ester 1 with (ethylthio)trimethylsilane in 
the presence of AlCl3 the desired product was obtained in 67% yield (Scheme 6.11). 
Subsequently thiolester 18 was used as substrate in our one-pot enantioselective CA 
amide formation. The reaction gave the product in 39% yield, which is within the error 
margin of the yield found for the corresponding methyl ester (40% yield). This suggest 
that the leaving group does not play a significant role in the progress of the reaction. 
The absence of an effect of the leaving group on the yield corresponds well with 
the suggested mechanism. In the proposed pathway the ester is activated by the 
magnesium ion. Magnesium is known to coordinate extremely well to oxygen[54] this 
coordination is more favourable than binding to sulphur. Therefore if the suggested 
pathway would be the correct one the yield, starting from the thioester, would most 
likely be similar or lower than the yield starting from the methoxy ester, since the 
coordination of the magnesium to the thioester is less favourable and therefore the 












Scheme 6.11: The use of thiol ester 18 in the one pot conjugate addition, amide formation.
From the data presented in table 6.1, it can be concluded that the nature of the 
amine has a large influence on the yield of the reaction. When aromatic amines, such 
as aniline or bromo aniline are used the yields are significantly higher than when 
a simple alkyl amine, such as propylamine is used. In the suggested mechanism 
(Scheme 6.8) the 1,2-addition of the amine would most probably be rate limiting step. 
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This means that, if the suggested pathway is correct, more nucleophilic amines would 
yield the best results since they would facilitate the nucleophilic addition to the ester. 
The amines used in the one-pot CA amidation reaction can be ordered by pKa* 
(Table 6.2 left) or by nucleophilicity (table 6.2 right). Generally when the pKa’s of 
amines are reported it’s actually the pKa of the conjugated base that is given. The 
actual pKa of amines lies around 30, but it is challenging to find literature values for 
specific amines. Assuming that the deprotonation of the amine follows the same 
trend as the deprotonation of the protonated amine gives the order shown in table 
6.2 (left column). From this table, it can be concluded that the yields obtained do not 
follow the trend in pKa. 
Besides ordering the amines based on their acidity they can also be ordered based 
upon nucleophilicity. Although it is difficult to extrapolate nucleophilicity parameters 
found under a specific set of conditions to other reaction conditions,[55] Mayr et al. 
have given a nucleophilicity parameter for primary and secondary amines.[56, 57] The 
nucleophilicity parameter (N) is based on the second order rate constants for the 
reaction between a certain amine and benzhydrylium tetrafluoroborates in water 
at 20 °C. Since no N is given for methylbenzyl amine, this N is estimated by taking 
the value of Et2NH (14.68) and add the difference between EtNH2 (12.87) and BnNH2 
(13.44). 
The yields obtained from the one pot CA amidation reaction follows the trend in 
nucleophilicity rather than the trend in acidity of the amine. These results support the 
hypothesized mechanism (Scheme 6.8). In the proposed pathway it is expected that 
the 1,2-addition is the rate determining step. Therefore a more nucleophilic amine 
facilitates the reaction leading to higher yields. 
amine pKa* yield Amine N yield
n-propylNH2 10,35 32 n-propylNH2 12.00 32
MeBnNH 9,68 79 Aniline 12.99 73
BnNH2 9,34 64 BnNH2 13.44 64
aniline 4,6 73 MeBnNH +/- 15.50 79
Table 6.2: Yields of the one pot CA amidation reaction of substrate 2 with different amines left; 
ordered by pKa (pKa is the pKa of the conjugated base),[58, 59] right; ordered by nucleophilicity 
parameter (N) based on second order rate constants for the reaction of benzhydrylium 
tetrafluoroborates in water at 20 °C.[57]
That the yield of the reaction and the nucleophilicity of the amine seem to 
correlate rather well, indicates that the nucleophilicity of the amine plays a role in the 
transformation, which supports the mechanism shown in scheme 6.8. This mechanism 
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is also supported by the fact that Lewis acid catalysed amidations of acids are known 
in the literature.[53]
6.2.4  Using amino acids as amines in the one-pot enantioselective  
CA amide formation protocol 
In many biological compounds that contain the β-alkyl substituted amide motif, 
the amide is derived from an amino acid. Both natural products depicted in figure 6.3 
illustrate this. In cyclotheonamide E5 and Orbiculamide A the β-substituted amide 
motif is attached to alanine and glycine, respectively. Therefore we considered it 
synthetically interesting to investigate if the one-pot enantioselective CA amide 
formation would allow the use of amino acids as amine. As the free acid might quench 
the enolate, we used the methyl ester protected version of the amino acid. The methyl 
ester of alanine and glycine were synthesized by first forming the acyl chloride with 
SOCl2 at low temperature. Subsequent heating at reflux in methanol yielded the HCl 
salts of the methyl esters in quantitative yield (Scheme 6.13).[60] Before use, the salts 



































Scheme 6.13: Esterification of alanine and glycine.
Subsequently the one pot CA amidation reaction with glycine methyl ester and 
alanine methyl ester was attempted under previously reported conditions. Both 
reactions yielded the β-substituted ester and the amino ester, indicating that the 
1,4-addition takes place but that the amidation step does not occur. To force the 
amide formation to occur, the second step of the reaction was performed by heating 
the reaction mixture in a sealed tube under overnight reflux and by heating the 
reaction mixture in a microwave (Scheme 6.14). In both cases no product formation 
was observed. 
Like the ester, the amino ester contains an α-proton that is slightly acidic. In the 
literature the pKa of several amino acids is determined to range between 15 and 17. 
For the alpha proton of alanine a pKa of 16.5 was found.[61] Assuming that the pKa 
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for the α-proton of the amino ester is similar to that of the amino acid and taking in 
to account that the pKa of ester enolates are around 25,[52] this makes the α-proton 
of the amino ester the most acidic proton. Therefore when both esters are present 
in the reaction, the amino ester will be deprotonated instead of the β-substituted 
ester. Once the amino enolate is formed it is highly unlikely that this will deprotonate 
the amine since it has a much higher pKa and the compound already has a negative 
charge. Therefore no further reaction occurs, yielding the β-substituted ester and 
amino ester (Scheme 6.15). 
Scheme 6.14: Additional attempted reactions with amino acid esters towards amide 21.
6.3 Conclusions
In conclusion, we have developed a highly enantioselective one pot procedure 
for the synthesis of β-substituted amides starting from the corresponding α,β-
unsaturated esters. This new methodology is based on the previously developed 
copper catalyzed enantioselective CA of Grignard reagents to α,β-unsaturated 
esters and subsequent direct formation of the corresponding amides by quenching 
the enolate with an amine without the need of extra reagents. This methodology is 
compatible with a range of α,β-unsaturated esters, Grignard reagents and amines, 
including primary and secondary amines bearing alkyl and aryl substituents. 
Importantly, this one pot two steps process occurs without racemization. Furthermore, 
the synthetic applicability of the process is demonstrated by performing the reaction 
on a 1.0 g scale. A possible mechanism was proposed namely via Lewis Acid assisted 
deprotonation of amine. The scope and subsequent experiments that show that the 
nucleophilicity of the amine plays an important role in the conversion rather than the 
acidity of the amine. This observation supports the proposed pathway. Furthermore 
literature precedent exists for Lewis Acid catalyzed amidations whereas literature 
pKa values suggest that direct deprotonation of an amine by an enolate is not viable. 
Finally it was attempted to use amino acids as amines in the one pot procedure 
for the synthesis of β-substituted amides. It turns out that amino acids cannot be 
used in this methodology. It is hypothesized that the α-proton of the amino ester is 
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sufficiently acidic to quench the enolate, therefore preventing the amidation. The one 
pot procedure to optically active β-substituted amides from simple starting materials 
renders this biologically interesting motive readily accessible, and therefore offers the 
prospect of the synthesis of new drug like molecules. 
6.4 Experimental
6.4.1 General Methods
Chromatography: Merck silica gel type 9385 230-400 mesh, TLC: Merck silica gel 60, 
0.25 mm. Components were visualized by UV and cerium/molybdenum staining. Mass 
spectra were recorded on a LTQ Orbitrap XL (ESI+). 1H- and 13C-NMR were recorded 
on a Varian AMX400 (400 and 100 MHz, respectively) or a Varian Mercury Plus (200 
and 50 MHz, respectively) using CDCl3 as solvent. Chemical shift values are reported 
in ppm with the solvent resonance as the internal standard (CHCl3: δ 7.26 for 1H, δ 
77.16 for 13C). Optical rotations were measured on a Schmidt + Haensch polarimeter 
(Polartronic MH8) with a 10 cm cell (c given in g/100 mL). Enantiomeric excess were 
determined by HPLC analysis using a Shimadzu LC-10ADVP HPLC equipped with a 
Shimadzu SPD-M10AVP diode array detector or by capillary GC analysis (Chiraldex 
B-PM (30 m x 0.25 mm x 0.25 µm) using a flame ionization detector. All reactions 
were carried out under a nitrogen atmosphere using flame dried glassware and 
using standard Schlenk techniques. Dichloromethane and MTBE were dried using the 
solvent purification system SPS 800 from MBraun. Methyl trans-cinnamate (4), copper 
salts (CuI and copper(I) bromide dimethylsulfide complex (CuBr.SMe2)), the amines 
propylamine and N-benzylmethylamine, all Grignard reagents (MeMgBr (3.0 M in 
Et2O), EtMgBr (3.0 M in Et2O), n-HexMgBr (2.0 M in Et2O) and Ligands L2 and L3 were 
purchased from Sigma-Aldrich. The benzyl amine was purchased at Acros and aniline 
at Merck; all amines were distilled before use. When reactions are performed at room 
temperature (r.t.) they are performed around 20 °C and 1.0 bar. 
6.4.2 General procedure for the amide synthesis
In a heat gun dried Schlenk tube equipped with septum and stirring bar, L2 (6.7 mg, 
10.5 µmol) and CuBr·SMe2 (1.85 mg, 9.0 µmol) were dissolved in MTBE (1.0 mL) and 
the mixture stirred under nitrogen at r.t. for 20 min. The mixture was then cooled to 
-75 °C and the Grignard reagent (0.45 mmol in solution) was added. After stirring for 
5 min, a solution of the substrate (0.3 mmol) in MTBE (0.20 mL) was added dropwise 
over 1 h using a syringe pump. After stirring at -75 °C for two additional hours, the 
corresponding amine (0.9 mmol) was added and the reaction mixture was stirred 
overnight while slowly warmed to r.t. Subsequently a saturated aqueous solution of 
NH4Cl (2 mL) was added. After extraction with DCM (3 x 10 mL) the combined organic 
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phases were dried over MgSO4 and concentrated under reduced pressure. The crude 
product was purified using flash chromatography on silicagel (pentane/ EtOAc as 
eluent) to yield the pure product. 
(E)-methyl hex-2-enoate (1)
In a roundbottom flask 2.0 g (17.52 mmol) E-hex-2-enoic acid was dissolved in 3.5 
mL (88 mmol) methanol containing 0.17 mL (5%, 17.52 mmol) sulphuric acid. The 
reaction mixture was stirred overnight at r.t. The reaction was quenched with H2O and 
the resulting aq. mixture was extracted 3 times with Et2O. The combined organic layers 
where dried with MgSO4 and concentrated under reduced pressure. The product was 
purified by column chromatography on silica (pent/ Et2O; 9/1) yielding 1.7 g (13.4 
mmol, 77%) of the pure product as a pale oil. 1H NMR (300 MHz, CDCl3) δ 6.97 (dt, J = 
15.7, 7.1 Hz, 1H), 5.82 (d, J = 15.7 Hz, 1H), 3.72 (s, 3H), 2.18 (dt, J = 7.2 Hz, 2H), 1.49 (dq, 
J = 7.3, 6.6 Hz, 2H), 1.01 – 0.83 (m, 3H).
(E)-methyl 5-phenylpent-2-enoate (2)
To a solution of 1.0 g (7.45 mmol) 3-phenylpropanal and 1.2 mL (8.2 
mmol) 2-(dimethoxyphosphino)acetate in 15 mL dry THF 1.0 mL (8.27 mmol) 
1,1,3,3-tetramethylguanidine was added under nitrogen atmosphere at -78 °C. The 
reaction mixture was stirred at -78 °C for 30 min after which the mixture was allowed 
to warm to r.t., where it was stirred for an additional 2 h. Subsequently the reaction 
was quenched with H2O, the resulting aq. solution was extracted 3 times with Et2O. 
The combined organic layers were dried with MgSO4 and concentrated under 
reduced pressure. The crude product was filtered over silica (pent/ EtOAc; 3/1). The 
pure product was obtained as a pale yellow oil 1.2 g (6.49 mmol, 85%). 1H NMR (400 
MHz, CDCl3) δ 7.29 (t, J = 7.4 Hz, 2H), 7.25 – 7.14 (m, 3H), 7.01 (dt, J = 15.8, 6.9 Hz, 1H), 
5.85 (d, J = 15.7 Hz, 1H), 3.72 (s, 3H), 2.78 (t, J = 7.8 Hz, 2H), 2.53 (dt, J = 8.3, 7.8 Hz, 2H).
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 (R)-3-Ethyl-N-phenylhexanamide (4)
Amide 4 was obtained from (E)-methyl 2-hexenoate (1) (64 mg, 0.5 mmol) following 
the general procedure, after purification by column chromatography on silica (pent/ 
EtOAc; 9/1) as a pale yellow oil (65 %, 71 mg) with 92% ee. [α]D20 = +47 (c 1.0 in CHCl3); 
1H NMR (300 MHz) δ 7.52 (d, J = 7.9 Hz, 2H), 7.44–7.18 (m, 2H), 7.08 (t, J = 7.4 Hz, 1H), 
2.26 (d, J = 7.0 Hz, 2H), 2.00–1.82 (m, 1H), 1.50–1.28 (m, 6H), 0.89 (t, J = 7.3 Hz, 6H); 13C 
NMR (50 MHz) δ 171.3 (C=O), 138.0 (C), 128.93 (CH), 124.1 (CH), 119.8 (CH), 42.5 (CH2), 
36.6 (CH), 35.6 (CH2), 26.2 (CH2), 19.8 (CH2), 14.4 (CH3), 10.8 (CH3); HRMS (APCI+, m/z): 
calculated for C14H22NO [M+H+]: 220.1696 found: 220.1696; Enantiomeric excess was 
determined by chiral HPLC analysis, Chiralcel OD-H column, n-heptane/i-PrOH 95:5, 
40 °C, 0.5 mL/min, 213 nm, retention times (min) t1: 34.74 (minor) and t2: 38.93 (major).
(R)-3-Ethyl-N-phenyl-5-phenylpentanamide (5)
Amide 5 was obtained starting from (E)-methyl 5-phenyl-2-pentenoate (2) 
(95 mg, 0.5 mmol) following the general procedure, after purification by column 
chromatography on silica (pent/ EtOAc; 9/1) as a pale yellow oil (73 %, 102 mg) oil 
with 88% ee. [α]D20 = -7 (c 1.0 in CHCl3); 1H NMR (200 MHz) δ 7.50 (m, 3H), 7.21 (m, 7H), 
2.78–2.51 (m, 2H), 2.32 (d, J = 7.0 Hz, 2H), 2.17–1.83 (m, 1H), 1.83–1.57 (m, 2H), 1.57–
1.34 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H); 13C NMR (50 MHz) δ 171.1 (C=O), 142.5 (C), 138.0 
(C), 128.9 (CH), 128.4 (CH), 128.3 (CH), 125.8 (CH), 124.2 (CH), 120.0 (CH), 42.3 (CH2), 
36.6 (CH), 35.2 (CH2), 33.0 (CH2), 26.1 (CH2), 10.7. (CH3); HRMS (APCI+, m/z): calculated 
for C16H26NO [M+H+]: 281.1852 found: 282.1853; Enantiomeric excess was determined 
by chiral HPLC analysis, Chiralcel OD-H column, n-heptane/i-PrOH 90:10, 40 °C, 0.5 mL/
min, 213 nm, retention times (min) t1: 12.8 (minor) and t2: 14.10 (major).
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(R)-N-(4-Bromophenyl)-3-ethylhexanamide (6)
Amide 6 was obtained starting from (E)-methyl 2-hexenoate (1) (37 mg, 0.3 mmol) 
following the general procedure, after purification by column chromatography on 
silica (pent/ Et2O; 9/1) as a white solid (77 %, 69 mg) with 93% ee. [α]D20 = -9. (c 1.0 in 
CHCl3); 1H NMR (300 MHz) δ 7.42 (s, 4H), 7.12 (s, NH), 2.25 (d, J = 7.0 Hz, 2H), 1.99–1.79 
(m, 1H), 1.49–1.12 (m, 6H), 0.94–0.80 (m, 6H); 13C NMR (75 MHz) δ 171.4 (C=O), 136.9 
(C), 132.1 (CH), 121.6 (CH), 118.7 (CBr), 42.8 (CH2), 36.8 (CH), 35.9 (CH2), 26.5 (CH2), 20.0 
(CH2), 14.5 (CH3), 11.0 (CH3); HRMS (APCI+, m/z): calculated for C14H21BrNO [M+H+]: 
298.0801 found 298.0803; Enantiomeric excess was determined by chiral HPLC 
analysis, Chiralcel OJ-H column, n-heptane/i-PrOH 98:2, 40 °C, 0.5 mL/min, 249 nm, 
retention times (min) t1: 47.7 (major) and t2: 49.6 (minor).
(R)-N-Benzyl-3-ethyl-5-phenylpentanamide (7)
Amide 7 was obtained starting from (E)-methyl 5-phenyl-2-pentenoate (2) 
(58 mg, 0.3 mmol) following the general procedure, after purification by column 
chromatography on silica (pent/ EtOAc; 9/1) as a pale yellow oil (64 %, 42 mg) with 
87% ee. [α]D20 = +8 (c 1.0 in CHCl3); 1H NMR (400 MHz) δ 7.24 (m, 10H), 5.67 (br s, NH), 
4.46 (dd, J = 12.7, 3.8 Hz, 1H) 4.42 (dd, J = 12.9, 3.6 Hz, 1H), 2.62 (td, J = 13.8, 8.2, Hz 
1H), 2.60 (td, J = 13.4, 8.3 Hz, 1H), 2.21 (dd, J = 14.3, 7.2 Hz, 1H), 2.14 (dd, J = 14.3, 
7.2 Hz, 1H) 1.89 (sept, J = 6.5 Hz, 1H), 1.69–1.59 (m, 2H), 1.48–1.33 (m, 2H), 0.91 (t, J 
= 7.4 Hz, 3H). 13C NMR (50 MHz) δ 172.3 (C=O), 142.6 (C), 138.4 (C), 128.7 (CH), 128.3 
(CH), 128.3 (CH), 127.9 (CH), 127.5 (CH), 125.7 (CH), 43.6 (CH2N), 41.3 (CH2), 36.5 (CH), 
35.2 (CH2), 33.0 (CH2), 26.1 (CH2), 10.7 (CH3); HRMS (APCI+, m/z): calculated for C20H26NO 
[M+H+]: 296.2009 found: 296.2008; Enantiomeric excess was determined by chiral 
HPLC analysis, Chiralcel OD-H column, n-heptane/i-PrOH 90:10, 40 °C, 0.5 mL/min, 212 
nm, retention times (min) t1: 25.12 (minor) and t2: 28.53 (major).
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(R)-N-Benzyl-3-ethyl-N-methylhexanamide (8)
Amide 8 was obtained starting from of (E)-methyl 2-hexenoate (1) (64 mg, 0.5 
mmol) following the general procedure, after purification by column chromatography 
on silica (pent/ EtOAc; 9/1) as a pale yellow oil (54 %, 67 mg) with 93% ee (2:3 mixture 
of conformers A and B). [α]D20 = +39 (c 1.0 in CHCl3); 1H NMR (400 MHz) δ 7.45–7.20 (m, 
4H), 7.16 (d, J = 7.4 Hz, 1H), 4.60 (s, NCH2Ph, conformer A), 4.54 (s, NCH2Ph, conformer 
B) 2.94 (s, NCH3, conformer B), 2.92 (s, NCH3, conformer A), 2.34–2.25 (m, 2H), 2.05–1.78 
(m, 1H), 1.45–1.20 (m, 6H), 1.01–0.77 (m, 6H); 13C NMR (50 MHz) δ 173.4 (C=O), 173.0 
(C=O), 137.7 (C), 128.9 (CH), 128.5 (CH), 128.0 (CH), 127.5 (CH), 127.2 (CH), 126.3 (CH), 
53.4 (CH2), 50.8 (CH2), 37.8 (CH2), 37.5 (CH2), 36.1 (CH3), 36.0 (CH3), 35.8 (CH), 35.7 (CH), 
26.3 (CH2), 26.2 (CH2), 19.8 (CH2), 14.4 (CH3), 10.9 (CH3); HRMS (APCI+, m/z): calculated 
for C16H26NO [M+H+]: 248.2009 found: 248.2015; Enantiomeric excess was determined 
by chiral HPLC analysis, Chiralcel OJ-H column, n-heptane/i-PrOH 98:02, 40 °C, 0.5 mL/
min, 212 nm, retention times (min) t1: 13.12 (minor) and t2: 13.87 (major).
(R)-N-Benzyl-3-ethyl-N-methyl-5-phenylpentanamide (9)
Amide 9 was obtained starting from (E)-methyl 5-phenyl-2-pentenoate (2) 
(95 mg, 0.5 mmol) following the general procedure, after purification by column 
chromatography on silica (pent/ EtOAc; 9/1) as a pale yellow oil (79 %, 122 mg) with 
91% ee (4:5 mixture of conformers A and B). [α]D20 = -10 (c 1.0 in CHCl3); 1H NMR (200 
MHz) δ 7.31 (m, 10H), 4.60 (s, NCH2Ph, conformer B), 4.52 (s, NCH2Ph, conformer A) 2.94 
(s, NCH3, conformer A), 2.89 (s, NCH3, conformer B), 2.61 (m, 2H), 2.35 (m, 2H), 2.16–1.92 
(m, 1H), 1.77–1.54 (m, 2H), 1.54–1.35 (m, 2H), 0.94 (t, J = 5.9 Hz, 3H, conformer B), 
0.87 (t, J = 5.8 Hz, 3H, conformer A); 13C NMR (50 MHz) δ 173.3.0 (C=O), 172.7 (C=O), 
142.7 (C), 137.6 (C), 136.8 (C), 129.6 (CH), 128.9 (CH), 128.8 (CH), 128.5 (CH), 128.4 (CH), 
128.3 (CH), 128.0 (CH), 127.5 (CH), 127.3 (CH), 126.3 (CH), 125.6 (CH), 53.9 (CH2), 50,9 
(CH2), 37.7 (CH2), 37.4 (CH2) 36.0 (CH), 35.4 (CH3), 35.3 (CH2), 33.1 (CH2), 26.3 (CH2), 26.2 
(CH2), 10.8 (CH3); HRMS (APCI+, m/z): calculated for C21H28NO [M+H+]: 310.2165 found: 
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310.2167; Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel OJ-H 
column, n-heptane/i-PrOH 95:5, 40 °C, 0.5 mL/min, 212 nm, retention times (min) t1: 
24.97 (minor) and t2: 26.45 (major).
(R)-3-Ethyl-N-propylhexanamide (10)
Amide 10 was obtained starting from of (E)-methyl 2-hexenoate (1) (38 mg, 0.3 
mmol) following the general procedure, after purification by column chromatography 
on silica (pent/ EtOAc; 9/1) as a pale yellow oil (52 %, 25 mg) with 96% ee. [α]D20 = +3 
(c 1.0 in CHCl3); 1H NMR (400 MHz) δ 5.49 (s, 1H), 3.22 (t, J = 6.8 Hz, 1H), 3.19 (t, J = 6.6 
Hz, 1H), 2.10–1.98 (m, 2H), 1.82 (m, 1H), 1.57–1.41 (m, 2H), 1.40–1.13 (m, 6H), 0.91 (t, J 
= 7.4 Hz, 3H), 0.88 (t, J = 6.9 Hz, 3H), 0.86 (t, J = 7.5 Hz, 3H); 13C NMR (50 MHz) δ 172.8 
(C=O), 41.6 (CH2), 41.1 (CH2), 36.5 (CH), 35.6 (CH2), 26.0 (CH2), 22.9 (CH2), 19.7 (CH2), 
14.3 (CH3), 11.3 (CH3), 10.7 (CH3); HRMS (APCI+, m/z): calculated for C11H24NO [M+H+]: 
186.1852 found: 186.1850; Enantiomeric excess was determined by chiral GC analysis, 
Chiraldex B-PM column, T 110 (5 min), 120 (5 min), 130 (5 min), 135 (15 min), ΔT 5 oC/ 
min retention times (min) t1: 27.54 (major) and t2: 28.83 (minor).
(R)-3-ethyl-5-phenyl-N-propylpentanamide (11)
Starting from (57 mg, 0.3 mmol) of (E)-methyl 5-phenylpent-2-enoate (2) following 
method A, the crude product was obtained which was purified using column 
chromatography on silica (pent/ EtOAc; 9/1) yielding the pure product as 24.5 mg (32 
%) pale yellow oil with 93% ee. [α]D20= -3.6 (c = 1.0), 1H NMR δ 7.26 (t, J = 3.6 Hz, 2H), 
7.18 (m, 2H), 5.35 (s, 1H), 3.20 (dd, J = 13.6, 6.4 Hz, 2H), 2.68 – 2.53 (m, 2H), 2.13 (dd, J = 
7.1, 1.3 Hz, 2H), 1.90 (m app. sep, J = 6.5 Hz, 1H), 1.69 – 1.56 (m, 3H), 1.56 – 1.34 (m, 4H), 
0.91 (2t, J = 7.4, 2.2 Hz, 6H). 13C NMR (50 MHz, CDCl3) δ 172.46 (C=O), 142.63 (C), 128.30 
(2 CH), 125.68 (CH), 41.44 (CH2NH), 41.18 (CH2C=O),36.50 (CH), 35.20 (CH2), 33.02 (CH2), 
26.04 (CH2), 22.90 (CH2), 11.36 (CH3), 10.66 (CH3); HRMS (APCI+, m/z): calculated for 
C16H26NO [M+H+]: 248.2009 found: 248.2017; Enantiomeric excess was determined by 
chiral HPLC analysis, Chiralcel OD-H column, n-heptane/i-PrOH 90:10, 40 °C, 213 nm, 
retention times (min): 12.8 (minor) and 14.10 (major).
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Method B: From methyl (R)-3-ethyl-5-phenylpentanoate
Methyl (R)-3-ethyl-5-phenylpentanoate (16) was synthesized following literature 
procedure.[62] In a Schlenk vessel at -78 °C 0.12 mL (1.5 mmol) propylamine was 
dissolved in 6 mL anhydrous DCM to this solution 0.5 mL (1.5 mmol) 3M EtMgBr 
solution in Et2O was dropwise added. This solution was transferred via a syringe to 
a solution of 66 mg (0.3 mmol) (R)-3-ethyl-5-phenylpentanoate dissolved in 0.6 mL 
dry DCM and stirred at -78 °C. The reaction mixture was allowed stir o.n. while slowly 
warming to r.t. The reaction was quenched with sat. aq. NH4Cl and the resulting 
mixture was extracted 3 times with DCM. The combined organic layers were dried 
with MgSO4 and concentrated under reduced pressure, yielding 74.6 mg (0.3 mmol) 
of the product. 
(S)-3-Methyl-N-phenethylpentanamide (12) 
Amide 12 was obtained starting from methyl crotonate (50 mg, 0.5 mmol) following 
the general procedure, after purification by column chromatography on silica (pent/ 
Et2O; 1/1) as a pale yellow oil (40%, 44 mg) with 98% ee. [α]D20 = +3 (c 1.0 in CHCl3); 1H 
NMR (400 MHz) δ 7.31 (t, J = 7.3 Hz, 2H), 7.24 (d, J = 7.1 Hz, 1H), 7.19 (d, J = 7.3 Hz, 2H), 
5.42 (br s, NH), 3.54 (t, J = 6.5 Hz, 1H), 3.53 (t, J = 6.4 Hz, 1H), 2.82 (t, J = 6.8 Hz, 2H), 2.13 
(m, 1H), 2.02–1.78 (m, 2H), 1.42–1.09 (m, 2H), 0.88 (d, J = 4.7 Hz, 3H), 0.87 (t, J = 7.5 Hz, 
3H); 13C NMR (50 MHz) δ 172.6 (C=O), 138.9 (C), 128.7 (CH), 128.6 (CH), 126.4 (CH), 44.2 
(CH2), 40.4 (CH2), 35.8 (CH2), 32.3 (CH), 29.3 (CH2), 19.1 (CH3), 11.3 (CH3); HRMS (APCI+, 
m/z): calculated for C14H22NO [M+H+]: 220.1697 found: 220.1696; Enantiomeric excess 
was determined by chiral HPLC analysis, Chiralcel OD-H column, n-heptane/i-PrOH 
98:2, 40 °C, 0.5 mL/min, 212 nm, retention times (min) t1: 28.60 (major) and t2: 35.59 
(minor).
(R)-N-Benzyl-3-phenethylnonanamide (13)
Amide 13 was obtained starting from (E)-methyl 5-phenyl-2-pentenoate (2) 
(58 mg, 0.3 mmol) following the general procedure, after purification by column 
chromatography on silica (pent/ EtOAc; 9/1) as a pale yellow oil (63 %, 67 mg) with 
90% ee. [α]D20 = -1 (c 1.0 in CHCl3); 1H NMR (400 MHz) δ 7.44–7.20 (m, 7H), 7.20–7.03 
(m, 3H), 5.64 (br t, J = 4.8 Hz, 1H), 4.43 (d, J = 5.7 Hz, 2H), 2.62 (t, J = 6.4 Hz, 1H), 2.61 (t, 
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J = 6.3 Hz, 1H) 2.25–2.12 (m, 2H), 1.97 (m, 1H), 1.72–1.45 (m, 2H), 1.45–1.15 (m, 10H), 
0.88 (t, J = 6.5 Hz, 3H); 13C NMR (50 MHz) δ 172.4 (C=O), 142.6 (C), 138.4 (C), 128.7 (CH), 
128.3 (CH), 128.3 (CH), 127.9 (CH), 127.5 (CH), 125.7 (CH), 43.6 (CH2), 41.8 (CH2), 35.7 
(CH), 35.3 (CH2), 33.7 (CH2), 33.0 (CH2), 31.9 (CH2), 29.0 (CH2), 26.4 (CH2), 22.7 (CH2), 14.1 
(CH3); HRMS (APCI+, m/z): calculated for C24H34NO [M+H+]: 352.2635 found: 352.2632; 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel OD-H column, 
n-heptane/i-PrOH 90:10, 40 °C, 0.5 mL/min, 212 nm, retention times (min) t1: 21.26 
(minor) and t2: 22.52 (major).
(R)-3-Methyl-N-phenylhexanamide (14)
In a dried Schlenk tube equipped with septum and stirring bar, (S)-Tol-Binap (10.2 
mg, 15 µmol) and CuI (1.91 mg, 10 µmol) were dissolved in MTBE (1 mL) and the 
mixture stirred under nitrogen atmosphere at r.t. for 20 min. The mixture was then 
cooled to -20 oC and MeMgBr (2.5 mmol) was added. After stirring for 5 min, a solution 
of (E)-methyl 2-hexenoate (1) (37 mg, 0.3 mmol) in MTBE (0.2 mL) was added dropwise 
over 1 h. After stirring for two additional hours, the temperature was lowered to -75 
oC, the amine (3.0 mmol) was added and the reaction mixture was stirred overnight 
while slowly warmed to r.t. Subsequently a saturated aqueous solution of NH4Cl was 
added. After extraction with DCM (3 x 10 mL) the combined organic phases were 
dried and concentrated to an oil which was purified using column chromatography 
on silica (pent/ EtOAc; 9/1) yielding the pure product as a pale yellow oil (47 %, 29.2 
mg) with 95% ee. [α]D20 = +1 (c 1.0 in CHCl3); 1H NMR (400 MHz) δ 7.51 (d, J = 7.9 Hz, 
2H), 7.31 (t, J = 7.9 Hz, 2H), 7.08 (t, J = 7.4 Hz, 1H), 2.44–2.24 (m, 1H), 2.19–1.97 (m, 
2H), 1.45–1.13 (m, 4H), 0.98 (d, J = 6.3 Hz, 3H), 0.90 (t, J = 6.9 Hz, 3H); 13C NMR (50 
MHz) δ 171.0 (C=O), 137.9 (C), 128.9 (CH), 124.1 (CH), 119.8 (CH), 45.6 (CH2), 39.1 (CH), 
30.6 (CH2), 20.1 (CH2), 19.6 (CH3), 14.2 (CH3); HRMS (APCI+, m/z): calculated for C13H20NO 
[M+H+]: 206.1539 found: 206.1540; Enantiomeric excess was determined by chiral 
HPLC analysis, Chiralcel OD-H column, n-heptane/i-PrOH 95:5, 40 °C, 0.5 mL/min, 254 
nm, retention times (min) t1: 35.38 (minor) and t2: 43.70 (major).
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(R)-3-phenyl-N-propylpentanamide (15) 
Method A:
Starting from (49 mg, 0.3 mmol) trans-methyl cinnamate following the general 
method, the product was obtained as a pale yellow oil in 13% yield and 94% ee. [α]
D
20= -14.0 (c is 1.0 in CHCl3), 1H NMR (201 MHz, cdcl3) δ 7.29 – 6.99 (m, 5H), 5.11 (s, 1H), 
3.11 – 2.78 (m, 3H), 2.35 (ddd, J = 22.6, 13.8, 7.5 Hz, 2H), 1.87 – 1.40 (m, 2H), 1.34 – 1.10 
(m, 3H), 0.72 (t, J = 7.3 Hz, 3H), 0.66 (t, J = 7.4 Hz, 3H). 13C NMR (50 MHz, cdcl3) δ 171.68 
(C=O), 144.10 (C), 128.48 (CH), 127.50 (CH), 126.42 (CH), 44.60 (CH2), 44.60 (CH), 41.03 
(CH2), 29.06 (CH2), 22.63 (CH2), 11.97 (CH3), 11.15 (CH3); HRMS (APCI+, m/z): calculated 
for C14H22NO [M+H+]: 220.1700 found: 220.1704; Enantiomeric excess was determined 
by chiral HPLC analysis, Chiralcel OD-H column, n-heptane/i-PrOH 90:10, 40 °C, 212 
nm, retention times (min): 14.98 (minor) and 15.87 (major).
Method B:
In a Schlenk tube equipped with septum and stirring bar, (S)-Tolbinap (10,21 mg, 
15,0 µmol) and CuI (1,905 mg, 10,0 µmol) were dissolved in 1 mL tBME and stirred 
under nitrogen at r.t. for 20 min. The mixture was then cooled to -40°C or -20oC and the 
ethyl magnesium bromide (2.50 mmol) was added. After stirring for 5 min, a solution 
of 49 mg (0.3 mmol) trans-methyl cinnamate in 0.2 mL DCM was added dropwise 
over 1h. After stirring for two additional hours, the temperature was lowered to -75oC, 
propyl amine (3.00 mmol) was added and the reaction mixture was stirred overnight 
while slowly warmed to r.t.. Subsequently a saturated aqueous solution of NH4Cl (2 
mL) was added. After extraction, three times, with DCM, the combined organic phases 
were dried and concentrated to an oil which was purified using flash chromatography 
yielding the product as a pale yellow oil in 22% yield and 91% ee.
(E)-phenyl hex-2-enoate (17)
In a round bottom flask 200 mg (1.7 mmol) E-hex-enoic acid was dissolved in 5 
mL EtOAc at 0 °C. To this solution 8.4 mg (0.6 mmol) AlCl3 was added. After stirring 
for 5 min. 165 mg ( 1.75 mmol) phenol and 239 mg (1.75 mmol) ZnCl2 were added. 
The reaction mixture was stirred for 2 h. at 0 °C and subsequently at r.t. for 9 h. The 
reaction was quenched by adding 1M aq. HCl to the solution, at 0 °C. The resulting aq. 
solution was extracted 3 times with Et2O, the combined organic layers were washed 
with water, dried with MgSO4 and the solvent evaporated under reduced pressure. 
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Column chromatography on silica (pent/ EtOAc; 9/1) yielded 196 mg (1.2 mmol, 69%) 
of the pure product as a clear oil. 1H NMR (300 MHz, CDCl3) δ 7.37 – 7.17 (m, 2H), 7.09 
(dt, J = 15.7, 7.0 Hz, 1H), 6.93 (t, J = 7.7 Hz, 1H), 6.88 – 6.76 (m, 2H), 5.84 (d, J = 15.7 Hz, 
1H), 2.22 (dt, J = 7.7, 7.1 Hz, 2H), 1.65 – 1.41 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H).
(E)-S-ethyl pent-2-enethioate (18)[28]
In a heat gun dried roundbottom flask equipped with a condenser, 318 mg (2.79 
mmol) methyl (E)-pent-2-enoate was dissolved in 9 mL dry THF. To this solution 447 
mg (3.34 mmol) AlCl3 and 1 mL (5.60 mmol) (ethylthio)trimethylsilane were added. 
The reaction mixture was stirred while heated at reflux for 2 h. The reaction mixture 
was allowed to cool down to r.t., and was quenched with aq. phosphate buffer of pH 7. 
The resulting aqueous mixture was extracted 3 times with Et2O, the combined organic 
layers were dried with MgSO4 and the solvent evaporated under reduced pressure. 
Column chromatography on silica (pent/Et2O; 50/1) yielded 270 mg (1.87 mmol, 67%) 
of the pure compound as a clear oil. 1H NMR (201 MHz, CDCl3) δ 6.94 (dt, J = 15.6, 6.3 
Hz, 1H), 6.10 (dt, J = 15.5, 1.7 Hz, 1H), 2.94 (q, J = 7.4 Hz, 2H), 2.22 (ddq, J = 7.4, 6.3, 1.7 
Hz, 2H), 1.28 (t, J = 7.4 Hz, 3H), 1.07 (t, J = 7.4 Hz, 3H).
HCl salt of methyl 2-aminopropanoate (19)[60] 
To a solution of 1.0 g (11.22 mmol) (L)-alanine in 6 mL dry methanol at 0 °C, 1.0 mL 
(14.6 mmol) SOCl2 was slowly added. The reaction mixture was stirred while heated at 
reflux for 3 h and subsequently stirred at r.t. for 45 h. The methanol was removed by 
evaporation under reduced pressure. The resulting crude product was washed three 
times with toluene, yielding the product as the HCl salt in quantitative yield. 1H NMR 
(300 MHz, CDCl3) δ 8.71 (br. s, 3H), 4.28 (br. s, 1H), 3.81 (s, 3H), 1.73 (d, J = 6.2 Hz, 3H).
HCl salt of methyl 2-aminoacetate (20)[60] 
To a solution of 1.0 g (13.32 mmol) glycine in 6 mL dry methanol at 0 °C, 1.3 mL 
(17.3 mmol) SOCl2 was slowly added. The reaction mixture was stirred while heated at 
reflux for 3 h and subsequently stirred at r.t. for 45 h. The methanol was removed by 
evaporation under reduced pressure. The resulting crude product was washed three 
times with toluene, yielding the product as the HCl salt in quantitative yield. 1H NMR 
(300 MHz, D2O) δ 3.78 (s, 2H), 3.69 (s, 3H).
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In this chapter the use of liposomes, consisting of N-phospho amino acid amphiphiles, 
as potential drug delivery system is investigated. We have observed that a N-phospho 
β-alanine amphiphile is capable of forming open vesicles. The mechanism for the formation 
of this specific type of vesicles is investigated. It is hypothesized that the formation of open 
vesicles is due to the loss of one of the alkyl chains, as a result of hydrolysis. Analysis of 
aged samples show that only the double tailed amphiphile starting material is present 
and no single tail amphiphile resulting from hydrolysis. It is therefore concluded that the 
formation of open vesicles is due to the intrinsic instability of the β-alanine liposome. 
At the same time, pH dependent studies of the β-alanine amphiphile showed that at 
pH values below the pKa of the amphiphile, emulsion droplets were formed. Being able 
to use a change in pH as a drug release mechanism is especially attractive since the pH 
around cancer cells is slightly more acidic than the pH of healthy tissue. Therefore, the 
morphology change from vesicle to emulsion droplet, is investigated as a potential drug 
release mechanism. It is presumed, that when a hydrophilic drug is loaded in to the 
β-alanine vesicles, it will be released once these vesicles collapse in to emulsion particles. 
To test this mechanism, the β-alanine liposomes were loaded with a fluorescent dye. These 
experiments showed that the β-alanine liposomes leak the fluorescent dye. The leakage 
is likely a result of the intrinsic instability of these β-alanine liposomes. It is expected that 
N-phospho amino acid amphiphiles that do form stable liposomes would be capable of 
pH triggered drug release. 
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7.1 Introduction
The previous chapters focused on obtaining homochirality, in the context of the 
origin of life. In this chapter the emphasis lies on another important factor considered 
key to the origin of life namely compartmentalization.[1, 2] As discussed in the 
introduction (chapter 1.2), the early replicators of life had to be protected from dilution 
and pollution from other compounds. A way of achieving compartmentalization is by 
forming a membrane around the replicator, a so called liposome. Besides protection 
the membrane would provide a way to let food in and metabolites out. Another 
advantage is that membranes can grow and divide, providing two shielded replicators. 
Such a replicating system could be viewed as the first primitive cell.[3]
Liposomes consist of amphiphiles, which are molecules that contain a hydrophobic 
and a hydrophilic part. Due to these different structural parts that repel each other, 
amphiphiles can self-assemble in to various aggregates depending on their size 
and shape. A good descriptor of the shape of the amphiphile that can predict the 
type of aggregate formed is the packing parameter, introduced in section 1.2. The 
use of amphiphiles as liposomal carriers has exploded over recent years.[4-10] When 
liposomes were first discovered by Bangham and Horne[11] it did not take long before 
it was realized that they could be used as mimics of biological membranes.[12] From 
then it only took a few years before these liposomes were used as drug carriers.[10, 
13] Aplplying liposomes as drug carriers can help with two difficulties encountered 
in drug delivery. First the liposome can assist in getting the drug to the desired 
location. Secondly the liposome protects the drug from degradation.[14] Moreover the, 
body can be protected from the drug. In the case of the highly toxic cancer drug cis-
platin, liposome carriers protect the body from the cis-platin decreasing the systemic 
toxicity whilst maintaining a high effective concentration at the tumor site.[15] There 
are two ways in which drugs can be transported by liposomes. When the drug is 
polar and hydrophilic it will be transported in the aqueous core of the liposome. 
If the drug is apolar and hydrophobic it will intercalate in the membrane of the 
liposome (figure 7.1).[16] In some cases, such as amphotericin B, the drug itself forms 
micelles, or combines with phospholipids to form a liposome.[17, 18] Other specialized 
encapsulation modes, such as in lipoplex structures or nanovehicels are described in 
reviews by Stuart and Engberts[19] and Murray et al..[20] 
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Figure 7.1:  Schematic representation of the transport modes of apolar and polar drugs by 
liposomes.
Initially mainly natural occurring phospholipids, such as phosphatidylcholines 
(PC’s) and phosphatidylethanolamines (PE), were used in varying ratios with additives 
such as cholesterol.[6, 21] However, the effectiveness of using liposomes depends on 
how fast and at which location the encapsulated drug is released. As long as the drug 
is inside the liposome it is not bioavailable. Therefore after the initial discovery of the 
rapid clearance of the liposomes in the body, many groups started to develop tailor 
made liposomes. These liposomes contain recognition sites, such as antibodies, to 
aid the liposome to the diseased part of the body19 and contain stabilizing groups 
to prevent fast clearance. A most effective and often used method of preventing fast 
clearance is by introducing poly-ethyleneglycol tails to the liposome thereby creating 
stealth-liposomes. [6, 7, 22, 23] 
Producing a tailor made liposome is time consuming, it can only be used in a 
specific situation and is not always effective.[24] Therefore it would be ideal to have a 
triggered release mechanism, for instance to allow cargo to be released by changes in 
pH[25] or by using a photo responsive liposome[26-28] In the case of treating tumors pH 
release mechanisms are particularly interesting since the pH in the vicinity of tumors 
is lower than in other parts of the body (the pH in tumors range from 5.8 to 7.6 with 
an average around 7.0).[29, 30] Therefore liposomes that release their cargo just below 
normal body pH (~7.4), provide in principle a general method for cancer treatment.[25] 
Di n-alkyl phosphates have been frequently used for their liposome forming 
capability and as an easy mimic of biological membranes.[31, 32] There are many 
natural occurring alkyl phosphates, phospholipids, such as phosphatidylcholine 
(PC), phosphatidylethanolamine (PE) and phosphatidylserine (PS) (Figure 7.2). 
Phospholipids often consist of a phosphonate group linked via a P-O bond to 
glycerol. The other two glycerol hydroxyl groups are bound via an ester linkage to 
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various alkyl chains. The length and unsaturation of the alkyl chains depends on the 
natural source of the pospholipid.[33] Engberts and coworkers synthesized several 
n-alkyl phosphate analogs to further investigate phase behavior and study the effect 
of chirality on the aggregation behavior (Figure 7.2).[34-36] Recently in our group a new 
class of alkyl phosphates, namely N-phosphoamino acids, were introduced.[37] These 
N-phosphoamino acids consist of only natural building blocks, two lauryl alcohols that 
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Figure 7.2: General structures of natural and synthetic phosphor-based amphiphiles.
These types of compounds, showing large resemblance to the compounds shown 
in chapter 4 but containing long alkyl chains, were first published by Zhao and 
coworkers.[38, 39] Due to the low solubility of the long alkyl chain alcohols, which are 
solids at room temperature, they report the use of a slightly elevated temperature to 
obtain the corresponding alkylphosphonates (Scheme 7.1). Subsequently they used 
the amino esters instead of the free amino acid at reduced temperature to obtain 
the corresponding phospho amino ester. The free phospho amino acid is obtained by 
hydrolysis of ester with 1M aq. NaOH. Unfortunately no rational is given on why the 
amino ester is used instead of the free amino acid.[38] 
Scheme 7.1:  Synthesis of aminophosphates carrying long alkyl chains as reported by Zhao and 
coworkers.[37, 38]
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Several syntheses are known which describe that the free amino acid can be directly 
coupled to a phosphite.[40-42] This method, the Atherton-Todd reaction, was used in 
our previous chapter and by Hulst et al. in our group.[43, 44] Therefore it was initially 
tried to employ the Atherton-Todd reaction for the synthesis of the N-phospho 
amino acid amphiphiles, since this would reduce the number of synthetic steps 
significantly (Scheme 7.2).[37, 45, 46] First the phosphonate containing long alkyl chains 
was synthesized by stirring lauryl alcohol with PCl3 in the presence of pyridine,[47] 
yielding the phosphonate in 86% yield. However, reacting the phosphonate directly 
with phenyl alanine in the presence of carbontetrachloride and trimethylamine did 
not yield the desired product but mainly starting materials. This was most probably 
due to the lower reactivity of the long alkyl chain phosphonate. It is likely that the 
longer alkyl chains introduce extra steric hindrance making the phosphonate less 
accessible for the Atherton-Todd reaction. Increasing the reaction temperature led to 
a mixture of undefined products. Due to the high polarity of these compounds, they 
could not be isolated via normal phase silica column chromatography.[37]
Scheme 7.2: Attempted synthesis of the phospho amino acid directly from the free amino acid.
To increase the reactivity of the phosphonate it was subsequently tried to start 
from the more reactive phosphoryl chloride and use a methyl protected amino acid 
to avoid side reactions. Other advantages of this two-step method is that there is 
no longer the need to use the highly toxic carbontetrachloride as a reagent and the 
amino ester phosphonate can be purified via column chromatography (Scheme 7.3). 
Increasing the reactivity by shifting from the phosphite to the phosphorylchloride had 
the desired effect, the coupling with the amino ester now proceeded readily affording 
various methylesters in good yields. The phospho amino acid could subsequently be 
obtained by hydrolysis of the corresponding phospho amino ester in ethanol and 1M 
aq. NaOH for 2 h at room temperature.[37] 
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Scheme 7.3:  General synthesis of the phospho amino esters, starting from the phosphoryl 
chloride and amino acid methyl ester.
7.2 Previous work and goal
Previous work in our group on the synthesis and characterisation of N-amino acid 
amphiphiles showed that most long alkyl chain phospho amino acids form vesicles 
but that some of these amphiphiles form thread like micelles (Table 7.1).[37] Of all tested 
amino acid based phospho amphiphiles that form vesicle some, namely β-alanine, 
glycine and alanine amino acid derived amphiphiles, showed the formation of open 
vesicles (Figure 7.3).[37] It is known that open vesicles arise when both double tailed 
as single tailed amphiphiles are present; see next sections for discussion. However, 
the open vesicle could also be an intermediate form between a bilayer vesicle and a 
bilayer sheet. 
Table 7.1:  Aggregation state of the various amino acid based amphiphiles. All samples were 
prepared using thin layer technique followed by hydration with 20 mM buffer solution 
followed by three freeze dry cycles. *Aggregates observed from an aqueous solution 
at pH 8.5 and room temperature. The pH values was adjusted using 20 mM TRIS buffer 
and concentrated HCl solution. ** Aggregates were prepared at 4 °C. † Aggregates 
were prepared at 70 °C.
Amino acid Aggregates* Phase
1a L-Phe Vesicle Lamellar
1b L-Gly Open Vesicle Lamellar
1c L-β-Ala Open Vesicle Lamellar
1d L-Ala Sheets/ open vesicle Lamellar
1e L-Val Vesicle Lamellar
1f L-Leu Vesicle Lamellar
1g L-Ile Vesicle Lamellar
1h L-Pro Vesicle Lamellar
1i L-Asp** Thread-like micelles Micellar
1i L-Asp† Vesicle Lamellar
1j L-Glu** Thread-like micelles/ disks Micellar
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1j L-Glu† Vesicle Lamellar
1k L-Ph-Gly Sheet/ vesicle Lamellar
1m L-Trp Vesicle Lamellar
1o L-Cys Twisted and coiled ribbons Lamellar
1p D-Phe Vesicle Lamellar
1q D-Pro Vesicle Lamellar
1r D-Trp Vesicle Lamellar
Figure 7.3: Cryo-TEM images of a) β-alanine b) alanine and c) glycine phospho amphiphiles.
We hypothesized that this open vesicle formation is due to the hydrolysis of one 
of the two aliphatic chains (Scheme 7.4) so that a mixture of double tailed and single 
tailed amphiphiles exists in solution (Figure 7.4).[37, 48] The hydrolysis of one of the 
alkyl chains could occur when the acid is deprotonated and an intramolecular attack 
occurs on the phosphorous atom (Scheme 7.4). The formation of mixed anhydride 4 
has been proposed by the group of Zhao,[48] in the case of R = isopropyl. Although 
Zhou et al. have never been able to isolate or directly detect a mixed anhydride, they 
do observe the formation of several other compounds that might be explained via 
this hydrolysis mechanism.
Scheme 7.4: Hydrolysis of one of the alkyl chains via a mixed anhydride species.[48]
It is known that two amphiphiles with a different packing parameter (Introduction 
1.2), as is the case for single and double tailed amphiphiles, can aggregate together 
to form open vesicles.[49-51] Double tailed amphiphiles often have a packing parameter 
between 0.5 and 1 or even larger. For amphiphiles with this packing parameter it is 
thermodynamically favourable for these to form a bilayer structure. Whereas for single 
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tailed amphiphiles that have a packing parameter < 0.3 it is thermodynamically more 
favourable to form micelles. When these two amphiphiles are mixed fi rst the single 
tailed amphiphiles will insert in to the bilayer. When the single tailed amphiphiles are 
above a certain concentration they will open the bilayer vesicle by forming a “micelle” 
on the edges of the bilayer (Scheme 7.4a). 
  
Figure 7.4: a, Schematic representation of the formation of open vesicles; b, Cryo-TEM image 
showing an open vesicle formed by mixing single tailed surfactant Triton-X100 with 
double tailed amphiphile DOPC.(reproduced from[49])
If indeed the formation of open vesicles is due to the hydrolysis of one of the alkyl 
chains the formation of open vesicles could be triggered or enhanced by increasing 
the temperature or the pH. At a higher temperature or at a higher pH it is expected 
that the hydrolysis reaction will proceed at a higher rate and that therefore more open 
vesicles will be formed. In this chapter we will investigate whether it is possible to 
control the opening of these aggregates by increasing the pH or the temperature. 
Subsequently we want to test if it is possible to use the controlled opening of these 
aggregates as a controlled release or slow release system (Figure 7.5).
Partial hydrolysis 
pH ~ 8.4 
Time/ higher 
pH 
Figure 7.5: Suggested slow release system by controlling, the rate of, formation of open vesicles.
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7.3 Results discussion
7.3.1 Synthesis and hydrolysis of the β-alanine phospho amphiphile
β-Alanine phospho amphiphile 3 was synthesized following the procedure given by 
Bastian et al..[37] In this synthesis the phosphorylchloride 1 is coupled to the β-alanine 
methyl ester, in DCM in the presence of triethyl amine as a base yielding ester 2 in 95% 
yield. Subsequent hydrolysis of ester 2 furnishes the desired acid 3 in 88% isolated 
yield (Scheme 7.5). As mentioned previously β-alanine amphiphile 3 is capable of 
forming open vesicles and was therefore chosen for our initial studies. 
Scheme 7.5: Synthesis of β-alanine phospho amphiphile 3
The formation of open vesicles by β-alanine amphiphile 3 was tested by Cryo-TEM. 
Images where taken of 3 in TRIS buffer at pH 8.5 to establish vesicle formation (Figure 
7.6). The same sample was taken two days later to establish if the amount of open 
vesicles was increased in time. In the two day old sample of β-alanine amphiphile 3, 
some open vesicles are observed, as indicated by the white arrow. However most of the 
compound has crashed out in solid sheets, indicated by the black arrow, or still forms 
closed vesicles (Figure 7.7). The formation of solid sheets is common for amphiphiles 
that exist in the bilayer phase. The formation of large bilayer sheets occurs over time 
because sheets do not contain any curvature and are therefore thermodynamically 
more stable then vesicles. When these sheets become so large that they are no longer 
soluble they crash out of solution as solid sheets. The timeline in which they form 
solid sheets depends on the stability of the liposome.[52, 53] Since Cryo-TEM only shows 
a small part of the total amphiphile population it is unsuitable to obtain quantitative 
data on the formation of single tailed amphiphiles.[54] 
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Figure 7.6:  Cryo-TEM images of the vesicles formed by the β-alanine phospho amphiphile, in 
image b) the arrow indicates an open vesicle.
Figure 7.7:  β-Alanine phospho amphiphile after 2 days, the white arrows indicate open vesicles 
and the black arrows solid sheets.
The formation of the single tailed β-alanine phospho amphiphile 5 upon hydrolysis 
of amphiphile 3 in water at pH 8.5 was followed in time by 31P NMR. It is expected 
that both β-alanine amphiphiles 3 and 5 would show a unique signal. From literature 
it is known that monoalkyl phosphonate compounds like 5 exhibit a 31P-NMR signal 
around 9 ppm,[55] whereas dialkyl phosphonate 3 has a 31P-NMR signal at 10.3 ppm 
(Scheme 7.4). The two unique signals would give us the opportunity to follow the 
hydrolysis directly and quantitatively. It is important to note that aggregates show 
particular 31P NMR spectra compared to molecules in solution.[56] This particular NMR 
spectrum arises because the chemical shift depends largely on the orientation of the 
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molecule with respect to the applied magnetic field (chemical shift anisotropy, CSA). 
Atoms usually do not have a symmetric electron cloud around the nucleus therefore 
the chemical shift of a molecule depends on the orientation of that molecule in 
the applied magnetic field resulting in CSA. In solution molecules are present in all 
orientations and are capable of fast isotropic reorientation therefore averaging the 
CSA and as a result a narrow symmetric NMR signal is obtained. Molecules that are in 
an aggregates state do not possess the freedom to move and rotate in every direction. 
In a bilayer for instance a molecule can only rotate freely around their long axis. 
Therefore the CSA is only partially averaged out resulting in a broad signal with a low 
field shoulder and a high field peak (Figure 7.8, top Lα).[56] However in cubic phases, 
micelles and small vesicles, the amphiphiles can move more freely resulting in an 
averaging out of the CSA with as a result a sharp 31P-NMR signal (Figure 7.8, bottom). 
Another obstacle in obtaining a NMR spectrum of an aggregate is that for NMR a high 
concentration is needed to obtain a good signal to noise ratio, typically about 20 mg/
mL. This concentration is much higher than for instance the concentrations necessary 
for Cryo-TEM or fluorescence spectroscopy and are sometimes above the solubility of 
the aggregate. 
Figure 7.8:  31P-NMR line shapes corresponding to different phospholipid phases (Lα = linear, 
bilayer, HH = hexagonal phase) ; adapted from ref[56]
N-PHOSPHO AMINO ACID LIPOSOMES AS POTENTIAL LIPOSOMAL CARRIERS 163
We were able to obtain a 31P NMR spectra of β-alanine amphiphile 3. The spectra 
shows a low field shoulder of about 40 ppm which is common for bilayer structures 
and supports that there are mainly bilayer vesicles present in the solution. Besides 
the main aggregate signal with a maximum around 3 ppm there seems to be an 
extra signal around 13 ppm. It is however not possible to determine by 31P NMR 
alone whether this is another compound or a different aggregation state, for instance 
micelles, of the same molecule. 
Figure 7.9:  31P NMR spectra of β-alanine phospho amphiphile 3 in Tris-buffer at pH 8.5, with 10% 
D2O.
Since the results obtained by 31P NMR were inconclusive, we decided to use mass 
spectrometry to determine if the single tailed β-alanine phospho amphiphile 5 was 
formed. UPLC-MS and Maldi measurement after several weeks still did not show any 
hydrolysed compound. Another sample was left at pH 8.5 for two months after which 
the water was removed by freeze drying and 1H and 31P NMR spectra were obtained. 
Both spectra only showed the β-alanine amphiphile 3 and TRIS, which was used as 
buffer compound (Figure 7.10). Therefore we can conclude that the formation of open 
vesicles is not due to the presence of single tailed vesicles that are formed once one 
of the two tails of amphiphile 3 are cleaved due to hydrolysis (Scheme 7.4). Therefore, 
using the hydrolysis of amphiphile 3 as a controllable slow release system was 
abandoned. Of all the synthesized amino acid amphiphiles only the β-alanine, glycine 
and alanine form open vesicles (Table 7.1). These three amino acids are the three 
amino acids with the least steric bulk. Decreasing the steric bulk of the head group 
increases the packing parameter (Introduction 1.X). Amphiphiles with a packing 
parameter between 0.5 and 1 exist in the lamellar phase. Two colloidal structures that 
are associated with the lamellar phase are bilayers and vesicles.[57] Of these two the 
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bilayer is thermodynamically the most stable state and vesicles are an often observed 
as a transient state.[58] Increasing the size of the head group increases the packing 
parameter, resulting in a more cylindrical amphiphile (P is close to 1) and therefore it 
becomes more unfavourable to be in a more rounded, vesicle, shape. This results in a 
short existence of the vesicle and a quick transition in to sheets. Therefore, in the case 
of amphiphile 3, the vesicles open and form bilayers due to too much curvature strain 
in the vesicle. As a result the vesicles are less stable and the formation of bilayer sheets 
occurs more rapidly than for other more stable bilayer vesicles.[53, 59] 
Figure 7.10:  1H-NMR spectra of a 2 month old β-alanine amphiphile 3 sample in CDCl3, the 
sample was stored at r.t. in Tris-Buffer at pH 8.5 for 2 months after which the water 
was evaporated and the remaining solid was dissolved in chloroform.
7.3.2 pH depended phase behavior of β-alanine phospho amphiphile 3
Whilst obtaining Cryo-TEM images of the β-alanine amphiphile 3, various samples 
were taken at different pH’s. During these measurements we observed that when 
the pH came below the pKa of the amphiphile, pH 7.44, the solution became more 
turbid. Cryo-TEM images of the aggregates of β-alanine amphiphile 3 at pH 6, showed 
that most vesicles “collapsed” in to emulsion particles (Figure 7.9). Since the emulsion 
particles do not contain an aqueous core, we hypothesized that a hydrophilic drug 
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would be released upon the collapse of a bilayer vesicle in to an emulsion particle. 
Furthermore pH dependent release is an important release mechanism in cancer 
treatment.[6, 29] pH triggered release is especially interesting for cancer treatment 
because cancer cells have an average pH around 7.0, and are therefore in a slightly 
more acidic environment than healthy cells, that have an average pH of 7.4.[5, 25] 
Figure 7.9:  Cryo-TEM image of amphiphile 3 at pH 6, the white arrow indicates a vesicle, whereas 
the black arrows indicate emulsion droplets.
The observation that at lower pH emulsion particles are formed gave rise to a 
new mechanism of controled release namely by lowering the pH (Figure 7.10). The 
formation of emulsion particles can be explained by the fact that at low pH, below 
the pKa of the amphiphile, the carboxylate of the amphiphile will be protonated and 
thus loses its strong amphiphilic character. When protonated β-alanine amphiphile 3 
becomes a large more apolar molecule, that has a decreased amphiphilic character. 
From figure 7.9 it can be concluded that, when β-alanine amphiphile 3 is protonated it 
forms an emulsion. It is expected that the protonation of the acid and the subsequent 
collaps of the vesicles to emulsion particles will occur around the pKa of the 
aggregate which is around pH 7.4.[37] The formation of stable nanoemulsions of apolar 
compounds in the presence of a surfactant is known in literature.[60, 61] In these cases 
the surfactant encapsulates the apolar compound. It is expected that in our case the 
molecules that are still deprotonated encapsulate the apolar protonated amphiphile. 
This way all charges are on the surface of the nano emulsion while all neutral material 
is inside the droplet. To the best of our knowledge, this is the first example of the 























Figure 7.10:  Potential mechanism for controlled release of water soluble compounds; via pH 
responsive emulsion formation.
The pKa of β-alanine amphiphile 3 is 7.44,[37] which is much higher than the pKa of 
β-alanine in free solution, which is around 3.60.[62] This large diff erence in pKa is known 
in literature[63] and a common eff ect in aggregate formation. This increased pH eff ect 
arises because in the bilayer of a vesicle all carboxylic acids are positioned next to each 
other. Once several carboxylic acids are deprotonated a negative charge will start to 
form on the surface of the bilayer. This negative charge will impede the deprotonation 
of the remaining acids and will therefore increase the overall pKa (Figure 7.11).[63] 
Figure 7.11:  Partially deprotonated state of the amphiphilic bilayer, showing that the few 
remaining protons are “shared” between acids.
To determine the pH at which the transition from vesicles to emulsions occurs 
the solvatochromic probe Nile Red[64] was added to a standard sample of (3 mg/mL) 
β-alanine amphiphile 3 in aggregated form. and the fl uorescence was measured at a 
range of diff erent pH values. As mentioned in the introduction (Section 1.X) Nile Red 
can be used as a probe to determine the polarity around the probe. When the polarity 
of the surroundings increases, the emission maximum (λmax) of the probe will shift to 
higher wavelengths. Due to the apolar nature of Nile Red (Figure 1.X) this probe will 
insert itself in to the bilayer of the vesicle, which consist of long hydrophobic alkyl 
chains. It is expected that once the emulsions are formed Nile Red will insert in to 
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the emulsion and therefore will be in a more hydrophobic environment shifting the 
emission maximum (λmax) to lower wavelengths.[64] 
Graph 7.1:  Change in λmax of Nile Red as a function of pH, in the presence of β-alanine 
amphiphile 3, samples consist of a 3 mg/mL aggregate solution to which 0.5 µL of a 
2.5 mM Nile Red solution in ethanol/ mL aggregate solution was added. 
Lowering the pH from 10 to 6 only causes a small decrease in λmax. This 4 nm 
decrease in λmax going from pH 10 to pH 6 is probably caused by the steady increase 
in protonation of the vesicle. Lowering the pH will result in more amphiphiles that 
will be protonated making the bilayer less polar and therefore the environment of 
the Nile Red probe more hydrophobic. While decreasing the pH from 6 to 5.5, the 
λmax suddenly shifts by 10 nm. We hypothesize that this sudden and significant shift is 
due to the transition of vesicles to emulsion particles. As expected upon formation of 
the emulsion particles the surroundings of the Nile Red probe becomes much more 
hydrophobic, resulting in a large change in the λmax.
 
Via visual inspection of the sample, it can be observed that at higher pH the solution 
is opague and clear but at pH values below 6 the solution becomes turbid. When 
the pH of the turbid emulsion is increased so that it is above 6 again an opaque and 
clear solution is obtained. These observations made us wonder if this process might 
be reversible. To test the reversibility of the vesicle/ emulsion formation the pH of a 
sample containing 3mg/mL of aggregated β-alanine amphiphile 3 in TRIS buffer, was 
lowered to pH 6 and subsequently adjusted again to pH 8.5. Cryo-TEM images of this 
sample show that indeed bilayer vesicles do start to form again (Figure 7.12). 
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Figure 7.12:  Cryo-TEM image of aggregated β-alanine amphiphile 3 that has been brought to 
pH 6 and subsequently brought back to pH 8.5. Scale bar represents 100 nm.
Now that it was clear that the formation of emulsion particles is reversible we 
wanted to know if this reversibility is robust and therefore could be achieved for 
several cycles. To test the robustness of this cycle Nile Red, dissolved in ethanol, was 
added to a solution of aggregated β-alanine amphiphile 3. Subsequently the pH of 
the sample was changed several times between pH 9 and pH 6. After each pH change 
the λmax was measured and plotted (Graph 7.2). The plot shows that when the pH 
changes from 9 to 6 the λmax also shifts significantly, indicating emulsion formation. 
Changing the pH back to 9 results in a shift to a significantly higher λmax obtaining a 
λmax similar to the original sample. Changing the pH back and forth between 9 and 
6 shows that the reversibility of emulsion and vesicles formation is quite robust. No 
fatigue is observed after 4 cycles. Slight changes in λmax both at pH 9 and at pH 6 are 
a result from the small variations in pH. The pH is adjusted manually and can vary 
between 8.9 and 9.1 for pH 9 and between 5.8 and 6.2 for pH 6. Although the use of 
liposomal oil-droplets as drug-carriers have been reported recently,[65] to the best of 
our knowledge using the formation of emulsions from vesicles as drug release system 
has not been described. 
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Graph 7.2:  Plot of the λmax of the Nile Red probe in an aggregate solution of β-alanine 
amphiphile 3 changing the pH from 9 to 6 and back four times.
Now that we have a method at hand for pH triggered release, namely by the 
collapse of the β-alanine amphiphile 3 vesicles in to emulsion particles, we wanted 
to include a compound and see how fast this would be released by the vesicles and 
if it would be released faster once the pH would be adjusted to pH 6. The experiment 
that we used for this purpose was the inclusion of the fluorescent molecule calcein 
in these vesicles.[28, 66] During this experiment vesicles are formed in the presence of a 
high calcein concentration so that the calcein molecules are included in the vesicles 
(Step 1, Figure 7.13). This mixture was passed through a filter (extruded) several 
times to ensure a homogeneous size distribution of the vesicles. Subsequently a size 
exclusion column was used to remove the free calcein from the vesicles (Step 2, Figure 
7.13).[66] When the closed vesicles contain calcein they will show a low fluorescent 
signal due to the exited state quenching of the calcein molecules by its neighbours. 
Once the vesicles open, collapse or leak the calcein becomes free in solution and 
the fluorescent signal will increase due to the fact that the diluted calcein molecules 
do no longer undergo quenching. To completely break up the vesicles so that the 
maximal fluorescence can be determined the surfactant Triton X100 is added to the 
vesicles (step 3, Figure 7.13).[66] 
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Figure 7.13:  Schematic representation of the calcein inclusion experiment. Step 1: formation of 
vesicles in the presence of calcein; Step 2: removal of the excess free calcein by size 
exclusion column chromatography; Step 3: opening of the vesicles by addition of 
the surfactant Triton X100.
First the method was tested on the well-known amphiphilic compound DOPC 
(Graph 7.3). Initially the fl uorescence of the calcein containing DOPC vesicles was 
measured before the addition of Triton X100. When the surfactant is added there is 
a sudden drop in intensity due to the opening of the fl uorimeter to add the Triton 
X100 to the solution (from 65 to 75 sec in Graph 7.3). After addition of the surfactant 
the vesicles are broken,[50] thereby releasing the calcein and increasing the intensity 
of the fl uorescence.
Graph 7.3:  Fluorescent signal as a function of time: after 70 s. the surfactant Triton X100 is added 
to calcein containing DOPC vesicles and a large increase in fl uorescence is observed, 
preceded by a decrease due to the opening of the lid of the fl uorimeter to add the 
surfactant.
Upon visual inspection of the vesicles prepared from β-alanine amphiphile 3 in the 
presence of calcein it was observed that this sample was signifi cantly less coloured 
than the DOPC sample. This indicates that there is either a lower vesicle concentration 
or that the vesicles contain less calcein. Fluorescence measurement of the β-alanine 
amphiphile 3 vesicles containing calcein showed a steady signal, upon addition of 
Triton X100 however the fl uorescent signal did not increase (Graph 7.4). 
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Graph 7.4:  Fluorescence as a function of time for calcein containing β-alanine amphiphile 
3 vesicles: only a decrease in fluorescence is observed due to opening of the 
fluorimeter to add the surfactant, after adding the Triton X100 no change is 
observed. 
That no increase in fluorescence is observed upon addition of Triton X100 to the 
calcein containing β-alanine amphiphile 3, indicates that either the vesicles are still 
intact after the addition of the surfactant or that the vesicles where already broken 
before the addition of Triton X100. Since Triton X100 is a commonly used mono tailed 
surfactant that disrupts the bilayer, it is unlikely that the vesicles are still intact after 
the addition of the surfactant. This indicates that the β-alanine amphiphile 3 vesicles 
already released the included calcein before the surfactant was added. The release 
of the fluorescent dye before the addition of the surfactant can be explained by the 
intrinsic instability of the vesicles formed from amphiphile 3. As discussed in the first 
part of this chapter these amphiphiles are capable of forming open vesicles. Since this 
was not a result of the hydrolysis of one of the aliphatic tails it is probably an intrinsic 
property of these vesicles. This corresponds with the Cryo-TEM image showing a 
collapse of most of the vesicles into sheets within two days. 
If one considers all the amino acid amphiphiles that were capable of forming open 
vesicles it is clear that mainly the smaller amino acids (β-alanine, alanine and glycine) 
form these open vesicles. It is possible that because these amphiphiles have a smaller 
head group than the other amino acid amphiphiles their packing parameter is larger 
and therefore approaching 1. It is thermodynamically unfavourable for bilayers with 
relatively high packing parameters to be in a curved (vesicle) state. As a result they 
prefer the formation of bilayers or less strained open vesicles rather than closed 
vesicles.[59] 
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7.4 Conclusion and outlook
From the results presented in this chapter it can be concluded that the formation 
of open vesicles from the N-phospho β-alanine amphiphile is not due to hydrolysis 
of one of the two alkyl tails. Cryo-TEM images of a two day old sample do not show a 
significantly increased amount of open vesicles. Furthermore Maldi, 1H and 31P NMR 
measurements of a 2 month old sample do not show the hydrolyzed compound. 
Therefore it is concluded that the formation of open vesicles is not due to the presence 
of single and double tailed amphiphiles but due to the intrinsic instability of these 
vesicles. That the amphiphiles are stable compounds, but that the vesicle is labile, is 
most likely also the case for the glycine and alanine amphiphiles. The intrinsic instability 
makes it difficult to use these three amino acids based amphiphiles for controlled 
release since uncontrolled release occurs within hours. That β-alanine amphiphile 
vesicles are intrinsically unstable was confirmed during preliminary calcein inclusion 
experiments. The addition of triton X100 did not increase the fluorescence indicating 
that the calcein was already released, due to the instability of the vesicles.
The mechanism of releasing water soluble drugs by including them in N-phospho 
amino acid amphiphiles based vesicles and releasing them by collapsing the vesicles 
in to an emulsion particle by lowering the pH could be very useful. However, to 
be applicable an amino acid amphiphile needs to be used that forms more stable 
vesicles than β-alanine amphiphile 3. This mechanism could be especially useful in 
cancer treatment since these cells produce a lower pH surrounding than healthy 
cells.[25] Other advantages are that these amphiphiles are easily accessible from simple 
benign starting materials. When the amphiphiles are hydrolyzed in vitro the resulting 
metabolites would cause no harm.[37] Another important advantage is that these 
N-phospho amino acid amphiphiles all have pKa values around the physiological 
pH of 7.4. This gives rise to the opportunity of tuning the pH at which the vesicles 
collapse, and the drug is released. One can simply choose the N-phospho amino acid 
amphiphile that has a pKa that is closest to the desired release pH. 
7.5 Experimental section
7.5.1 Materials and Methods
All chemicals and reagents were purchased from commercial suppliers (Acros, TCI 
and Sigma-Aldrich) and used without further purification. Dry solvents were taken 
from an MBraun solvent purification system (SPS-800). Thin layer chromatographic 
(TLC) analysis was performed on Merck silicagel 60/Kieselguhr F254, 0.25 mm TLC 
plates and spots were visualized by UV and staining with KMnO4 stain. Column 
chromatography was performed using silica gel (P60, 230 – 400 mesh). 
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1H-NMR-, 13C-NMR-, 31P-NMR-, were recorded on a Varian AMX400 (400 and 100.59 
MHz, respectively) using CDCl3 as a solvent (CDCl3: δ 7.26 for 1H-NMR, δ 77.16 for 
13C-NMR). Data are reported as follows: chemical shifts, multiplicity (s= singlet, 
d= doublet, t= triplet, q= quartet, qi= quintet, br= broad, m= multiplet) coupling 
constants J (Hz) and integration.
High resolution mass spectrometry (HRMS) was carried out on a LTQ ORBITRAP XL 
spectrometer (Thermo Scientific) employing electron impact ionization in positive ion 
mode (EI+) and negative ion mode (EI-). 
Optical rotations were measured on a Schmidt + Haensch polarimeter (Polartronic 
MH8) with a 10 cm cell (concentration c given in g/100 mL). Melting points were 
measured on a Büchi B-545 and recorded in °C.
A pH-meter (Sartorius PB-11) equipped with a glass combination electrode was 
used for pH adjustments of the reaction buffers and for the pH determination of 
aggregate solutions. 
A Jasco FP6200 fluorimeter was used for all fluorescence measurements, all 
measurements where preformed at room temperature, without stirring. 
Cryo TEM images were taken on an FEI Tecnai T20 transmission electron microscope 
and on a Philips CM12 cryo transmission electron microscope operating at 200 and 





After dissolving a N-phosphoamino acid in chloroform the solvent was carefully 
evaporated under a slow stream of nitrogen gas and continuing rotation. The resulting 
thin film was stored for 30 min under high vacuum to assure the complete removal 
of the organic solvent. Subsequently, an aqueous buffered solution was added to 
achieve a final concentration of 3 mg/ mL. The resulting sample was vortexed to 
obtain a homogenous suspension. At least three freeze-thaw cycles were performed 
and the sample was sonicated during thawing, to enable aggregate formation. The 
resulting turbid solution was used for cryo-TEM measurements.
Buffer preparation:
pH 8.5 (20 mM TRIS buffer): 1.21 g of tris(hydroxymethyl)aminomethane was 
dissolved in 500 mL water and the pH was adjusted by adding 1M aqueous HCl 
solution. Next water was added to obtain a total volume of 500 mL.
A 3 µl liter solution was placed on a glow discharged holy carbon coated grid 
(Quantifol 3.5/1) blotted and vitrified in ethane (Vitrobot, FEI). Grids were observed 
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in a Philips CM120 or a FEI Tecnai T20 electron microscope operating at 120 or 200 
keV, using a Gatan cryo-stage (model 626). Images were recorded under lowdose 
conditions.
Nile Red fluorescence measurements
For the Nile Red fluorescence measurements the aggregate samples were prepared 
as described for Cryo-TEM imaging. Per 1 mL aggregate solution 0.5 µL of a 2.5 mM 
Nile Red solution in ethanol was added. The λmax of the solution was determined by 
pipetting at least 3 mL in to a 1 cm by 1 cm fluoresence cuvet. As excitation wavelength 
550 nm was used unless otherwise stated. The obtained spectra where plotted and a 
log-normal fit was used to determine the excitation maximum.[64] 
Calcein inclusion
The lipid (20 mg) was dissolved in 1 mL chloroform. Subsequently the chloroform 
was removed by an air flow whilst rotating the lipid solution. Upon evaporation of 
the chloroform the film was dried under high vacuum for at least 15 min. A solution 
of 200 mM calcein in 20 mM TRIS-buffer pH 8.5 was prepared, after solvation of the 
calcein NaOH was added until the pH was 8.5 again. Subsequently 1 mL of the calcein 
solution was added to the lipid film. The solution was freeze dried at least 3 times to 
ensure that the vesicles are formed. The resulting vesicle solution was extruded 11 
times through a 200 nm pore size polycarbonate filter. The resulting homogenized 
vesicle solution was separated from the free calcein via a Sephadex G5 size exclusion 
column. The column was first equilibrated with 20 mM TRIS buffer (pH 8.5). The first 
fraction, a dark orange band, was collected which contains the calcein filled vesicles, 
the second fraction is the light orange to yellow free calcein fraction.[66] The dark 
orange band was collected in Eppendorf cups and kept in the fridge until use. 
7.5.3 Synthesis and characterization
Didodecyl phosphorochloridate (1) [37]
To an ice cooled solution of 5.1 g (27.4 mmol) lauryl alcohol and 7.26 mL (52.2 mmol) 
Et3N in 100 mL dry toluene was slowly added a solution of 2 g (13.0 mmol) phosphorus 
oxychloride in 20 mL toluene. After the reaction mixture was slowly warmed to room 
temperature it was stirred vigorously overnight. The resulting suspension was filtered 
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under suction through Celite® and rinsed with toluene. The combined filtrates were 
dried (MgSO4), subsequently the solvent and remaining Et3N were removed by rotary 
evaporation. The colourless oil was used without further purification (full conversion). 
1H-NMR (CDCl3, 400 MHz): δ (ppm) = 4.18 (t, J= 9.6 Hz, 4H); 1.73 (m, 4H); 1.39 (m, 4H); 
1.26 (br, 32H); 0.88 (t, J= 6.5 Hz, 6H). 13C-NMR (CDCl3, 100 MHz): δ (ppm) = 69.88 (d, J= 
7.3 Hz, 2C, CH2); 32.04 (2C, CH2); 29.94 (d, J= 7.8 Hz, 2C, CH2); 29.75 (4C, CH2); 29.67 (2C, 
CH2); 29.58 (2C, CH2); 29.47 (2C, CH2), 29.16 (2C, CH2); 25.45 (2C, CH2); 22.81 (2C, CH2), 
14.12 (2C, CH3). 31P-NMR (CDCl3, 162 MHz): δ (ppm) = 4.8.
Methyl 3-((bis(dodecyloxy)phosphoryl)amino)propanoate (2)[37] 
A solution of 1.00 g (2.2 mmol) didodecyl phosphorochloridate in 25 mL dry CH2Cl2 
was cooled to 0 °C and 460 mg (3.3 mmol) β-alanine methyl ester hydrochloride was 
added in one portion. After addition of 2 mL (14.0 mmol) triethylamine the reaction 
mixture was stirred for 5 h at room temperature. Subsequently the mixture was 
quenched with water and the organic phase was extracted once with aq. 1 M HCl and 
once with brine. Drying of the organic solution with MgSO4 and rotary evaporating of 
the solvent led to the crude product. Purification by column chromatography (SiO2, 
Et2O/CH2Cl2 8:2, Rf = 0.4) yielded the product as a colourless solid with an isolated 
yield of 95 % (1.12 g., 2.15 mmol). 1H-NMR (CDCl3, 400 MHz): δ (ppm) = 3.95 (t, J= 6.8 
Hz, 4H); 3.67 (s, 3H); 3.16 (m, 2H); 3.1 (m, 1H, NH); 2.51 (t, J= 6 Hz, 2H); 1.63 (qi, J= 7.6 
Hz, 4H); 1.23 (br, 36H); 0.85 (t, J= 6.8 Hz, 6H). C-NMR (CDCl3, 100 MHz): δ (ppm) = 173.08 
(1C; CO); 66.91 (2C, CH2); 52.18 (1C, CH3); 37.48 (1C, CH2); 36.31 (d, J= 4.5 Hz, 1C, CH2); 
32.37 (2C, CH2); 30.83 (d, J= 6.9 Hz, 2C, CH2); 30.11 (2C, CH2); 30.09 (2C, CH2); 30.04 (2C, 
CH2); 30 (2C, CH2); 29.80 (2C, CH2), 29.66 (2C,CH2); 26.04 (2C, CH2); 23.14 (2C, CH2), 14.56 









3-((bis(dodecyloxy)phosphoryl)amino)propanoic acid (3)[37] 
A 1M aqueous solution of 1 mL NaOH was added to a solution of 519 mg (1 mmol) 
methyl ester 2 in 1 mL EtOH the mixture was stirred for 2h at room temperature. 
Water (~5mL) and 2 mL of a aq.1 M HCl solution were added. The acidic solution was 
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extracted three times with CH2Cl2 and the combined organic layers were dried with 
MgSO4. Rotary evaporation of the solvent led to the product. No further purification 
was necessary. 3 was obtained as a slowly crystalizing white solid with an isolated 
yield of 88% (444 mg, 0.88 mmol). 1H-NMR (CDCl3, 400 MHz): δ (ppm) 4.73 (br, 1H, OH); 
3.97 (t, J= 6.4 Hz, 4H); 3.63 (t, J= 6.8 Hz, 1H, NH); 3.09 (m, 2H); 2.84 (t, J= 5.6 Hz, 2H); 
1.65 (qi, J= 7.2 Hz, 4H); 1.24 (br, 36H); 0.86 (t, J= 6.8 Hz, 6H). 13C-NMR (CDCl3, 100 MHz): 
δ (ppm) = 175.13 (1C; CO); 67.02 (2C, CH2); 42.76 (1C, CH2); 33.59 (1C, CH2); 32.08 (2C, 
CH2); 30.47 (d, J= 7 Hz, 2C, CH2); 29.81 (2C, CH2); 29.78 (2C, CH2); 29.74 (2C, CH2); 29.68 
(2C, CH2); 29.50 (2C, CH2), 29.34 (2C,CH2); 25.71 (2C, CH2); 22.81 (2C, CH2), 14.26 (2C, 
CH3). 31P-NMR (CDCl3, 162 MHz): δ (ppm) = 10.14. 
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In this chapter the aggregation behaviour of a novel carnosine based amphiphile 
is investigated. This compound is readily prepared from simple starting materials and 
provides an interesting mimic for the binding of the biological relevant carnosine motive. 
The carnosine based amphiphile showed temperature and pH responsive aggregation. 
Changes in the colloidal form of the carnosine amphiphile occur in the physiological 
region (pH 6-9 and 4 to 40 °C). This makes the system interesting for biological applications, 
since under physiological conditions multiple aggregates are available. Additionally the 
colloidal change is accompanied by a physical change in the material, namely from a 
solution to a hydrogel. Therefore this compound can be switched from a hydrogel to a 
liposome solution by changing the pH and or the temperature. This combined with the 
biocompatibility of this compound opens up wide variety of biological applications.
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8.1 Introduction and goal
Introducing complexity via the self-assembly of simple molecules into complicated 
aggregates is an interesting and economical way of obtaining more complex 
structures.[1, 2] Helices or twisted ribbons are an extraordinary interesting group since 
they resemble biologically structures such as DNA and the secondary, tertiary and 
quaternary structure op peptides.[3] Furthermore their axial twist provides helices with 
intrinsic chirality. Often the chirality of the self-assembled helices is determined by 
the molecular structure of the units that build the helices.[4-6] 
Amino acids and small peptides provide a wide variety of possible monomers to 
obtain larger complex structures. Since amino acids are readily available, contain many 
supramolecular non-covalent binding sides and possess chirality they are especially 
attractive building blocks for self-assembling monomers.[3, 7, 8] In the literature there 
are several examples of peptide or amino acid based amphiphiles that are capable 
of forming helices and or twisted ribbons (Figure 8.1). In certain examples the helices 
close and helical tubes are formed that show a distinct CD signal.[3, 9-11]
Figure 8.1: Schematic representation of twisted ribbons, helices and helical tubes.
Chiral structures such as twisted ribbons, helices and helical tubes are still 
considered a rarity and their formation is not always well understood.[9] Recently in 
our laboratories it was found that dipeptide N-phospho amphiphile 1 forms various 
aggregates (Figure 8.2).[12] Twisted ribbons as well as vesicles and tubes were observed 
when amphiphile 1 was allowed to aggregate in aqueous media at pH 8.5. When 
the solution containing aggregated 1 was kept at room temperature for 6 hours or 
heated to 70° C for 2 hours mainly tubes where observed (Figure 8.1). Therefore this 
aggregate seems to exhibit temperature dependent aggregation behaviour, which 



















Figure 8.2: N-phospho dipeptide 1.
Moreover, the head group of amphiphile 1 consists of a carnosine moiety. Carnosine 
is a dipeptide consisting of β-alanine and histidine, and it is present in muscle and 
brain tissue.[13] Due to its ability to chelate metallic cations it acts as an antioxidant 
in the human body.[14-16] Studying the aggregation behaviour of amphiphile 1 could 
therefore provide insights in to the preferred binding behaviour of the biologically 
relevant carnosine motif in addition to the possibility of pH or temperature controlled 
self-assembly. The use of compound 1 is especially interesting since the compound 
itself[12] and the parts of which it consist which will be its metabolites are biocompatible. 
Therefore it could be implemented in biological applications. 
A systematic study of amphiphile 1, could therefore bring new insights and add to 
the existing knowledge about the mechanism by which these aggregated structures 
are formed. This knowledge could subsequently be used to determine how the 
carnosine moiety binds and behaves in biological systems. To achieve this goal we set 




Compound 1 was synthesized following a slightly modified procedure.[12] First, 
phospho amino acid 2 was synthesized following the procedure described in chapter 
7 (molecule 3). Subsequently phospho amino acid 2 is coupled to L-histidine methyl 
ester 3, via an EDC coupling, providing methyl ester 4 in 40% yield (Scheme 8.1). Usually 
HOBt is used in this coupling reaction to prevent racemisation of the amino acid. Even 
though no chirality can be lost since β-alanine does not contain a stereogenic centre, 
it was found that when the reaction was performed in the absence of HOBt, lower 
yields were obtained. Subsequent hydrolysis of the methyl ester in the presence of 
sodium hydroxide provided the desired phospho dipeptide 1 in quantitative yield. 
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Scheme 8.1: Synthesis of N-phospho dipeptide 1.
8.2.2 Studies of the aggregation behaviour
8.2.2.1 pH Dependency
With the aim of investigating the aggregation behavior of phosphor dipeptide 1, 
the aggregation behavior of 1 was studied at different pH’s. Since the protonation of 
the compound varies with varying pH it was expected that a change in the pH could 
influence the aggregation behavior. For the visualization of the aggregates Cryo-TEM 
(chapter 1.2.1) was used. 
Several samples of amphiphile 1 in Tris-buffer where prepared at different pH’s 
and Cryo-TEM images were taken to visualize their aggregation behavior (Figure 8.3). 
These images show that at lower pH values (2-7) twisted ribbons, consisting of stacked 
bilayers, are formed while at higher pH 8-9 bilayer vesicles are obtained (Figure 8.3 d) 
and e)). From these results we can conclude that amphiphile 1 forms a bilayer which at 
pH values below 8, stack and form twisted ribbons while at pH 8 or higher the bilayer 
closes upon itself forming vesicles (Figure 8.4).
Figure 8.3:  pH dependent aggregation of amphiphile 1; a) pH 2, twisted ribbons; b) pH 5, 
twisted ribbons; c) pH 7 twisted ribbons; d) pH 8 squared vesicles; e) pH 9 vesicles. 
Scale bars represent 100 nm.
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Figure 8.4:  Schematic representation of the observed, pH-dependent aggregation behavior of 
amphiphile 1.
8.2.2.2 Temperature dependency
In this section we focus on determining the effect of temperature on the aggregates 
formed from amphiphile 1. Since amphiphile 1 showed remarkable responsive 
behavior at pH 8 (see paragraph 8.2.2.1) the temperature dependence studies at were 
performed at pH7, pH 8 and pH 9. 
When these samples are measured at elevated temperatures, namely 40 °C, at all 
pH values amphiphile 1 forms vesicles (figure 8.5 d), e) and f )). At room temperature 
only at pH 8 and 9 vesicles were observed. Increasing the temperature from room 
temperature to 40 °C at pH 7, results in the formation of vesicles instead of twisted 
ribbons. Samples that were prepared at 4 °C, shows the formation of twisted ribbons 
at pH 7 and 9 (Figure 8.5 a) and c)). At pH 8 the formation of tubes is observed (Figure 
8.5 b)). Therefore it can be concluded that at lower temperatures amphiphile 1 
prefers to form extended structures such as twisted ribbons or tubes while at higher 
temperatures the formation of vesicles is preferred. Additionally it can be concluded 
that the transition temperature from tubes or ribbons to vesicles is pH dependent. 
At higher pH values the transition temperature is lower than at lower pH values, vide 
infra.
It is probable that hydrogen bonding and/ or π-π-stacking plays an important role 
in the formation of the twisted ribbons and tubes. This type of non-covalent bonding 
can induce directionality and therefore plays an essential role in the formation 
of larger aggregated structures such as tubes and ribbons.[17] If indeed hydrogen 
bonding plays an important role in the formation of the extended structures this also 
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explains the formation of vesicles at higher temperatures. At higher temperature the 
hydrogen bonding is no longer sufficient to maintain the higher ordered structures 
such as tubes or ribbons, causing the amphiphile to form vesicles. Since the pH 
determines the protonation state of the amphiphile, it has an effect on the hydrogen 
bonding capacity of the amphiphile. It is therefore not surprising that a change in pH 
causes a change in transition temperature.
Figure 8.5:  Aggregate formation of amphiphile 1; a) at pH 7 and 4 °C; b) at pH 8 and 4 °C; c) at pH 
9 at 4 °C; d) at pH 7 at 40 °C; e) at pH 8 at 40 °C. Scale bars represent 100 nm. 
With the aim of determining the transition temperature more precisely the 
fluorescent probe Nile Red was used. As explained in section 1.X, the λmax of Nile Red 
shifts depending on the polarity of the surroundings of the probe. It was hypothesized 
that Nile Red, that intercalates in to the bilayer, would show a different λmax when it 
is intercalated in twisted ribbons then when it would be intercalated into a bilayer 
vesicle. To test this hypothesis samples were prepared of amphiphile 1 with Nile Red 
according to literature procedure.[18] These samples were placed in a temperature 
controlled fluorimeter and the fluorescence of the probe was measured while slowly 
increasing the temperature from 4 °C to 40 °C. 
Graph 8.1 shows the change in the λmax of the sample prepared at pH 7. A steady 
increase in the λmax, indicating an increase in the polarity of the surroundings of the 
probe, is observed. Although a sudden change in the λmax is not observed, a change 
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in slope is visible around 30 °C. It is hypothesized that when vesicles are formed the 
system is less rigid then when long ribbons are formed. Therefore increasing the 
temperature by one degree will lead to a larger flexibility in the vesicle state than 
when the amphiphile is in the twisted ribbon state. If the bilayer is more flexible more 
water can access the bilayer which increases the polarity of the environment of the 
probe. This would result in a bigger change in λmax per degree Celsius, once in the 
amphiphile is in the vesicle state, and therefore a steeper slope. This change in slope 
is visible at pH 7 at 30 °C and at pH 8 at 10 °C. At pH 9 a change in slope seems to 
start around 6 °C. Since the area with a low slope exists of two measuring points this 
transition temperature is not as clear and sound as for pH 8 and 9. A clear trend is 
observed that when the solution becomes more basic the transition temperature 
at which the twisted ribbons start to form is decreased. Ribbon formation seems to 
occur at pH 8 around 10 °C, therefore the transition temperature at pH 9 is expected 
to be below 10 °C. Because the λmax is measured between 4 °C and 40 °C, only a start of 
a change in slope seems to be visible due to a limited measuring range. 
The transition temperatures found in the fluorescent experiments correspond with 
the observed transitions in the previously obtained Cryo-TEM images. These images 
show twisted ribbons at pH 7 at room temperature but vesicles at pH 8 at room 
temperature; this corresponds well with a transition temperature of 30 °C for pH 7, a 
transition temperature of 10 °C for pH 8 and a transition temperature around or below 
6 for pH 9. 
Graph 8.1:  Change in λmax of Nile Red measured as a result of increasing the temperature from  
4 to 40° at 0.5 C° per min, for solutions at pH 7, pH 8 and pH 9
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To test if the same transition temperature would be found starting from vesicles 
instead of from ribbons, a sample with pH 7 at 40 ° was slowly cooled to 4 °C while 
measuring the fluorescence of the Nile Red probe (Graph 8.2). During this experiment 
no change in slope is observed. From the time dependent studies it is know that it 
takes time, depending on the pH of the sample, to form the twisted ribbons. Therefore 
this transition from vesicles to twisted ribbons is most likely relatively slow, and 
therefore more difficult to observe than the sudden transition from twisted ribbons 
to vesicles. 
Graph 8.2:  Change in λmax of Nile Red measured as a result of decreasing the temperature from 
40 to 4° at 0.5 C° per min, at pH 7.
8.2.2.3 Phase Diagram
The data gathered from the Cryo-TEM images and the fluorescent experiments can 
used to construct a phase diagram for amphiphile 1 (Figure 8.6). The phase diagram 
shows that at elevated temperatures and higher pH values, vesicles are the preferred 
aggregation state. At lower temperatures or lower pH values more ordered colloids 
such as tubes or twisted ribbons are observed. Presumably the hydrogen bonding, 
and possibly also π-π-stacking of the imidazole ring, is responsible for the formation 
of the more ordered aggregates. At higher temperatures the hydrogen bonding is 
no longer sufficient to sustain the more ordered structures resulting in the formation 
of vesicles. A similar process seems to occur at higher pH values. In the more basic 
environment more carboxylic acids are deprotonated. It is anticipated that when too 
many acid sites are deprotonated, the hydrogen bonding pattern is disrupted due 
to a lack of available protons. Additionally, the increase in anions results in a higher 
repulsion between the head groups. The loss of hydrogen bonding and the increase 
in repulsive forces break up the directionality in the aggregation resulting in a loss of 
the complex (ribbons,tubes) self-assembly. This type of behavior has been observed 
in similar systems in the literature, for a discussion see section 8.3.
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Figure 8.6:  Phase behavior diagram of Amphiphile 1 indicates that above 40 °C only vesicles 
are formed. At 20 °C the pH starts to influence the aggregation and only above pH 
7 vesicles are observed and below pH 7 twisted ribbons are observed. Decreasing 
the temperature to 4 °C results in complex aggregation in all cases, however at pH 8 
tubes are formed and at pH 9 twisted ribbons. Scale bars correspond to 100 nm.
8.2.2.4 Time dependency
Subsequently the change of the aggregates formed by amphiphile 1 in water was 
studied over time. This was motivated by the observation that when a sample of 1 
at pH 8 aged, while being stored at 4 °C for one week, this sample forms a hydrogel. 
From this observation we concluded that different aggregates are formed under 
these conditions then vesicles. Cryo-TEM images of this gel sample at pH 8 showed 
that long hollow tubes are formed (figure 8.7). Initial images of samples at pH 8 at 
4 °C only show short not well ordered tubes. Therefore it is expected that these long 
hollow tubes are formed upon aging. 
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Figure 8.7:  Cryo-TEM image of an aged sample of amphiphile 1 in TRIS buffer that was kept at 4 
°C for 7 days at pH 8. The black scale bar represent 100 nm.
Figure 8.8:  Time dependence, Cryo-TEM pictures taken after one week of aged samples of 
amphiphile 1 that were kept for 7 d at room temperature at, a) pH 2; b) pH 5 ;c) and 
d) pH 7; e) pH 9. All black scale bars represent 100 nm.
First the stability of the different aggregates that form at various pH values was 
investigated over time. As can be seen from the Cryo-TEM pictures in figure 8.8 the 
twisted ribbons formed at pH 2 are not stable, but over time collapse in to sheets 
consisting out of multiple bilayers (figure 8.8 a)). However the twisted ribbons formed 
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at pH 5 and 7 and the vesicles formed at pH 9 are relatively stable as they remain in the 
same aggregation state for 7 days.
The aggregates formed at pH 8 seem to be highly time responsive. When the 
sample is freshly made amphiphile 1 forms vesicles at room temperature (Figure 8.9 
a)). However, when this sample is kept for 1 day it forms long twisted ribbons (Figure 
8.9 b)). Once these twisted ribbons are formed they seem relatively stable. This is 
illustrated by the fact that if the twisted ribbons formed after 1 day are cooled to 4 °C 
they stay intact (Figure 8.9 c)). However, they do seem to break, since no ribbons are 
found that span the entire Cryo-TEM image. 
Also at lower temperatures, at pH 8, the formation of tubes seems to be time 
dependent. If a sample is prepared at 4 °C and an image is taken directly, both vesicles 
as well as tube like aggregates are observed (Figure 8.9 d)). Once this sample is one 
day old, mainly tubes are observed (Figure 8.9 e)) albeit not as well defined as when 
they are left for one week (Figure 8.7). Furthermore these tubes do not seem to be 
stable once formed. If the tubes are allowed to warm up slowly to room temperature 
they form twisted ribbons. Therefore it can be concluded that the formation of hollow 
tubes is not a thermodynamic minimum. 
Figure 8.9:  Agregation of amphiphile 1 at pH 8 a) at r.t.; b) sample a) after 1 day at r.t.; c) sample 
b) after being cooled to 4 °C, black arrows indicate ice; d) at 4 °C; e) sample d) after  
1 day at 4 °C; f ) sample e) after being warmed to r.t. Black scale bars represent 100 
nm.
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Our results show that at most pH ranges the formed aggregates remain stable 
over a period of one week. However aggregates at pH 8 seem to be much more time 
responsive, the formation of twisted ribbons and tubes takes several hours to a few 
days. The observation that once hollow tubes (Figure 8.9 b)) are allowed to warm to 
room temperature the tubes do not stay intact but form twisted ribbons (Figure 8.9 f )) 
is especially interesting, since this indicates that for amphiphile 1, the tubes are not a 
thermodynamic minimum. In section 8.3 the formation of tubes from twisted ribbons 
and vice versa is discussed in detail and compared to literature studies. Overall, it can 
be concluded that the formation of twisted ribbons at pH 8 takes time (at least 1 day) 
and the proper temperature (r.t.). However once they are formed they are relatively 
stable. 
8.2.2.5 Gel Formation
In samples where long twisted ribbons or hollow tubes are formed, the solution 
appears to be more viscous then the samples were vesicles are the preferred 
aggregated state. Considering the extensive ribbons that are visible in figure 8.3, and 
because compound 1 has multiple hydrogen bonding sites, it is not surprising that 1 
is capable of forming a hydrogel.[19-22] To determine whether indeed a gel was formed, 
the inverted test-tube method was used.[19] For this purpose a sample of 500 µL with 
a concentration of 3 mg/mL amphiphile at pH 7 was prepared. When the vial in which 
it resided was turned upside down, the solution remained at the bottom of the tube. 
Therefore it can be concluded that at under these conditions amphiphile 1 forms a 
hydrogel. 
8.2.2.6 Layer thickness
During this investigation it was observed that at pH 9 twisted ribbons are formed 
that are either 3 or 2 bilayers thick (Figure 8.10). The formation of two types of twisted 
ribbons in the same sample was not observed for amphiphile 1 at pH 7 or 8. At these 
pH values twisted ribbons consisting of 3 or 4 bilayers were found (Figures 8.8 d); 
4 bilayers pH7 and 8.9b); 3 bilayers pH 8). Figure 8.10 shows a magnification of the 
ribbons seen at pH 9. It is possible to see that most of the twisted ribbons contain 2 
bilayers (white arrow), but some 3 (black arrow). Assuming the darker stripes are the 
head groups, which would correspond to the head groups being on the outside of the 
bilayer. The average thickness of the hydrocarbon tails in the bilayer can be measured 
to be 2.2 nm and the entire thickness of one bilayer to be 5.5 nm. This corresponds 
well with literature values of C12 alkyl chains that are not in the crystalline phase.[23, 24]
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Figure 8.10:  Magnification of the observed twisted ribbons at pH 9 at 4 °C, black arrow indicates 
a ribbon that consist of 3 bilayers and the white arrow indicates a ribbon that 
consist of 2 bilayers. Scale bar represents 100 nm. 
8.3 Discussion and comparison to known literature systems
Many systems exist that are capable of forming helices or twisted ribbons.[3] 
They can for instance be based on polymers,[5, 25-28] biological sources[29-31] or gemini 
surfactants with chiral counter ions.[10, 32-34] In this discussion we will mainly focus on 
structures that contain amino acids and compare them to the observed aggregation 
behaviour of amphiphile 1. 
One of the oldest known helix forming amino acid based amphiphiles are 
glutamates of general structure 5.[35-37] In many examples R is a spacer containing 
a trimethylammonium headgroup or one or more amino acids. Yamada et al. used 
amphiphile 5 with X = NH and a peptidic headgroup.[36, 38] They found that when 
larger peptide sequences are used, the ribbons form more rapidly than with shorter 
sequences. Subsequently they changed the amide linkages that are present in the 
head group for ester linkages. The modification to ester linkages destroyed the helix 
formation. This example supports the aggregation model we envision for phospho 










X = O or NH
Figure 8.11: General structure of Glutamate based amphiphiles.
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Several studies have been performed towards the binding and aggregation 
behaviour of amphiphiles based on the amyloid forming Aβ-peptide, which is 
associated with Alzheimer’s disease.[33, 40] This peptidic sequence contains several 
phenyl alanine moieties. Stupp et al. prepared two model amphiphiles, one with 
three phenyl alanines 6 and one with three alanines 7. When these amphiphiles were 
allowed to aggregate only amphiphile 6 that contains the phenylalanine moieties, 
as the original Aβ-peptide does, showed the formation of twisted ribbons and, after 
4 weeks, helices. This finding indicates that besides hydrogen bonding π-π-stacking 
can also play a crucial role in the ribbon formation.[33] Because phospho amphiphile 
1 contains an imidazole ring, π-π-stacking could play an important role in the 
aggregate formation of this amphiphile as well. Further investigations and modelling 
performed by Lynn et al. indicate that for the Aβ-peptide aggregates, antiparallel 
β-sheet formation initiates the tube formation.[40] The formation of β-sheets would 
also explain the importance of the presence of multiple amino acids and the amide 
functionality in the previous examples reported by Yamada.[36] Amphiphile 1 only 
contains one amide linkage, however the NH-P=O motive could act similar to an 
additional amide bond. Therefore these two hydrogen bonding motives could initiate 






















































Figure 8.12: Phenyl alanine based amphiphile 6 and alanine based amphiphile 7.
Two examples are know that in which amphiphiles with carnosine as a peptidic 
headgroup have been investigated.[41, 42] In these cases an amphiphile is obtained by 
attaching a C16 tail via a amide linkage to the β-alanine nitrogen (Figure 8.13). Hamley 
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et al. show that this amphiphile forms bilayers that stack upon each other.[41] At lower 
concentrations (0.05 w%) solely tapes are formed, while at higher concentrations (0.1 
w%) both tapes as well as twisted thin fibrils are formed. The formation of a bilayer 















Figure 8.13: Carnosine based amphiphile 8.
That the chirality at the molecular level is essential for the chirality at the 
supramolecular level has been shown by several groups.[10, 43, 44] Changing the molecular 
chirality of the amino acid included in the polar head group is usually accompanied 
by changing the chirality of the helix.[43] Also the directionality of H-bonding groups 
is important as illustrated by Duan et al..[44] They have found that changing from an 
meta-pyridine to an ortho- or para-pyridine moiety in the headgroup of a double 
tailed amphiphile, the aggregation structure is changed from a helix to fibres or 
tubes, respectively. Huc et al. have shown that achiral geminal surfactants containing 
an ammonium head group are capable of forming twisted ribbons or helices in the 
presence of a chiral counter ion.[10] Further studies provided that changing the ee 
of the counter ion has a direct effect on the pitch of the twisted ribbon.[32] However 
in some cases helices can be formed from achiral molecules. In this case there is no 
preferred helical twist so that a racemic mixture is formed. The formation of racemic 
helices is indicated by the absence of a CD-signal.[45] 
The formation of hollow tubes from twisted ribbons and helices has recently been 
shown directly using Cryo-TEM imaging.[9] Danino et al. followed the aggregation of 
lysine based amphiphile 9 over time. Initially, thin fibers are formed that within a day 
form twisted ribbons (Figure 8.15 B2). These twisted ribbons increase in thickness and 
pitch so that helices are formed (Figure 8.15 B3 and B4). When the pitch increases 
even further the helices close, this occurs after several months, and nanotubes are 
obtained (Figure 8.15 B5)). The aggregation is, just as for amphiphile 1, temperature 
dependent and when the aggregates are heated to 45 °C micelles are formed (Figure 
8.15 C).
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Figure 8.14: Lysine based amphiphile 9, used by Danino et al.[9]
Figure 8.15: Aggregate formation of amphiphile 9 followed over time. Adapted from ref.[9]
Also the earlier mentioned amyloid Aβ-peptide amphiphile showed initially the 
formation of twisted ribbons and the formation of helices after four weeks.[33] There 
have been many examples where the pitch of the helix decreases over time to such an 
extent that the helices close and form chiral tubes.[3, 9, 33] Several theories exist on how 
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and why helices or twisted ribbons form.[10, 46-48] A main difference between helices 
and twisted ribbons is that to form helices, the bilayers need to possess a cylindrical 
curvature, whereas to form twisted ribbons the bilayers possess Gaussian, saddle-
like curvature (Figure 8.16). Oda et al. proposed that helices, and tubules, form if the 
bilayer is in the crystalline phase and twisted ribbons if the bilayer is in a fluid phase. 
They base this hypothesis on the observation that longer geminial surfactants, which 
possess a lower crystalline transition temperature, prefer the helical aggregation 
where sorter surfactants prefer to aggregate as a twisted ribbon. The calculations 
performed by Oda et al. indicate that in principle the twisted ribbon is the preferred 
aggregation state, but that once the alkyl chains become longer and the bilayer is 
in the crystalline state it is no longer possible to maintain the Gaussian curvature, 
therefore changing to a helical aggregation.[10] Schnur et al. point out that it is not 
a clear cut case that all helices consists of bilayers that are in the crystalline state so 
that the preference for helices or twisted ribbons might have a different origin.[46] The 
observation that twisted ribbons overtime can form helices or nanotubes,[3, 9] also 
indicates that the twisted ribbons is not the thermodynamic minimum. 
Figure 8.16:  Schematic representation of a tubule, derived from a helix,; a helix; a sheet and a 
twisted ribbon (top). Curvature exhibited by the bilayers to obtain these structures; 
cilindrical for helices and Gausian, saddle-like, for twisted ribbons (bottom). 
Adapted from Ref.[10]
So far much of the known literature seem to indicate that hollow tubes, as observed 
for amphiphile 1 at pH 7 or 8 at lower temperatures, occur when helical structures 
decrease in pitch as to form tubes.[9, 49] However, in the case of amphiphile 1 no helices 
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are observed but only twisted ribbons. Furthermore the Cryo-TEM images at 4 °C after 
one day and after one week at pH 8 seem to indicate that these tubes are not formed 
via helices that close. Since in the images after 1 day only short and often imperfect, 
not straight, tubes are formed, indicates that the process of tube formation is still 
ongoing. However, in this tube forming state no helices are observed. It would be 
extremely interesting to obtain CD spectra of amphiphile 1 when it is aggregated as 
tubes. These spectra could indicate if the self-assembled nanotubes are chiral in itself. 
Furthermore CD-spectroscopy could indicate whether β-sheet formation is present in 
these aggregated structures since β-sheets show well established CD-signals.[50] 
8.4 Conclusion
From the data presented in this chapter we can conclude that amphiphile 1, a 
highly interesting and versatile self-assembling compound, which is readily prepared 
from simple starting materials. Initial tests from our laboratories and literature 
precedent indicates that this amphiphile is most likely biocompatible. Furthermore 
this amphiphile shows interesting and unique temperature and pH responsive 
aggregation in the physiological region (pH 6-9 and 4 to 40 °C). Not only does the type 
of aggregation of this amphiphile change, from vesicles to tubes or twisted ribbons, 
this change is accompanied by a physiological change in the material namely from 
a solution to a hydrogel. Therefore this compound can be readily switched from a 
hydrogel to a liposome solution by changing the pH and or the temperature. This 
combined with the biocompatibility of this compound opens up wide variety of 
potential biological applications.
8.5 Experimental
All chemicals and reagents were purchased from commercial suppliers (Acros, TCI 
and Sigma-Aldrich) and used without further purification. Thin layer chromatographic 
(TLC) analysis was performed on Merck silicagel 60/Kieselguhr F254, 0.25 mm TLC 
plates and spots were visualized by UV and staining with KMnO4 stain. Column 
chromatography was performed using silica gel (P60, 230 – 400 mesh). 
1H-NMR-, 13C-NMR-, 31P-NMR spectra, were recorded on a Varian AMX400 (400 and 
100.59 MHz, respectively) using CDCl3 as a solvent (CDCl3: δ 7.26 for 1H-NMR, δ 77.16 
for 13C-NMR). Data are reported as follows: chemical shifts, multiplicity (s= singlet, 
d= doublet, t= triplet, q= quartet, qi= quintet, br= broad, m= multiplet) coupling 
constants J (Hz) and integration.
High resolution mass spectrometry (HRMS) was carried out on a LTQ ORBITRAP XL 
spectrometer (Thermo Scientific) employing electron impact ionization in positive ion 
mode (EI+) and negative ion mode (EI-). 
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Melting points were measured on a Büchi B-545 and recorded in °C.
A pH-meter (Sartorius PB-11) equipped with a glass combination electrode was 
used for pH adjustments of the reaction buffers and for the pH determination of 
aggregate solutions. 
Cryo TEM images were taken on an FEI Tecnai T20 transmission electron microscope 
and on a Philips CM12 cryo transmission electron microscope operating at 200 and 




Sample preparation: After dissolving a N-phospho amino acid in chloroform the 
solvent was carefully evaporated under a slow stream of air and continuing rotation. 
The resulting thin film was stored for 30 min under high vacuum to assure the 
complete removal of the organic solvent. Subsequently, an aqueous buffered solution 
was added to achieve a final concentration of 3 mg/ mL. The resulting sample was 
vortexed to obtain a homogenous suspension. At least three freeze-thaw cycles 
were performed and the sample was sonicated during thawing, to enable aggregate 
formation. The resulting turbid solution was used for cryo-TEM measurements.
Buffer preparation:
pH 8.5 (20 mM TRIS buffer): 1.21 g of tris(hydroxymethyl)aminomethane was 
dissolved in 500 mL water and the pH was adjusted by adding 1M aqueous HCl 
solution. Next water was added to obtain a total volume of 500 mL.
Nile Red fluorescence measurements
For the Nile Red fluorescence measurements the aggregate samples were prepared 
as described for Cryo-TEM imaging. Per 1 mL aggregate solution 0.5 µL of a 2.5 mM 
Nile Red solution in ethanol was added. The λmax of the solution was determined by 
pipetting at least 3 mL into a 1 cm by 1 cm fluoresence cuvet. As excitation wavelength 
550 nm was used unless otherwise stated. Emission spectra were recorded with 
excitation provided by a 75 W Xe lamp coupled to a Quantum Northwest QPOD2e 
temperature controlled cell holder via a Zolix Omni150 monochromator, 300 l/mm 
grating and 500 nm blaze. Emitted light was collected at 90° with a suitable long 
pass filter (Thorlabs) via an SMA coupled 200 micron core fibre to a Shamrock 163 
spectrograph (Andor Technology) and iDus-420-OE CCD (Andor Technology). Spectra 
were typically recorded as 10 accumulations of 10 s duration. Spectra were calibrated 
with the emission of TL room lights. The obtained spectra where plotted and a log-
normal fit was used to determine the excitation maximum.[18] 
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methyl (3-((bis(undecyloxy)phosphoryl)amino)propanoyl)-D-histidinate 4
In a Schlenk vessel 250 mg (0.5 mmol) phospho β-alanine 2 (for preparation, see 
chapter 7) 133 mg (0.55 mmol) l-Histidine methyl ester, 144 mg (0.75 mmol) 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide and 115 mg (0.75 mmol) hydroxybenzotriazol 
were dissolved in 10 mL THF and stirred for 5 min at r.t.. To the solution 0.15 mL (2.1 
mmol) trimethylamine was added. The reaction mixture was stirred at r.t. for 25 h. The 
reaction was quenched by addition of 10 mL water. The mixture was extracted with 
DCM (3 times). The combined organic layers were washed with 1M aq. HCl (2 times) 
and sat. aq. NaHCO3 (3 times). The organic layer was subsequently dried with brine 
and MgSO4. Evaporation of the solvent under reduced pressure yielded the crude 
product wich was purified via column chromatography (SiO2, DCM/MeOH, 95/5). This 
gave the product as a pale yellow solid in 40% yield (124 mg, 0.20 mmol). 1H NMR (300 
MHz, CDCl3) δ 7.79 (s, 1H), 7.41 (d, J = 8.0 Hz, 1H), 6.87 (s, 1H), 4.85 (dd, J = 13.2, 6.0 Hz, 
1H), 4.09 – 3.80 (m, 4H), 3.72 (s, 3H), 3.24 – 3.10 (m, 2H), 3.16 (d, J = 5.5 Hz, 3H), 2.59 – 
2.35 (m, 2H), 1.75 – 1.52 (m, 4H), 1.24 (s, 36H), 0.86 (t, J = 6.4 Hz, 6H), 13C-NMR (300 MHz, 
CDCl3) δ 172.52 (CO), 172.08 (CO), 135.86 (CH), 134.16 (C), 116.4 (CH), 66.68 (2C, CH2), 
52.88 (CH), 52.4 (CH3), 38.15 (CH2), 38.03 (CH2), 31.81 (2C, CH2), 30.27 (d, CH2), 29.45 (2C, 
CH2), 29.52, (2C, CH2), 29.49 (2C, CH2), 29.44 (2C, CH2), 29.33 (2C, CH2), 29.12 (2C, CH2), 
25.47 (2C, CH2), 22.53 (2C, CH2), 13.91 (2C, CH3); 31P NMR (121 MHz, CDCl3) δ 8.81.[12]
(3-((bis(undecyloxy)phosphoryl)amino)propanoyl)-D-histidine 1
In a glass vial 124 mg of 4 was dissolved in 1 mL ethanol and 0.2 mL 1M aq. NaOH. 
The reaction mixture was stirred at r.t. for 2 h. Subsequently 1 mL 1M aq. HCl was 
added and the product was extracted with DCM (3 times). The combined organic 
layers were dried over MgSO4. Evaporation of the solvent in vacuo yielded the pure 
product in quantitative yield (120 mg, 99%); 1H NMR (400 MHz, CDCl3) δ 14.2 (s, 1H), 
13.86 (s, 1H), 8.6 (s, 1H), 7.27 (s, 1H), 4.9 (m, 1H), 4.3 (br, 1H), 3.96 (m, 4H), 3.27 (m, 2H), 
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3.17 (m, 2H), 2.61 (m, 1H), 2.49 (m, 1H), 1.64 (q, J = 6.0 Hz, 4H), 1.23 (br, 36H), 0.86 (t, J 
= 6.8 Hz, 6H); 13C (100 MHz, CDCl3) δ 173.81 (CO), 171.84 (CO), 133.73 (CH), 127.96 (C), 
110.72 (CH), 67.26 (2, CH2), 52.18 (CH), 38.02 (CH2), 37.38 (CH2), 31.83 (2, CH2), 30.22 (d, 
2, CH2), 29.6 (2, CH2), 29.56 (4, CH2), 29.50 (2, CH2), 29.27 (2, CH2), 29.19 (2, CH2), 26.73 
(2, CH2), 25.50 (2, CH2), 22.54 (2, CH3), 13.92 (2, CH3); 31P NMR (162 MHz, CDCl3) δ 8.70.[12]
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Many biological molecules such as, sugars, amino acids and nucleic acids, are chiral 
molecules. This means that of these molecules two mirror images exist. Surprisingly, 
in nature only one mirror image of the two possible mirror images, also known as 
enantiomers, is present. It would be thermodynamically more favourable to have a 
racemic (fifty-fifty) mixture of enantiomers. The presence of only one enantiomer 
in nature, known as homochirality, poses a big mystery. Because nature’s building 
blocks, amino acids and sugars, are chiral, the structures that are based on them, 
such as proteins and DNA, are therefore chiral. One of the functions of proteins is 
to catalyse chemical reactions. Proteins with this function are called enzymes. Since 
enzymes are chiral themselves, they are capable of maintaining the homochirality of 
life. If by accident a molecule of the wrong chirality would be present it would not be 
selected by the enzyme, as it does not fit. One can imagine these enzymes to be left 
gloves that have a pocket that fits a left hand. If a right hand would be present it will 
not fit in to this left glove and would therefore not be selected to react. 
Before life emerged, no enzymes were present to select the correct enantiomer. This 
makes the origin of homochirality comparable to the chicken and egg problem: which 
came first, homochirality or life? Generally it is assumed that homochirality emerged 
before life; it has even been mentioned as a prerequisite for life. This is supported by 
the idea that homochiral enzymes could not have come into existence without at 
least some excess, a small bias, of one of the two enantiomers. 
Since both enantiomers are energetically exactly the same, a racemic mixture 
represents the lowest energy state possible. It could be that two chemical cycles of 
opposite chirality co-exist. Because these cycles are thermodynamically identical, 
there has to be an external driving force to tip the balance in favour of one, thereby 
creating homochirality. Disruption of the thermodynamically favored racemic 
situation is called symmetry breaking, and would result in a small excess of one of the 
enantiomers over the other. This small excess subsequently needs to be amplified. 
Therefore two challenges exist in the origin of homochirality, being the initial 
symmetry breaking and subsequent amplification of this initial enantiomeric excess, 
both in a prebiotic environment. 
One important mechanism of achieving chiral amplification, is asymmetric 
autocatalysis. In an autocatalytic reaction, the product of a reaction is capable of 
catalysing its own formation. In asymmetric autocatalysis also the chirality of the 
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product is governed by the catalyst. Thereby, the product plays the chiral selecting role 
that enzymes have now.  The first two chapters focus on developing an asymmetric 
autocatalytic reaction that forms biologically relevant compounds under prebiotically 
viable conditions. 
In chapter two we studied the ring opening of maleic anhydride by an amine 
nucleophile as a potential asymmetric autocatalytic reaction. This reaction provides 
an α-amino acid core and proceeds in water at elevated temperatures. Furthermore, 
the reaction starts from simple starting materials and forms multiple new functional 
groups in addition to a stereogenic centre. The lack of a sigmoidal kinetic profile 
allowed us to dismiss the possibility of an autocatalytic reaction.
In the third chapter, the conjugate addition of LDA to an α,β-unsaturated ester, 
which has been reported to be an autocatalytic reaction, was investigated for its 
potential enantioselectivity. To investigate the possibility of asymmetric auto-
induction, an enantiomerically enriched sample of the product was prepared. 
Subsequently the reaction was performed in the presence of the enantioenriched 
product, as a selective catalyst. The degree of enantiomeric enrichment in the product, 
showed no enhanced enantioselectivity. This result indicated that this reaction is not 
asymmetric.
In the fourth chapter, another method of chiral amplification was investigated: 
attrition enhanced deracemization. To obtain a single chirality in the solid phase via 
attrition enhanced deracemization, a system needs to fulfil two requirements. First 
a compound has to be able to form two distinct enantiomerically pure crystals, as a 
conglomerate does. Second, in solution an equilibrium between both enantiomers 
(racemization) needs to be obtained. Enantiomorphic materials such as NaClO3 fulfil 
these requirements automatically, since as soon as they dissolve, they become achiral 
and therefore they “racemize” in solution. When both requirements are fulfilled, a 
process known as Ostwald ripening causes larger crystals to grow at the expense of 
smaller ones, this would in the end lead to one big crystal. Because the crystals of 
conglomerates are enantiomerically pure it would lead to homochirality in the solid 
phase. A pyrrolidine, which was known to be a conglomerate was used as starting 
point. However no suitable racemisation conditions could be found, which was the 
second prerequisite.
In the fifth chapter, another method was tried to achieve homochirality, namely 
the difference in solubility between a racemic compound and its pure enantiomer. 
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This is a simple, robust and prebiotically viable method to amplify a tiny chiral bias 
to obtain high enantiomeric excess in the solution phase. Here we have shown that 
phosphoramidites have an exceptionally large difference in solubility between the 
racemate and pure enantiomers, leading to almost enantiopure compounds in the 
solution phase.
Chapter six focussed on the development of a method to produce chiral building 
blocks for the (pharmaceutical) industry. A highly enantioselective one pot procedure 
for the synthesis of β-substituted amides starting from the corresponding α,β-
unsaturated esters was developed. Additionally, experiments were performed to 
obtain insight into the reaction mechanism. 
The last two chapters focussed on the self-assembly of amino acid derived 
amphiphiles. In chapter 7, the use of liposomes as potential drug delivery system 
was investigated. We have observed that a soap-like molecule is capable of forming 
open vesicles. The mechanism for the formation of this specific type of vesicles was 
investigated. It was hypothesized that the formation of open vesicles is due to a change 
in the molecule that occurs over time. If so, it would mean that these vesicles slowly 
open and could in this way slowly release a medicine in a patient. It was concluded 
that the formation of open vesicles is a property of the original molecule and are 
therefore always present. Since the vesicle did seem to break upon changing the pH 
this could be a viable release mechanism for a more stable vesicle. A pH triggered 
release system is extra interesting since it was found that the pH around cancer tissue 
is different than around healthy tissue. 
In the last chapter, the aggregation behaviour of a di-amino acid based soap-like 
molecule was investigated. This compound is readily prepared from simple starting 
materials and showed temperature and pH responsive aggregation. Changes in the 
colloidal form of the soap molecule occur in the physiological region (pH 6-9 and 4 
to 40 °C). This makes the system interesting for biological applications, since under 
physiological conditions multiple aggregates are available. Additionally, the colloidal 
change is accompanied by a physical change in the material, going from a solution to 
a hydrogel. Therefore this compound can be switched from a hydrogel to a liposome 
solution by changing the pH and or the temperature. This combined with the 
biocompatibility of this compound opens up wide variety of biological applications.
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Veel biologische moleculen, zoals suikers, aminozuren en nucleïnezuren, zijn 
chirale moleculen. Dit betekent dat van deze moleculen twee spiegelbeelden 
bestaan. Verrassenderwijs is in de natuur slechts één spiegelbeeld van de twee 
mogelijke spiegelbeelden, ook bekend als enantiomeren aanwezig. Een racemisch 
(fifty-fifty) mengsel van enantiomeren is thermodynamisch is het het meest gunstig. 
De aanwezigheid van slechts één van de twee enantiomeren in het leven zoals 
wij dat kennen, bekend als homochiraliteit, vormt een groot mysterie. Omdat de 
bouwstenen van de natuur, aminozuren en suikers, chiraal zijn zijn de structuren die 
erop gebaseerd zijn, zoals eiwitten en DNA, chiraal. Een van de functies van eiwitten 
is het katalyseren van chemische reacties. Eiwitten met deze functie worden enzymen 
genoemd. Omdat enzymen chiraal zijn, zijn zij in staat de reactie alleen te laten plaats 
vinden met het juiste enantiomeer. Als per ongeluk een molecuul van de verkeerde 
chiraliteit aanwezig zou zijn zou niet worden geselecteerd door het enzym, omdat 
het niet past. Men kan zich deze enzymen voorstellen als linker handschoenen, die 
zullen alleen linker handen selecteren. Als een rechterhand aanwezig zou zijn zal het 
niet passen in deze linker handschoen en zou dus niet worden geselecteerd om te 
reageren.
Voordat het leven ontstond, waren geen enzymen aanwezig om het juiste 
enantiomeer selecteren. Dit maakt de oorsprong van homochirality een kip en 
ei-probleem: wie was er eerst, homochiraliteit of het leven? Algemeen wordt 
aangenomen dat homochiraliteit ontstond  voor dat het leven ontstond; Het is zelfs 
genoemd als een voorwaarde voor het leven. Dit wordt ondersteund door het idee 
dat homochirale enzymen niet tot stand kunnen komen zonder op zijn minst een 
kleine overmaat van één van de twee enantiomeren.
Aangezien beide enantiomeren energetisch equivalent zijn is een racemisch 
mengsel de laagst mogelijke energietoestand. Theoretisch is het mogelijk dat twee 
chemische cycli van tegengestelde chiraliteit naast elkaar bestaan. Omdat deze cycli 
thermodynamisch identiek zijn, is er een externe aandrijfkracht nodig die de balans 
laat doorslaan ten gusnte van één, wat zou resulteren in homochiraliteit. Verstoring 
van de thermodynamisch gunstige racemische toestand staat bekent als het breken 
van symmetrie, en leid tot een geringe overmaat van één van de enantiomeren. 
Deze geringe overmaat moet vervolgens worden vergroot. Het ontstaan van 
homochiraliteit is derhalve op te splitsen in twee stukken, het breken van symmetrie 
en de daaropvolgende amplificatie van de oorspronkelijke enantiomere overmaat.
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Een belangrijk mechanisme voor het bereiken chirale amplificatie is asymmetrisch 
autokatalyse. In een autokatalytische reactie, katalyseert het product van eeen reactie 
zijn eigen formatie. In een asymmetrische autokatalyse wordt ook de chiraliteit van 
het product wordt bepaald door de katalysator. In feite speelt het product de rol 
van chirale selector die enzymen nu hebben. De eerste twee hoofdstukken van dit 
proefschrift richten zich op het ontwikkelen van een asymmetrische autokatalytische 
reactie die biologisch relevante verbindingen vormt.
In hoofdstuk twee wordt de ringopening van maleïnezuuranhydride door een 
amine onderzocht als mogelijke asymmetrische autokatalytische reactie. Deze 
reactie levert een α-aminozuur op en verloopt in water bij verhoogde temperaturen. 
Daarnaast maakt deze reactie gebruik van eenvoudige uitgangsmaterialen en vormt 
meerdere nieuwe functionele groepen en een stereogeen centrum. Het ontbreken van 
een sigmoïdaal kinetisch profiel toonde aan dat deze reactie geen autokatalytische 
reactie is.
In het derde hoofdstuk staat de geconjugeerde additie van LDA aan een α, 
β-onverzadigde ester, centraal. Deze reactie staat beschreven in de literatuure als 
een autokatalytische reactie, en word in hoofdstuk drie onderzocht op zijn potentiele 
enantioselectiviteit. Om de mogelijkheid van asymmetrische auto-inductie te 
onderzoeken, werd het product bereid met een enatniomere overmaat. Vervolgens 
werd de reactie uitgevoerd in aanwezigheid van het product met enantiomere 
overmaat, als een selectieve katalysator. De mate van enantiomere verrijking van het 
product gaf aan dat er geen enantioselective selectie plaats vind, hieruit kon worden 
geconcludeerd dat deze reactie niet asymmetrisch is. 
In het vierde hoofdstuk werd een andere methode voor de amplificatie van 
chiralieit onderzocht: attrition enhanced deracemization. Om één chiraliteit in de 
vaste fase te verkrijgen via attrition enhanced deracemization, moet een systeem aan 
twee eisen voldoen. De eerste is dat de desbetreffende verbinding een conglomeraat 
vormd, dit betekend dat beide enantiomeren apart kristalyseren als enantiomeer 
zuivere kristallen. De tweede is dat beide enantiomeren in elkaar kunnen overgaan in 
oplossing, racemisatie. Enantiomorfe materialen zoals NaClO3 voldoen automatisch 
aan deze eisen omdat ze zodra ze oplossen, achiraal worden en daarom “racemiseren”. 
Wanneer aan beide voorwaarden is voldaan zorgt een proces genaamd Ostwald 
ripening dat grotere kristallen groeien ten koste van kleinere. Uiteindelijk leidt dit 
tot een groot kristal. Omdat de kristallen van conglomeraten enantiomeer zuiver 
zijn, leidt dit tot homochiraliteit in de vaste fase. Een pyrrolidine, waarvan bekend 
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is dat het een conglomeraat is, werd gebruikt als start materiaal. Er zijn echter geen 
geschikte condities gevonden waaronder racemisatie plaats vind. Hierdoor kon niet 
worden voldaan aan de tweede vorowaarde.
In het vijfde hoofdstuk werd nog een andere methode uitgeprobeerd om 
homochiraliteit te bereiken. Deze methode is gebaseerd op  het verschil in 
oplosbaarheid tussen een racemische verbinding en zijn zuivere enantiomeer. 
Dit is een eenvoudige, robuuste en prebiotisch realistische methode om een 
kleine chirale overmaat in de vaste fase te amplificeren met als resultaat een hoge 
enantiomere overmaat in de oplossings. In dit hoofdstuk hebben we aangetoond dat 
fosforamidieten een uitzonderlijk grote verschil in oplosbaarheid vertonen tussen 
het racemaat en de zuivere enantiomeren, waardoor bijna enantiomeerzuivere 
verbindingen kunnen worden verkregen in de oplossing.
Hoofdstuk zes richt zich op de ontwikkeling van een nieuwe methode om chirale 
bouwstenen te produceren voor de (farmaceutische) industrie. Deze methode beslaat 
een enantioselectieve procedure voor de synthese van β-gesubstitueerde amiden 
uitgaande van de overeenkomstige α, β-onverzadigde ester. Daarnaast werden 
experimenten uitgevoerd om inzicht te krijgen in het reactiemechanisme.
De laatste twee hoofdstukken zijn gericht op de zelf-assemblage van op aminozuur 
gebaseerde zeepmoleculen. In hoofdstuk 7, word onderzocht of de liposomen 
gevormd door deze zeepmoleculen kunnen dienen als geneesmiddel afgiftesysteem. 
We hebben waargenomen dat een speciefiek zeepachtige molecuul in staat is om 
open vesicles te vormen. Het mechanisme voor de vorming van deze specifieke open 
vesicles werd onderzocht. Er werd verondersteld dat de vorming van open vesicles 
over tijd plaats vond door een verandering aan het molecuul. Hier van uitgaande, 
zou dat betekenen dat deze vesicles langzaam open gaan en op die manier langzaam 
een geneesmiddel vrijgeven. Omdat geen verandering in het molecuul kon worden 
waargenomen werd geconcludeerd dat de vorming van open vesicles eigen is aan 
het molecuul. Tevens werd ontdekt dat de vesicle breekt bij een kleine verandering in 
pH. Dit zou ook kunnen dienen als vrijgreef mechanisme van een stabieler vesicle. Een 
pH geactiveerd afgiftesysteem is extra interessant omdat bekend is dat de pH rond 
kankerweefsel anders is dan rond gezond weefsel.
In het laatste hoofdstuk, werd het aggregatiegedrag bestudeerd van een 
zeep molecuul gebaseerd op een di-aminozuur. Deze verbinding is gemakkelijk te 
verkrijgen vanuit eenvoudige uitgangsmaterialen. Het molecuul vormd verschillende 
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aggregatie toestanden, helices, vesicels of tubes afhankelijk van de pH en temperatuur. 
Deze veranderingen vinden plaats onder fysiologische gcondities (pH 6-9 en 4-40 °C), 
dit maakt het systeem interessant voor biologische toepassingen. Bovendien gaat 
de colloïdale verandering gepaard met een fysieke verandering namelijk van een 
oplossing naar een hydrogel. Dit gecombineerd met de biocompatibiliteit van deze 
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